Updated on 2024/12/21

写真a

 
MATSUMOTO Masaki
 
Organization
Academic Assembly Institute of Medicine and Dentistry IGAKU KEIRETU Professor
Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Molecular Genetics Professor
Title
Professor
External link

Degree

  • 博士(理学) ( 1998.3   福岡大学 )

Research Interests

  • システム生物学

  • バイオインフォマティクス

  • 質量分析

  • Proteomics

  • プロテオミクス

Research Areas

  • Life Science / Cell biology

Research History (researchmap)

  • Kyushu University

    2020.4 - 2023.3

      More details

  • Niigata University   Department of Omics and Systems Biology,   Professor

    2019.8

      More details

  • Kyushu University   Medical Institute of Bioregulation   Associate Professor

    2009.1 - 2020.3

      More details

  • Kyushu University   Medical Institute of Bioregulation   Assistant Professor

    2007.4 - 2008.12

      More details

  • Kyushu University   Medical Institute of Bioregulation

    2004.4 - 2007.3

      More details

  • Kyushu University   Medical Institute of Bioregulation

    2001.4 - 2004.3

      More details

  • Kyushu University   Medical Institute of Bioregulation

    1999 - 2001

      More details

  • 科学技術振興事業団 派遣職員(技術員)

    1998 - 1999

      More details

▶ display all

Research History

  • Niigata University   Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Molecular Genetics   Professor

    2019.8

Education

  • Fukuoka University   Graduate School, Division of Natural Science

    - 1998

      More details

  • Fukuoka University   理学研究科   化学

    - 1998

      More details

    Country: Japan

    researchmap

  • Fukuoka University   Faculty of Science

    - 1993

      More details

  • Fukuoka University   Faculty of Science   化学

    - 1993

      More details

    Country: Japan

    researchmap

Professional Memberships

Committee Memberships

  • 日本プロテオーム学会   理事・会長  

    2024.1 - 2025.12   

      More details

    Committee type:Academic society

    researchmap

  • Japanese Proteomics Society   General Council Member  

    2015.1 - 2020.12   

      More details

    Committee type:Academic society

    researchmap

 

Papers

  • jPOST environment accelerates the reuse and reanalysis of public proteome mass spectrometry data

    Shujiro Okuda, Akiyasu C Yoshizawa, Daiki Kobayashi, Yushi Takahashi, Yu Watanabe, Yuki Moriya, Atsushi Hatano, Tomoyo Takami, Masaki Matsumoto, Norie Araki, Tsuyoshi Tabata, Mio Iwasaki, Naoyuki Sugiyama, Yoshio Kodera, Satoshi Tanaka, Susumu Goto, Shin Kawano, Yasushi Ishihama

    Nucleic Acids Research   2024.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    jPOST (https://jpostdb.org/) comprises jPOSTrepo (https://repository.jpostdb.org/) (over 2000 projects), a repository for proteome mass spectrometry data, the reanalysis of raw proteome data based on a standardised protocol using UniScore, and jPOSTdb (https://globe.jpostdb.org/) (over 600 datasets), a database that integrates the reanalysed data. The jPOST reanalysis protocol rescores MS/MS spectra using a new scale, UniScore, to evaluate the extent to which the spectral peaks correspond to the amino acid sequences identified by search engines. However, the metadata registered in the repository database is insufficient for conducting the reanalysis. To address this issue, the Japanese Proteomics Society launched a data journal, the Journal of Proteome Data and Methods (JPDM), which accepts data descriptor articles detailing metadata that can be reanalysed. Within jPOST, raw proteome data is reanalysed based on the metadata described in the JPDM data descriptor articles, utilising UniScore. The reanalysed data is deposited in jPOSTdb, and a link to the JPDM articles is added to jPOSTrepo. These reanalysis accelerations within the jPOST environment will promote FAIR data principles and open science.

    DOI: 10.1093/nar/gkae1032

    researchmap

  • iMPAQT reveals that adequate mitohormesis from TFAM overexpression leads to life extension in mice. International journal

    Ko Igami, Hiroki Kittaka, Mikako Yagi, Kazuhito Gotoh, Yuichi Matsushima, Tomomi Ide, Masataka Ikeda, Saori Ueda, Shin-Ichiro Nitta, Manami Hayakawa, Keiichi I Nakayama, Masaki Matsumoto, Dongchon Kang, Takeshi Uchiumi

    Life science alliance   7 ( 7 )   2024.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mitochondrial transcription factor A, TFAM, is essential for mitochondrial function. We examined the effects of overexpressing the TFAM gene in mice. Two types of transgenic mice were created: TFAM heterozygous (TFAM Tg) and homozygous (TFAM Tg/Tg) mice. TFAM Tg/Tg mice were smaller and leaner notably with longer lifespans. In skeletal muscle, TFAM overexpression changed gene and protein expression in mitochondrial respiratory chain complexes, with down-regulation in complexes 1, 3, and 4 and up-regulation in complexes 2 and 5. The iMPAQT analysis combined with metabolomics was able to clearly separate the metabolomic features of the three types of mice, with increased degradation of fatty acids and branched-chain amino acids and decreased glycolysis in homozygotes. Consistent with these observations, comprehensive gene expression analysis revealed signs of mitochondrial stress, with elevation of genes associated with the integrated and mitochondrial stress responses, including Atf4, Fgf21, and Gdf15. These found that mitohormesis develops and metabolic shifts in skeletal muscle occur as an adaptive strategy.

    DOI: 10.26508/lsa.202302498

    PubMed

    researchmap

  • Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity

    Yunfan Bai, Keigo Morita, Toshiya Kokaji, Atsushi Hatano, Satoshi Ohno, Riku Egami, Yifei Pan, Dongzi Li, Katsuyuki Yugi, Saori Uematsu, Hiroshi Inoue, Yuka Inaba, Yutaka Suzuki, Masaki Matsumoto, Masatomo Takahashi, Yoshihiro Izumi, Takeshi Bamba, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda

    iScience   27 ( 3 )   109121 - 109121   2024.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.isci.2024.109121

    researchmap

  • PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer. International journal

    Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi, Kiyotaka Oshikawa, Noriyo Hayakawa, Mai Itoh, Chiyoko Nishime, Masami Suzuki, Aiko Nagayama, Yuko Kawai, Takako Hishiki, Tomomi Matsuura, Yoshiko Naito, Akiko Kubo, Arisa Yamamoto, Yujiro Yoshioka, Tomokazu Kurahori, Misa Nagasaka, Minako Takizawa, Naoharu Takano, Koji Kawakami, Michiie Sakamoto, Masatoshi Wakui, Takushi Yamamoto, Yuko Kitagawa, Yasuaki Kabe, Kenichi Horisawa, Atsushi Suzuki, Masaki Matsumoto, Makoto Suematsu

    Cancer research   2024.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Triple-negative breast cancer (TNBC) chemoresistance hampers the ability to effectively treat patients. Identification of mechanisms driving chemoresistance can lead to strategies to improve treatment. Here, we revealed that protein arginine methyltransferase-1 (PRMT1) simultaneously methylates D-3-phosphoglycerate dehydrogenase (PHGDH), a critical enzyme in serine synthesis, and the glycolytic enzymes PFKFB3 and PKM2 in TNBC cells. 13C metabolic flux analyses showed that PRMT1 methylation of these three enzymes diverts glucose toward intermediates in the serine-synthesizing and serine/glycine cleavage pathways, thereby accelerating the production of methyl donors in TNBC cells. Mechanistically, PRMT1-dependent methylation of PHGDH at R54 or R20 activated its enzymatic activity by stabilizing 3-phosphoglycerate binding and suppressing polyubiquitination. PRMT1-mediated PHGDH methylation drove chemoresistance independently of glutathione synthesis. Rather, activation of the serine synthesis pathway supplied α-ketoglutarate and citrate to increase palmitate levels through activation of fatty acid synthase (FASN). Increased palmitate induced protein S-palmitoylation of PHGDH and FASN to further enhance fatty acid synthesis in a PRMT1-dependent manner. Loss of PRMT1 or pharmacological inhibition of FASN or protein S-palmitoyltransferase reversed chemoresistance in TNBC. Furthermore, immunohistochemistry coupled with imaging mass spectrometry in clinical TNBC specimens substantiated that PRMT1-mediated methylation of PHGDH, PFKFB3, and PKM2 correlates with chemoresistance and that metabolites required for methylation and fatty acid synthesis are enriched in TNBC. Together, these results suggest that enhanced de novo fatty acid synthesis mediated by coordinated protein arginine methylation and protein S-palmitoylation is a therapeutic target for overcoming chemoresistance in TNBC.

    DOI: 10.1158/0008-5472.CAN-23-2266

    PubMed

    researchmap

  • Extracellular disposal of nuclear waste by APP: a protective mechanism impaired in Alzheimer’s disease

    Godfried Dougnon, Takayoshi Otsuka, Yuka Nakamura, Akiko Sakai, Tomoyuki Yamanaka, Noriko Matsui, Asa Nakahara, Ai Ito, Atsushi Hatano, Masaki Matsumoto, Hironaka Igarashi, Akiyoshi Kakita, Masaki Ueno, Hideaki Matsui

    2024.2

     More details

    Publisher:Cold Spring Harbor Laboratory  

    Abstract

    Although the amyloid beta (Aβ) hypothesis<sup>1</sup>has long been central to Alzheimer’s disease (AD) research, effective therapeutic strategies remain elusive<sup>2,3</sup>. Here we re-evaluate the functions of amyloid precursor protein (APP) and reveal its critical function in protecting against nuclear impairment-induced cell death and inflammation<sup>4,5</sup>. Overexpression of APP mitigated etoposide or lamin A knockdown-induced nuclear damage, while APP removal or mutations exacerbated these effects. Interestingly, neurons differentiated from induced pluripotent stem cells (iPSCs) exhibited similar patterns, and notably, familial AD-associated mutant APP failed to confer protection against nuclear impairment. We identify APP’s interaction with a cytoplasmic structure of nuclear origin, termed “nuclear waste”, and propose its role in extracellular waste disposal. Intriguingly, cells lacking APP showed impaired nuclear waste clearance, leading to abnormal cytoplasmic accumulation of the nuclear waste. Similarly, neuron-specific APP overexpression using adeno-associated virus (AAV) in mice reduced neuronal death and inflammation caused by nuclear damage. Conversely, shRNA-mediated APP exacerbated these effects, and mutant APP associated with familial AD lacked protective effects. Moreover, postmortem analysis of AD brains revealed accumulation of abnormal nuclear waste in the neurocytoplasm, irregular nuclear morphology, and reduced APP levels per neuron. Our data underscore APP’s crucial role in disposing of nuclear waste, maintaining cellular homeostasis, and suggest its dysregulation as a potential contributor to AD pathogenesis. Restoring APP waste clearance in AD could be a promising target for disease-modifying therapies.

    DOI: 10.1101/2024.02.10.579739

    researchmap

  • Multiomics analysis of cultured mouse periodontal ligament cell-derived extracellular matrix. International journal

    Masaru Kaku, Lay Thant, Azusa Dobashi, Yoshiki Ono, Megumi Kitami, Masaru Mizukoshi, Moe Arai, Hajime Iwama, Kohei Kitami, Yoshito Kakihara, Masaki Matsumoto, Isao Saito, Katsumi Uoshima

    Scientific reports   14 ( 1 )   354 - 354   2024.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A comprehensive understanding of the extracellular matrix (ECM) is essential for developing biomimetic ECM scaffolds for tissue regeneration. As the periodontal ligament cell (PDLC)-derived ECM has shown potential for periodontal tissue regeneration, it is vital to gain a deeper understanding of its comprehensive profile. Although the PDLC-derived ECM exhibits extracellular environment similar to that of periodontal ligament (PDL) tissue, details of its molecular composition are lacking. Thus, using a multiomics approach, we systematically analyzed cultured mouse PDLC-derived ECM and compared it to mouse PDL tissue as a reference. Proteomic analysis revealed that, compared to PDL tissue, the cultured PDLC-derived ECM had a lower proportion of fibrillar collagens with increased levels of glycoprotein, corresponding to an immature ECM status. The gene expression signature was maintained in cultured PDLCs and was similar to that in cells from PDL tissues, with additional characteristics representative of naturally occurring progenitor cells. A combination of proteomic and transcriptomic analyses revealed that the cultured mouse PDLC-derived ECM has multiple advantages in tissue regeneration, providing an extracellular environment that closely mimics the environment in the native PDL tissue. These findings provide valuable insights for understanding PDLC-derived ECM and should contribute to the development of biomimetic ECM scaffolds for reliable periodontal tissue regeneration.

    DOI: 10.1038/s41598-023-51054-8

    PubMed

    researchmap

  • Effect of Sparc knockout on the extracellular matrix of mouse periodontal ligament cells

    Moe Arai, Masaru Kaku, Lay Thant, Megumi Kitami, Yoshiki Ono, Azusa Dobashi, Hajime Iwama, Masaru Mizukoshi, Kohei Kitami, Masaki Matsumoto, Isao Saito, Katsumi Uoshima

    Biochemical and Biophysical Research Communications   692   149364 - 149364   2024.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2023.149364

    researchmap

  • DNA hypomethylation characterizes genes encoding tissue-dominant functional proteins in liver and skeletal muscle Reviewed

    Hideki Maehara, Toshiya Kokaji, Atsushi Hatano, Yutaka Suzuki, Masaki Matsumoto, Keiichi I. Nakayama, Riku Egami, Takaho Tsuchiya, Haruka Ozaki, Keigo Morita, Masaki Shirai, Dongzi Li, Akira Terakawa, Saori Uematsu, Ken-ichi Hironaka, Satoshi Ohno, Hiroyuki Kubota, Hiromitsu Araki, Fumihito Miura, Takashi Ito, Shinya Kuroda

    Scientific Reports   13 ( 1 )   2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Each tissue has a dominant set of functional proteins required to mediate tissue-specific functions. Epigenetic modifications, transcription, and translational efficiency control tissue-dominant protein production. However, the coordination of these regulatory mechanisms to achieve such tissue-specific protein production remains unclear. Here, we analyzed the DNA methylome, transcriptome, and proteome in mouse liver and skeletal muscle. We found that DNA hypomethylation at promoter regions is globally associated with liver-dominant or skeletal muscle-dominant functional protein production within each tissue, as well as with genes encoding proteins involved in ubiquitous functions in both tissues. Thus, genes encoding liver-dominant proteins, such as those involved in glycolysis or gluconeogenesis, the urea cycle, complement and coagulation systems, enzymes of tryptophan metabolism, and cytochrome P450-related metabolism, were hypomethylated in the liver, whereas those encoding-skeletal muscle-dominant proteins, such as those involved in sarcomere organization, were hypomethylated in the skeletal muscle. Thus, DNA hypomethylation characterizes genes encoding tissue-dominant functional proteins.

    DOI: 10.1038/s41598-023-46393-5

    researchmap

    Other Link: https://www.nature.com/articles/s41598-023-46393-5

  • A stepwise and digital pattern of RSK phosphorylation determines the outcome of thymic selection Reviewed

    Shintaro Funasaki, Atsushi Hatano, Hirokazu Nakatsumi, Daisuke Koga, Osamu Sugahara, Kanae Yumimoto, Masaya Baba, Masaki Matsumoto, Keiichi I. Nakayama

    iScience   26 ( 9 )   107552 - 107552   2023.9

     More details

    Authorship:Corresponding author   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.isci.2023.107552

    researchmap

  • The ASC‐1 complex promotes translation initiation by scanning ribosomes Reviewed

    Yuki Kito, Akinobu Matsumoto, Kazuya Ichihara, Chisa Shiraishi, Ronghao Tang, Atsushi Hatano, Masaki Matsumoto, Peixun Han, Shintaro Iwasaki, Keiichi I Nakayama

    The EMBO Journal   2023.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:EMBO  

    DOI: 10.15252/embj.2022112869

    researchmap

  • RPL3L-containing ribosomes determine translation elongation dynamics required for cardiac function. Reviewed International journal

    Chisa Shiraishi, Akinobu Matsumoto, Kazuya Ichihara, Taishi Yamamoto, Takeshi Yokoyama, Taisuke Mizoo, Atsushi Hatano, Masaki Matsumoto, Yoshikazu Tanaka, Eriko Matsuura-Suzuki, Shintaro Iwasaki, Shouji Matsushima, Hiroyuki Tsutsui, Keiichi I Nakayama

    Nature communications   14 ( 1 )   2131 - 2131   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although several ribosomal protein paralogs are expressed in a tissue-specific manner, how these proteins affect translation and why they are required only in certain tissues have remained unclear. Here we show that RPL3L, a paralog of RPL3 specifically expressed in heart and skeletal muscle, influences translation elongation dynamics. Deficiency of RPL3L-containing ribosomes in RPL3L knockout male mice resulted in impaired cardiac contractility. Ribosome occupancy at mRNA codons was found to be altered in the RPL3L-deficient heart, and the changes were negatively correlated with those observed in myoblasts overexpressing RPL3L. RPL3L-containing ribosomes were less prone to collisions compared with RPL3-containing canonical ribosomes. Although the loss of RPL3L-containing ribosomes altered translation elongation dynamics for the entire transcriptome, its effects were most pronounced for transcripts related to cardiac muscle contraction and dilated cardiomyopathy, with the abundance of the encoded proteins being correspondingly decreased. Our results provide further insight into the mechanisms and physiological relevance of tissue-specific translational regulation.

    DOI: 10.1038/s41467-023-37838-6

    PubMed

    researchmap

  • In situ digestion of alcohol-fixed cells for quantitative proteomics. Reviewed International journal

    Atsushi Hatano, Tomoyo Takami, Masaki Matsumoto

    Journal of biochemistry   173 ( 4 )   243 - 254   2023.3

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Currently, the bottom-up approach, in which proteins are digested by enzymes such as trypsin prior to mass spectrometry, is the mainstream approach in mass spectrometer-based proteomics. In this approach, the enzymatic digestion process strongly affects the reproducibility of protein identification and quantification. Here, we quantitatively evaluated the enzymatic digestion of proteins under various conditions by quantitative proteomics using data-independent acquisition and found that proteins precipitated with acetone after solubilization with SDS were fully digestible without re-solubilization. This result implies that organic solvent treatment makes cells amenable to trypsin digestion. Direct trypsin digestion of methanol-fixed cells achieved the same digestion efficiency and quantitative reproducibility as the conventional method. Furthermore, this method was found to be equally applicable to mouse liver samples. The establishment of this method indicates that the sample preparation process in bottom-up proteomics can be simplified while maintaining high digestion efficiency and is expected to become a general method for sample preparation in bottom-up proteomics in the future.

    DOI: 10.1093/jb/mvac101

    PubMed

    researchmap

  • Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1. Reviewed International journal

    Reona Wada, Shun Fujinuma, Hirokazu Nakatsumi, Masaki Matsumoto, Keiichi I Nakayama

    Journal of biochemistry   173 ( 2 )   129 - 138   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mechanistic target of rapamycin complex 1 (mTORC1) is a serine-threonine kinase that is activated by extracellular signals, such as nutrients and growth factors. It plays a key role in the control of various biological processes, such as protein synthesis and energy metabolism by mediating or regulating the phosphorylation of multiple target molecules, some of which remain to be identified. We have here reanalysed a large-scale phosphoproteomics data set for mTORC1 target molecules and identified pre-B cell leukemia transcription factor 2 (PBX2) as such a novel target that is dephosphorylated downstream of mTORC1. We confirmed that PBX2, but not other members of the PBX family, is dephosphorylated in an mTORC1 activity-dependent manner. Furthermore, pharmacological and gene knockdown experiments revealed that glycogen synthase kinase 3 (GSK3) and protein phosphatase 1 (PP1) are responsible for the phosphorylation and dephosphorylation of PBX2, respectively. Our results thus suggest that the balance between the antagonistic actions of GSK3 and PP1 determines the phosphorylation status of PBX2 and its regulation by mTORC1.

    DOI: 10.1093/jb/mvac094

    PubMed

    researchmap

  • HSF1 phosphorylation establishes an active chromatin state via the TRRAP–TIP60 complex and promotes tumorigenesis Reviewed

    Mitsuaki Fujimoto, Ryosuke Takii, Masaki Matsumoto, Mariko Okada, Keiich I. Nakayama, Ryuichiro Nakato, Katsunori Fujiki, Katsuhiko Shirahige, Akira Nakai

    Nature Communications   13 ( 1 )   2022.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Transcriptional regulation by RNA polymerase II is associated with changes in chromatin structure. Activated and promoter-bound heat shock transcription factor 1 (HSF1) recruits transcriptional co-activators, including histone-modifying enzymes; however, the mechanisms underlying chromatin opening remain unclear. Here, we demonstrate that HSF1 recruits the TRRAP-TIP60 acetyltransferase complex in HSP72 promoter during heat shock in a manner dependent on phosphorylation of HSF1-S419. TRIM33, a bromodomain-containing ubiquitin ligase, is then recruited to the promoter by interactions with HSF1 and a TIP60-mediated acetylation mark, and cooperates with the related factor TRIM24 for mono-ubiquitination of histone H2B on K120. These changes in histone modifications are triggered by phosphorylation of HSF1-S419 via PLK1, and stabilize the HSF1-transcription complex in HSP72 promoter. Furthermore, HSF1-S419 phosphorylation is constitutively enhanced in and promotes proliferation of melanoma cells. Our results provide mechanisms for HSF1 phosphorylation-dependent establishment of an active chromatin status, which is important for tumorigenesis.

    DOI: 10.1038/s41467-022-32034-4

    researchmap

    Other Link: https://www.nature.com/articles/s41467-022-32034-4

  • LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19 Reviewed International journal

    Hideyuki Shimizu, Manabu Kodama, Masaki Matsumoto, Yasuko Orba, Michihito Sasaki, Akihiko Sato, Hirofumi Sawa, Keiichi I. Nakayama

    iScience   25 ( 11 )   105314 - 105314   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Cold Spring Harbor Laboratory  

    <title>SUMMARY</title>Although numerous promising therapeutic targets for human diseases have been discovered, most have not been successfully translated into clinical practice<sup>1</sup>. A bottleneck in the application of basic research findings to patients is the enormous cost, time, and effort required for high-throughput screening of potential drugs<sup>2</sup> for given therapeutic targets. Recent advances in 3D docking simulations have not solved this problem, given that 3D protein structures with sufficient resolution are not always available and that they are computationally expensive to obtain. Here we have developed LIGHTHOUSE, a graph-based deep learning approach for discovery of the hidden principles underlying the association of small-molecule compounds with target proteins, and we present its validation by identifying potential therapeutic compounds for various human diseases. Without any 3D structural information for proteins or chemicals, LIGHTHOUSE estimates protein-compound scores that incorporate known evolutionary relations and available experimental data. It identified novel therapeutics for cancer, lifestyle-related disease, and bacterial infection. Moreover, LIGHTHOUSE predicted ethoxzolamide as a therapeutic for coronavirus disease 2019 (COVID-19), and this agent was indeed effective against alpha, beta, gamma, and delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are rampant worldwide. Given that ethoxzolamide is already approved for several diseases, it could be rapidly deployed for the treatment of patients with COVID-19. We envision that LIGHTHOUSE will bring about a paradigm shift in translational medicine, providing a bridge from bench side to bedside.

    DOI: 10.1101/2021.09.25.461785

    PubMed

    researchmap

  • Multi-omics-based label-free metabolic flux inference reveals obesity-associated dysregulatory mechanisms in liver glucose metabolism. Reviewed International journal

    Saori Uematsu, Satoshi Ohno, Kaori Y Tanaka, Atsushi Hatano, Toshiya Kokaji, Yuki Ito, Hiroyuki Kubota, Ken-Ichi Hironaka, Yutaka Suzuki, Masaki Matsumoto, Keiichi I Nakayama, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda

    iScience   25 ( 2 )   103787 - 103787   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Glucose homeostasis is maintained by modulation of metabolic flux. Enzymes and metabolites regulate the involved metabolic pathways. Dysregulation of glucose homeostasis is a pathological event in obesity. Analyzing metabolic pathways and the mechanisms contributing to obesity-associated dysregulation in vivo is challenging. Here, we introduce OMELET: Omics-Based Metabolic Flux Estimation without Labeling for Extended Trans-omic Analysis. OMELET uses metabolomic, proteomic, and transcriptomic data to identify relative changes in metabolic flux, and to calculate contributions of metabolites, enzymes, and transcripts to the changes in metabolic flux. By evaluating the livers of fasting ob/ob mice, we found that increased metabolic flux through gluconeogenesis resulted primarily from increased transcripts, whereas that through the pyruvate cycle resulted from both increased transcripts and changes in substrates of metabolic enzymes. With OMELET, we identified mechanisms underlying the obesity-associated dysregulation of metabolic flux in the liver.

    DOI: 10.1016/j.isci.2022.103787

    PubMed

    researchmap

  • Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. Reviewed International journal

    Taisuke Kato, Ri-Ichiroh Manabe, Hironaka Igarashi, Fuyuki Kametani, Sachiko Hirokawa, Yumi Sekine, Natsumi Fujita, Satoshi Saito, Yusuke Kawashima, Yuya Hatano, Shoichiro Ando, Hiroaki Nozaki, Akihiro Sugai, Masahiro Uemura, Masaki Fukunaga, Toshiya Sato, Akihide Koyama, Rie Saito, Atsushi Sugie, Yasuko Toyoshima, Hirotoshi Kawata, Shigeo Murayama, Masaki Matsumoto, Akiyoshi Kakita, Masato Hasegawa, Masafumi Ihara, Masato Kanazawa, Masatoyo Nishizawa, Shoji Tsuji, Osamu Onodera

    The Journal of clinical investigation   131 ( 22 )   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cerebral small vessel disease (CSVD) causes dementia and gait disturbance due to arteriopathy. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a hereditary form of CSVD caused by loss of high-temperature requirement A1 (HTRA1) serine protease activity. In CARASIL, arteriopathy causes intimal thickening, smooth muscle cell (SMC) degeneration, elastic lamina splitting, and vasodilation. The molecular mechanisms were proposed to involve the accumulation of matrisome proteins as substrates or abnormalities in transforming growth factor β (TGF-β) signaling. Here, we show that HTRA1-/- mice exhibited features of CARASIL-associated arteriopathy: intimal thickening, abnormal elastic lamina, and vasodilation. In addition, the mice exhibited reduced distensibility of the cerebral arteries and blood flow in the cerebral cortex. In the thickened intima, matrisome proteins, including the hub protein fibronectin (FN) and latent TGF-β binding protein 4 (LTBP-4), which are substrates of HTRA1, accumulated. Candesartan treatment alleviated matrisome protein accumulation and normalized the vascular distensibility and cerebral blood flow. Furthermore, candesartan reduced the mRNA expression of Fn1, Ltbp-4, and Adamtsl2, which are involved in forming the extracellular matrix network. Our results indicate that these accumulated matrisome proteins may be potential therapeutic targets for arteriopathy in CARASIL.

    DOI: 10.1172/JCI140555

    PubMed

    researchmap

  • An extensive and dynamic trans-omic network illustrating prominent regulatory mechanisms in response to insulin in the liver. Reviewed International journal

    Fumiko Matsuzaki, Shinsuke Uda, Yukiyo Yamauchi, Masaki Matsumoto, Tomoyoshi Soga, Kazumitsu Maehara, Yasuyuki Ohkawa, Keiichi I Nakayama, Shinya Kuroda, Hiroyuki Kubota

    Cell reports   36 ( 8 )   109569 - 109569   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    An effective combination of multi-omic datasets can enhance our understanding of complex biological phenomena. To build a context-dependent network with multiple omic layers, i.e., a trans-omic network, we perform phosphoproteomics, transcriptomics, proteomics, and metabolomics of murine liver for 4 h after insulin administration and integrate the resulting time series. Structural characteristics and dynamic nature of the network are analyzed to elucidate the impact of insulin. Early and prominent changes in protein phosphorylation and persistent and asynchronous changes in mRNA and protein levels through non-transcriptional mechanisms indicate enhanced crosstalk between phosphorylation-mediated signaling and protein expression regulation. Metabolic response shows different temporal regulation with transient increases at early time points across categories and enhanced response in the amino acid and nucleotide categories at later time points as a result of process convergence. This extensive and dynamic view of the trans-omic network elucidates prominent regulatory mechanisms that drive insulin responses through intricate interlayer coordination.

    DOI: 10.1016/j.celrep.2021.109569

    PubMed

    researchmap

  • A ubiquitin-like protein encoded by the "noncoding" RNA TINCR promotes keratinocyte proliferation and wound healing. Reviewed International journal

    Akihiro Nita, Akinobu Matsumoto, Ronghao Tang, Chisa Shiraishi, Kazuya Ichihara, Daisuke Saito, Mikita Suyama, Tomoharu Yasuda, Gaku Tsuji, Masutaka Furue, Bumpei Katayama, Toshiyuki Ozawa, Teruasa Murata, Teruki Dainichi, Kenji Kabashima, Atsushi Hatano, Masaki Matsumoto, Keiichi I Nakayama

    PLoS genetics   17 ( 8 )   e1009686   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although long noncoding RNAs (lncRNAs) are transcripts that do not encode proteins by definition, some lncRNAs actually contain small open reading frames that are translated. TINCR (terminal differentiation-induced ncRNA) has been recognized as a lncRNA that contributes to keratinocyte differentiation. However, we here show that TINCR encodes a ubiquitin-like protein that is well conserved among species and whose expression was confirmed by the generation of mice harboring a FLAG epitope tag sequence in the endogenous open reading frame as well as by targeted proteomics. Forced expression of this protein promoted cell cycle progression in normal human epidermal keratinocytes, and mice lacking this protein manifested a delay in skin wound healing associated with attenuated cell cycle progression in keratinocytes. We termed this protein TINCR-encoded ubiquitin-like protein (TUBL), and our results reveal a role for TINCR in the regulation of keratinocyte proliferation and skin regeneration that is dependent on TUBL.

    DOI: 10.1371/journal.pgen.1009686

    PubMed

    researchmap

  • The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro. Reviewed International journal

    Takenobu Nii, Katsuhiro Konno, Masaki Matsumoto, Kanit Bhukhai, Suparerk Borwornpinyo, Kazuhiro Sakai, Suradej Hongeng, Daisuke Sugiyama

    Molecules (Basel, Switzerland)   26 ( 7 )   2021.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Hematopoietic stem and progenitor cell (HSPC) transplantation is a curative treatment of hematological disorders that has been utilized for several decades. Although umbilical cord blood (UCB) is a promising source of HSPCs, the low dose of HSPCs in these preparations limits their use, prompting need for ex vivo HSPC expansion. To establish a more efficient method to expand UCB HSPCs, we developed the bioactive peptide named SL-13R and cultured UCB HSPCs (CD34+ cells) with SL-13R in animal component-free medium containing a cytokine cocktail. Following 9 days of culture with SL-13R, the numbers of total cells, CD34+, CD38- cells, and hematopoietic stem cell (HSC)-enriched cells were significantly increased relative to control. Transplantation of cells cultured with SL-13R into immunodeficient NOD/Shi-scid/IL-2Rγ knockout mice confirmed that they possess long-term reconstitution and self-renewal ability. AHNAK, ANXA2, and PLEC all interact with SL-13R. Knockdown of these genes in UCB CD34+ cells resulted in reduced numbers of hematopoietic colonies relative to SL-13R-treated and non-knockdown controls. In summary, we have identified a novel bioactive peptide SL-13R promoting expansion of UCB CD34+ cells with long-term reconstitution and self-renewal ability, suggesting its clinical use in the future.

    DOI: 10.3390/molecules26071995

    PubMed

    researchmap

  • Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle. Reviewed International journal

    Riku Egami, Toshiya Kokaji, Atsushi Hatano, Katsuyuki Yugi, Miki Eto, Keigo Morita, Satoshi Ohno, Masashi Fujii, Ken-Ichi Hironaka, Saori Uematsu, Akira Terakawa, Yunfan Bai, Yifei Pan, Takaho Tsuchiya, Haruka Ozaki, Hiroshi Inoue, Shinsuke Uda, Hiroyuki Kubota, Yutaka Suzuki, Masaki Matsumoto, Keiichi I Nakayama, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda

    iScience   24 ( 3 )   102217 - 102217   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Systemic metabolic homeostasis is regulated by inter-organ metabolic cycles involving multiple organs. Obesity impairs inter-organ metabolic cycles, resulting in metabolic diseases. The systemic landscape of dysregulated inter-organ metabolic cycles in obesity has yet to be explored. Here, we measured the transcriptome, proteome, and metabolome in the liver and skeletal muscle and the metabolome in blood of fasted wild-type and leptin-deficient obese (ob/ob) mice, identifying components with differential abundance and differential regulation in ob/ob mice. By constructing and evaluating the trans-omic network controlling the differences in metabolic reactions between fasted wild-type and ob/ob mice, we provided potential mechanisms of the obesity-associated dysfunctions of metabolic cycles between liver and skeletal muscle involving glucose-alanine, glucose-lactate, and ketone bodies. Our study revealed obesity-associated systemic pathological mechanisms of dysfunction of inter-organ metabolic cycles.

    DOI: 10.1016/j.isci.2021.102217

    PubMed

    researchmap

  • Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Reviewed International journal

    Yoshikazu Johmura, Takehiro Yamanaka, Satotaka Omori, Teh-Wei Wang, Yuki Sugiura, Masaki Matsumoto, Narumi Suzuki, Soichiro Kumamoto, Kiyoshi Yamaguchi, Seira Hatakeyama, Tomoyo Takami, Rui Yamaguchi, Eigo Shimizu, Kazutaka Ikeda, Nobuyuki Okahashi, Ryuta Mikawa, Makoto Suematsu, Makoto Arita, Masataka Sugimoto, Keiichi I Nakayama, Yoichi Furukawa, Seiya Imoto, Makoto Nakanishi

    Science (New York, N.Y.)   371 ( 6526 )   265 - 270   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Removal of senescent cells (senolysis) has been proposed to be beneficial for improving age-associated pathologies, but the molecular pathways for such senolytic activity have not yet emerged. Here, we identified glutaminase 1 (GLS1) as an essential gene for the survival of human senescent cells. The intracellular pH in senescent cells was lowered by lysosomal membrane damage, and this lowered pH induced kidney-type glutaminase (KGA) expression. The resulting enhanced glutaminolysis induced ammonia production, which neutralized the lower pH and improved survival of the senescent cells. Inhibition of KGA-dependent glutaminolysis in aged mice eliminated senescent cells specifically and ameliorated age-associated organ dysfunction. Our results suggest that senescent cells rely on glutaminolysis, and its inhibition offers a promising strategy for inducing senolysis in vivo.

    DOI: 10.1126/science.abb5916

    PubMed

    researchmap

  • Transomics analysis reveals allosteric and gene regulation axes for altered hepatic glucose-responsive metabolism in obesity. Reviewed International journal

    Toshiya Kokaji, Atsushi Hatano, Yuki Ito, Katsuyuki Yugi, Miki Eto, Keigo Morita, Satoshi Ohno, Masashi Fujii, Ken-Ichi Hironaka, Riku Egami, Akira Terakawa, Takaho Tsuchiya, Haruka Ozaki, Hiroshi Inoue, Shinsuke Uda, Hiroyuki Kubota, Yutaka Suzuki, Kazutaka Ikeda, Makoto Arita, Masaki Matsumoto, Keiichi I Nakayama, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda

    Science signaling   13 ( 660 )   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Impaired glucose tolerance associated with obesity causes postprandial hyperglycemia and can lead to type 2 diabetes. To study the differences in liver metabolism in healthy and obese states, we constructed and analyzed transomics glucose-responsive metabolic networks with layers for metabolites, expression data for metabolic enzyme genes, transcription factors, and insulin signaling proteins from the livers of healthy and obese mice. We integrated multiomics time course data from wild-type and leptin-deficient obese (ob/ob) mice after orally administered glucose. In wild-type mice, metabolic reactions were rapidly regulated within 10 min of oral glucose administration by glucose-responsive metabolites, which functioned as allosteric regulators and substrates of metabolic enzymes, and by Akt-induced changes in the expression of glucose-responsive genes encoding metabolic enzymes. In ob/ob mice, the majority of rapid regulation by glucose-responsive metabolites was absent. Instead, glucose administration produced slow changes in the expression of carbohydrate, lipid, and amino acid metabolic enzyme-encoding genes to alter metabolic reactions on a time scale of hours. Few regulatory events occurred in both healthy and obese mice. Thus, our transomics network analysis revealed that regulation of glucose-responsive liver metabolism is mediated through different mechanisms in healthy and obese states. Rapid changes in allosteric regulators and substrates and in gene expression dominate the healthy state, whereas slow changes in gene expression dominate the obese state.

    DOI: 10.1126/scisignal.aaz1236

    PubMed

    researchmap

  • A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis. Reviewed International journal

    Tadasuke Tsukiyama, Juqi Zou, Jihoon Kim, Shohei Ogamino, Yuki Shino, Takamasa Masuda, Alessandra Merenda, Masaki Matsumoto, Yoichiro Fujioka, Tomonori Hirose, Sayuri Terai, Hidehisa Takahashi, Tohru Ishitani, Keiichi I Nakayama, Yusuke Ohba, Bon-Kyoung Koo, Shigetsugu Hatakeyama

    Nature communications   11 ( 1 )   4586 - 4586   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Frequent mutation of the tumour suppressor RNF43 is observed in many cancers, particularly colon malignancies. RNF43, an E3 ubiquitin ligase, negatively regulates Wnt signalling by inducing degradation of the Wnt receptor Frizzled. In this study, we discover that RNF43 activity requires phosphorylation at a triplet of conserved serines. This phospho-regulation of RNF43 is required for zebrafish development and growth of mouse intestinal organoids. Cancer-associated mutations that abrogate RNF43 phosphorylation cooperate with active Ras to promote tumorigenesis by abolishing the inhibitory function of RNF43 in Wnt signalling while maintaining its inhibitory function in p53 signalling. Our data suggest that RNF43 mutations cooperate with KRAS mutations to promote multi-step tumorigenesis via the Wnt-Ras-p53 axis in human colon cancers. Lastly, phosphomimetic substitutions of the serine trio restored the tumour suppressive activity of extracellular oncogenic mutants. Therefore, harnessing phospho-regulation of RNF43 might be a potential therapeutic strategy for tumours with RNF43 mutations.

    DOI: 10.1038/s41467-020-18257-3

    PubMed

    researchmap

  • Chemical acetylation of mitochondrial transcription factor A occurs on specific lysine residues and affects its ability to change global DNA topology. Reviewed International journal

    Yuan Fang, Masaru Akimoto, Kouta Mayanagi, Atsushi Hatano, Masaki Matsumoto, Shigeru Matsuda, Takehiro Yasukawa, Dongchon Kang

    Mitochondrion   53   99 - 108   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Chemical acetylation is postulated to occur in mitochondria. Mitochondrial transcription factor A (TFAM or mtTFA), a mitochondrial transcription initiation factor as well as the major mitochondrial nucleoid protein coating the entire mitochondrial genome, is proposed to be acetylated in animals and cultured cells. This study investigated the properties of human TFAM, in conjunction with the mechanism and effects of TFAM acetylation in vitro. Using highly purified recombinant human TFAM and 3 kb circular DNA as a downsized mtDNA model, we studied how the global TFAM-DNA interaction is affected/regulated by the quantitative TFAM-DNA relationship and TFAM acetylation. Results showed that the TFAM-DNA ratio strictly affects the TFAM property to unwind circular DNA in the presence of topoisomerase I. Mass spectrometry analysis showed that in vitro chemical acetylation of TFAM with acetyl-coenzyme A occurs preferentially on specific lysine residues, including those reported to be acetylated in exogenously expressed TFAM in cultured human cells, indicating that chemical acetylation plays a crucial role in TFAM acetylation in mitochondria. Intriguingly, the modification significantly decreased TFAM's DNA-unwinding ability, while its DNA-binding ability was largely unaffected. Altogether, we propose TFAM is chemically acetylated in vivo, which could change mitochondrial DNA topology, leading to copy number and gene expression modulation.

    DOI: 10.1016/j.mito.2020.05.003

    PubMed

    researchmap

  • Novel localizations and interactions of intercellular bridge proteins revealed by proteomic profiling†. Reviewed International journal

    Tokuko Iwamori, Naoki Iwamori, Masaki Matsumoto, Hiroyuki Imai, Etsuro Ono

    Biology of reproduction   102 ( 5 )   1134 - 1144   2020.4

     More details

    Language:English  

    Intercellular bridges (ICBs) connecting germ cells are essential for spermatogenesis, and their deletion causes male infertility. However, the functions and component factors of ICBs are still unknown. We previously identified novel ICB-associated proteins by proteomics analysis using ICB enrichment. Here, we performed immunoprecipitation-proteomics analyses using antibodies specific to known ICB proteins MKLP1, RBM44, and ectoplasmic specialization-associated protein KIAA1210 and predicted protein complexes in the ICB cores. KIAA1210, its binding protein topoisomerase2B (TOP2B), and tight junction protein ZO1 were identified as novel ICB proteins. On the other hand, as well as KIAA1210 and TOP2B, MKLP1 and RBM44, but not TEX14, were localized at the XY body of spermatocytes, suggesting that there is a relationship between ICB proteins and meiotic chromosomes. Moreover, small RNAs interacted with an ICB protein complex that included KIAA1210, RBM44, and MKLP1. These results indicate dynamic movements of ICB proteins and suggest that ICB proteins could be involved not only in the communication between germ cells but also in their epigenetic regulation. Our results provide a novel perspective on the function of ICBs and could be helpful in revealing the biological function of the ICB.

    DOI: 10.1093/biolre/ioaa017

    PubMed

    researchmap

  • The Autism-Related Protein SETD5 Controls Neural Cell Proliferation through Epigenetic Regulation of rDNA Expression. Reviewed International journal

    Tadashi Nakagawa, Satoko Hattori, Risa Nobuta, Ryuichi Kimura, Makiko Nakagawa, Masaki Matsumoto, Yuko Nagasawa, Ryo Funayama, Tsuyoshi Miyakawa, Toshifumi Inada, Noriko Osumi, Keiichi I Nakayama, Keiko Nakayama

    iScience   23 ( 4 )   101030 - 101030   2020.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Haploinsufficiency of SETD5 is implicated in syndromic autism spectrum disorder (ASD), but the molecular mechanism underlying the pathological role of this protein has remained unclear. We have now shown that Setd5+/- mice manifest ASD-related behavioral phenotypes and that the expression of ribosomal protein genes and rDNA is disturbed in the brain of these mice. SETD5 recruited the HDAC3 complex to the rDNA promoter, resulting in removal of the histone mark H4K16ac and its reader protein TIP5, a repressor of rDNA expression. Depletion of SETD5 attenuated rDNA expression, translational activity, and neural cell proliferation, whereas ablation of TIP5 in SETD5-deficient cells rescued these effects. Translation of cyclin D1 mRNA was specifically down-regulated in SETD5-insufficient cells. Our results thus suggest that SETD5 positively regulates rDNA expression via an HDAC3-mediated epigenetic mechanism and that such regulation is essential for translation of cyclin D1 mRNA and neural cell proliferation.

    DOI: 10.1016/j.isci.2020.101030

    PubMed

    researchmap

  • Cell cycle-dependent localization of the proteasome to chromatin. Reviewed International journal

    Yuki Kito, Masaki Matsumoto, Atsushi Hatano, Tomoyo Takami, Kiyotaka Oshikawa, Akinobu Matsumoto, Keiichi I Nakayama

    Scientific reports   10 ( 1 )   5801 - 5801   2020.4

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    An integrative understanding of nuclear events including transcription in normal and cancer cells requires comprehensive and quantitative measurement of protein dynamics that underlie such events. However, the low abundance of most nuclear proteins hampers their detailed functional characterization. We have now comprehensively quantified the abundance of nuclear proteins with the use of proteomics approaches in both normal and transformed human diploid fibroblasts. We found that subunits of the 26S proteasome complex were markedly down-regulated in the nuclear fraction of the transformed cells compared with that of the wild-type cells. The intranuclear proteasome abundance appeared to be inversely related to the rate of cell cycle progression, with restraint of the cell cycle being associated with an increase in the amount of proteasome subunits in the nucleus, suggesting that the nuclear proteasome content is dependent on the cell cycle. Furthermore, chromatin enrichment for proteomics (ChEP) analysis revealed enrichment of the proteasome in the chromatin fraction of quiescent cells and its apparent dissociation from chromatin in transformed cells. Our results thus suggest that translocation of the nuclear proteasome to chromatin may play an important role in control of the cell cycle and oncogenesis through regulation of chromatin-associated transcription factors.

    DOI: 10.1038/s41598-020-62697-2

    PubMed

    researchmap

  • A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer. Reviewed International journal

    Manabu Kodama, Kiyotaka Oshikawa, Hideyuki Shimizu, Susumu Yoshioka, Masatomo Takahashi, Yoshihiro Izumi, Takeshi Bamba, Chisa Tateishi, Takeshi Tomonaga, Masaki Matsumoto, Keiichi I Nakayama

    Nature communications   11 ( 1 )   1320 - 1320   2020.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Glucose metabolism is remodeled in cancer, but the global pattern of cancer-specific metabolic changes remains unclear. Here we show, using the comprehensive measurement of metabolic enzymes by large-scale targeted proteomics, that the metabolism both carbon and nitrogen is altered during the malignant progression of cancer. The fate of glutamine nitrogen is shifted from the anaplerotic pathway into the TCA cycle to nucleotide biosynthesis, with this shift being controlled by glutaminase (GLS1) and phosphoribosyl pyrophosphate amidotransferase (PPAT). Interventions to reduce the PPAT/GLS1 ratio suppresses tumor growth of many types of cancer. A meta-analysis reveals that PPAT shows the strongest correlation with malignancy among all metabolic enzymes, in particular in neuroendocrine cancer including small cell lung cancer (SCLC). PPAT depletion suppresses the growth of SCLC lines. A shift in glutamine fate may thus be required for malignant progression of cancer, with modulation of nitrogen metabolism being a potential approach to SCLC treatment.

    DOI: 10.1038/s41467-020-15136-9

    PubMed

    researchmap

  • Tyrosine pre-transfer RNA fragments are linked to p53-dependent neuronal cell death via PKM2. Reviewed International journal

    Masanori Inoue, Kazumasa Hada, Hiroshi Shiraishi, Hiroyuki Yatsuka, Hiroyuki Fujinami, Ikuko Morisaki, Yoshihiro Nishida, Etsuro Matsubara, Tohru Ishitani, Reiko Hanada, Masaki Matsumoto, Josef M Penninger, Kenji Ihara, Toshikatsu Hanada

    Biochemical and biophysical research communications   525 ( 3 )   726 - 732   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Fragments of transfer RNA (tRNA), derived either from pre-tRNA or mature tRNA, have been discovered to play an essential role in the pathogenesis of various disorders such as neurodegenerative disease. CLP1 is an RNA kinase involved in tRNA biogenesis, and mutations in its encoding gene are responsible for pontocerebellar hypoplasia type-10. Mutation of the CLP1 gene results in the accumulation of tRNA fragments of several different kinds. These tRNA fragments are expected to be associated with the disease pathogenesis. However, it is still unclear which of the tRNA fragments arising from the CLP1 gene mutation has the greatest impact on the onset of neuronal disease. We found that 5' tRNA fragments derived from tyrosine pre-tRNA (5' Tyr-tRF) caused p53-dependent neuronal cell death predominantly more than other types of tRNA fragment. We also showed that 5' Tyr-tRF bound directly to pyruvate kinase M2 (PKM2). Injection of zebrafish embryos with PKM2 mRNA ameliorated the neuronal defects induced in zebrafish embryos by 5' Tyr-tRF. Our findings partially uncovered a mechanistic link between 5' Tyr-tRF and neuronal cell death that is regulated by PKM2.

    DOI: 10.1016/j.bbrc.2020.02.157

    PubMed

    researchmap

  • The role of Mediator and Little Elongation Complex in transcription termination. Reviewed International journal

    Hidehisa Takahashi, Amol Ranjan, Shiyuan Chen, Hidefumi Suzuki, Mio Shibata, Tomonori Hirose, Hiroko Hirose, Kazunori Sasaki, Ryota Abe, Kai Chen, Yanfeng He, Ying Zhang, Ichigaku Takigawa, Tadasuke Tsukiyama, Masashi Watanabe, Satoshi Fujii, Midori Iida, Junichi Yamamoto, Yuki Yamaguchi, Yutaka Suzuki, Masaki Matsumoto, Keiichi I Nakayama, Michael P Washburn, Anita Saraf, Laurence Florens, Shigeo Sato, Chieri Tomomori-Sato, Ronald C Conaway, Joan W Conaway, Shigetsugu Hatakeyama

    Nature communications   11 ( 1 )   1063 - 1063   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mediator is a coregulatory complex that regulates transcription of Pol II-dependent genes. Previously, we showed that human Mediator subunit MED26 plays a role in the recruitment of Super Elongation Complex (SEC) or Little Elongation Complex (LEC) to regulate the expression of certain genes. MED26 plays a role in recruiting SEC to protein-coding genes including c-myc and LEC to small nuclear RNA (snRNA) genes. However, how MED26 engages SEC or LEC to regulate distinct genes is unclear. Here, we provide evidence that MED26 recruits LEC to modulate transcription termination of non-polyadenylated transcripts including snRNAs and mRNAs encoding replication-dependent histone (RDH) at Cajal bodies. Our findings indicate that LEC recruited by MED26 promotes efficient transcription termination by Pol II through interaction with CBC-ARS2 and NELF/DSIF, and promotes 3' end processing by enhancing recruitment of Integrator or Heat Labile Factor to snRNA or RDH genes, respectively.

    DOI: 10.1038/s41467-020-14849-1

    PubMed

    researchmap

  • In-Line Sample Processing System with an Immobilized Trypsin-Packed Fused-Silica Capillary Tube for the Proteomic Analysis of a Small Number of Mammalian Cells. Reviewed International journal

    Kosuke Hata, Yoshihiro Izumi, Takeshi Hara, Masaki Matsumoto, Takeshi Bamba

    Analytical chemistry   92 ( 4 )   2997 - 3005   2020.2

     More details

    Authorship:Corresponding author   Language:English  

    Omics analysis at single-cell resolution has helped to demonstrate the shaping of cellular heterogeneity on the basis of the expression of various molecules. However, in-depth proteomic analysis of low-quantity samples has remained challenging because of difficulties associated with the measurement of large numbers of proteins by shotgun proteomics using nanoflow liquid chromatography tandem mass spectrometry (nano-LC/MS/MS). To meet such a demand, we developed a method called in-line sample preparation for efficient cellular proteomics (ISPEC) in which cells were captured, directly lysed, and digested with immobilized trypsin within fused-silica capillaries. ISPEC minimized sample loss during the sample preparation processes with a relatively small number of mammalian cells (<1000 cells) and improved the stability and efficiency of digestion by immobilized trypsin, compared to a conventional preparation method. Using our optimized ISPEC method with nano-LC/MS/MS analysis, we identified 1351, 351, and 60 proteins from 100 cells, 10 cells, and single cells, respectively. The linear response of the signal intensity of each peptide to the introduced cell number indicates the quantitative recovery of the proteome from a very small number of cells. Thus, our ISPEC strategy facilitates quantitative proteomic analysis of small cell populations.

    DOI: 10.1021/acs.analchem.9b03993

    PubMed

    researchmap

  • Production of BBF2H7-derived small peptide fragments via endoplasmic reticulum stress-dependent regulated intramembrane proteolysis. Reviewed International journal

    Koji Matsuhisa, Atsushi Saito, Longjie Cai, Masayuki Kaneko, Takumi Okamoto, Fumika Sakaue, Rie Asada, Fumihiko Urano, Kanta Yanagida, Masayasu Okochi, Yukitsuka Kudo, Masaki Matsumoto, Keiichi I Nakayama, Kazunori Imaizumi

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology   34 ( 1 )   865 - 880   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Intramembrane cleavage of transmembrane proteins is a fundamental cellular process to produce important signals that elicit biological responses. These proteolytic events are known as regulated intramembrane proteolysis (RIP). ATF6 and BBF2H7 are transmembrane basic leucine zipper transcription factors and are subjected to RIP by site-1 protease (S1P) and site-2 protease (S2P) sequentially in response to endoplasmic reticulum (ER) stress. However, the detailed mechanisms responsible for RIP of the transcription factors, including the precise cutting sites, are still unknown. In this study, we demonstrated that S1P cleaves BBF2H7 just before the RXXL S1P recognition motif. Conversely, S2P cut at least three different sites in the membrane (next to Leu380, Met381, and Leu385), indicating that S2P cleaves the substrates at variable sites or via a multistep process. Interestingly, we found BBF2H7-derived small peptide (BSP) fragments located between the S1P and S2P cleavage sites in cells exposed to ER stress. Major type of BSP fragments was composed of 45 amino acid including partial transmembrane and luminal regions and easily aggregates like amyloid β (Aβ) protein. These results advance the understanding of poorly characterized ER stress-dependent RIP. Furthermore, the aggregable peptides produced by ER stress could link to the pathophysiology of neurodegenerative disorders.

    DOI: 10.1096/fj.201901748R

    PubMed

    researchmap

  • A fail-safe system to prevent oncogenesis by senescence is targeted by SV40 small T antigen. Reviewed

    Oshikawa K, Matsumoto M, Kodama M, Shimizu H, Nakayama KI

    Oncogene   2019.12

     More details

    Authorship:Corresponding author  

    DOI: 10.1038/s41388-019-1139-1

    PubMed

    researchmap

  • The pericentromeric protein shugoshin 2 cooperates with HSF1 in heat shock response and RNA Pol II recruitment. Reviewed

    Takii R, Fujimoto M, Matsumoto M, Srivastava P, Katiyar A, Nakayama KI, Nakai A

    The EMBO journal   38 ( 24 )   e102566   2019.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:EMBO  

    DOI: 10.15252/embj.2019102566

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.15252/embj.2019102566

  • Frequent Detection of Pituitary-Derived PrPres in Human Prion Diseases. Reviewed International journal

    Honda H, Matsumoto M, Shijo M, Hamasaki H, Sadashima S, Suzuki SO, Aishima S, Kai K, Nakayama KI, Sasagasako N, Iwaki T

    Journal of neuropathology and experimental neurology   78 ( 10 )   922 - 929   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Human prion diseases including sporadic Creutzfeldt-Jakob disease (sCJD), inherited prion diseases, and acquired human prion diseases are lethal neurodegenerative diseases. One of the major sources of iatrogenic Creutzfeldt-Jakob disease was human growth hormone (hGH-iCJD) derived from contaminated cadaveric pituitaries. The incidence of hGH-iCJD has decreased since changing from growth hormone extracted from human cadaveric pituitaries to recombinant pituitary hormones. However, extensive analysis on the localization and detecting of abnormal prion protein in the pituitary gland are limited. In this study, we examined 9 autopsied brains and pituitary glands from 6 patients with prion disease (3 Gerstmann-Sträussler-Scheinker disease, 2 sCJD, and 1 dura mater graft-associated CJD) and 3 individuals with nonprion diseases. Western blot analysis of pituitary samples demonstrated unique glycoforms of normal cellular prion protein with molecular weights of 30-40 kDa, which was higher than the typical 25-35 kDa prion protein in brains. Proteomic analysis also revealed prion protein approximately the molecular weight of 40 kDa in pituitary samples. Moreover, proteinase K-resistant Prion protein was frequently detected in pituitary samples of the prion diseases. Immunohistochemistry for Prion protein revealed mosaic cellular distribution preferentially in growth hormone- or prolactin-producing cells.

    DOI: 10.1093/jnen/nlz075

    PubMed

    researchmap

  • tRNA代謝異常によるp53依存的神経細胞死の分子機構解明

    井上 真紀, 波田 一誠, 白石 裕士, 石谷 太, 松本 雅記, 井原 健二, 花田 俊勝

    日本生化学会大会プログラム・講演要旨集   92回   [1P - 308]   2019.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • tRNA代謝異常によるp53依存的神経細胞死の分子機構解明

    井上 真紀, 波田 一誠, 白石 裕士, 石谷 太, 松本 雅記, 井原 健二, 花田 俊勝

    日本生化学会大会プログラム・講演要旨集   92回   [1P - 308]   2019.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • Tricarboxylic acid cycle activity suppresses acetylation of mitochondrial proteins during early embryonic development in Caenorhabditis elegans Reviewed

    Kazumasa Hada, Keiko Hirota, Ai Inanobe, Koichiro Kako, Mai Miyata, Sho Araoi, Masaki Matsumoto, Reiya Ohta, Mitsuhiro Arisawa, Hiroaki Daitoku, Toshikatsu Hanada, Akiyoshi Fukamizu

    Journal of Biological Chemistry   294 ( 9 )   3091 - 3099   2019.3

     More details

    Publishing type:Research paper (scientific journal)  

    © 2019 Hada et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc. The tricarboxylic acid (TCA) cycle (or citric acid cycle) is responsible for the complete oxidation of acetyl-CoA and formation of intermediates required for ATP production and other anabolic pathways, such as amino acid synthesis. Here, we uncovered an additional mechanism that may help explain the essential role of the TCA cycle in the early embryogenesis of Caenorhabditis elegans. We found that knockdown of citrate synthase (cts-1), the initial and rate-limiting enzyme of the TCA cycle, results in early embryonic arrest, but that this phenotype is not because of ATP and amino acid depletions. As a possible alternative mechanism explaining this developmental deficiency, we observed that cts-1 RNAi embryos had elevated levels of intracellular acetyl-CoA, the starting metabolite of the TCA cycle. Of note, we further discovered that these embryos exhibit hyperacetylation of mitochondrial proteins. We found that supplementation with acetylase-inhibiting polyamines, including spermidine and putrescine, counteracted the protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Contrary to the hypothesis that spermidine acts as an acetyl sink for elevated acetyl-CoA, the levels of three forms of acetylspermidine, N1-acetylspermidine, N8-acetylspermidine, and N1,N8-diacetylspermidine, were not significantly increased in embryos treated with exogenous spermidine. Instead, we demonstrated that the mitochondrial deacetylase sirtuin 4 (encoded by the sir-2.2 gene) is required for spermidine’s suppression of protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Taken together, these results suggest the possibility that during early embryogenesis, acetyl-CoA consumption by the TCA cycle in C. elegans prevents protein hyperacetylation and thereby protects mitochondrial function.

    DOI: 10.1074/jbc.RA118.004726

    Scopus

    PubMed

    researchmap

  • The jPOST environment: an integrated proteomics data repository and database Reviewed

    Yuki Moriya, Shin Kawano, Shujiro Okuda, Yu Watanabe, Masaki Matsumoto, Tomoyo Takami, Daiki Kobayashi, Yoshinori Yamanouchi, Norie Araki, Akiyasu C Yoshizawa, Tsuyoshi Tabata, Mio Iwasaki, Naoyuki Sugiyama, Satoshi Tanaka, Susumu Goto, Yasushi Ishihama

    Nucleic Acids Research   47 ( D1 )   D1218 - D1224   2019.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    DOI: 10.1093/nar/gky899

    PubMed

    researchmap

  • Reconstruction of global regulatory network from signaling to cellular functions using phosphoproteomic data. Reviewed International journal

    Kentaro Kawata, Katsuyuki Yugi, Atsushi Hatano, Toshiya Kokaji, Yoko Tomizawa, Masashi Fujii, Shinsuke Uda, Hiroyuki Kubota, Masaki Matsumoto, Keiichi I Nakayama, Shinya Kuroda

    Genes to cells : devoted to molecular & cellular mechanisms   24 ( 1 )   82 - 93   2019.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cellular signaling regulates various cellular functions via protein phosphorylation. Phosphoproteomic data potentially include information for a global regulatory network from signaling to cellular functions, but a procedure to reconstruct this network using such data has yet to be established. In this paper, we provide a procedure to reconstruct a global regulatory network from signaling to cellular functions from phosphoproteomic data by integrating prior knowledge of cellular functions and inference of the kinase-substrate relationships (KSRs). We used phosphoproteomic data from insulin-stimulated Fao hepatoma cells and identified protein phosphorylation regulated by insulin specifically over-represented in cellular functions in the KEGG database. We inferred kinases for protein phosphorylation by KSRs, and connected the kinases in the insulin signaling layer to the phosphorylated proteins in the cellular functions, revealing that the insulin signal is selectively transmitted via the Pi3k-Akt and Erk signaling pathways to cellular adhesions and RNA maturation, respectively. Thus, we provide a method to reconstruct global regulatory network from signaling to cellular functions based on phosphoproteomic data.

    DOI: 10.1111/gtc.12655

    PubMed

    researchmap

  • Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16 Reviewed

    Hiroyuki Hosokawa, Maile Romero-Wolf, Mary A. Yui, Jonas Ungerbäck, Maria L. G. Quiloan, Masaki Matsumoto, Keiichi I. Nakayama, Tomoaki Tanaka, Ellen V. Rothenberg

    Nature Immunology   19 ( 12 )   1427 - 1440   2018.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Nature  

    DOI: 10.1038/s41590-018-0238-4

    PubMed

    researchmap

  • The promise of targeted proteomics for quantitative network biology Reviewed

    Masaki Matsumoto, Keiichi I Nakayama

    Current Opinion in Biotechnology   54   88 - 97   2018.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publisher:Elsevier Ltd  

    Proteomics is a powerful tool for obtaining information on a large number of proteins with regard to their expression levels, interactions with other molecules, and posttranslational modifications. Whereas nontargeted, discovery proteomics uncovers differences in the proteomic landscape under different conditions, targeted proteomics has been developed to overcome the limitations of this approach with regard to quantitation. In addition to technical advances in instruments and informatics tools, the advent of the synthetic proteome composed of synthetic peptides or recombinant proteins has advanced the adoption of targeted proteomics across a wide range of research fields. Targeted proteomics can now be applied to measurement of the dynamics of any proteins of interest under a variety of conditions as well as to estimation of the absolute abundance or stoichiometry of proteins in a given network. Multiplexed targeted proteomics assays of high reproducibility and accuracy can provide insight at the quantitative level into entire networks that govern biological phenomena or diseases. Such assays will establish a new paradigm for data-driven science.

    DOI: 10.1016/j.copbio.2018.02.014

    Scopus

    PubMed

    researchmap

  • Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure. Reviewed International journal

    Junichi Matsumoto, Shingo Takada, Shintaro Kinugawa, Takaaki Furihata, Hideo Nambu, Naoya Kakutani, Masaya Tsuda, Arata Fukushima, Takashi Yokota, Shinya Tanaka, Hidehisa Takahashi, Masashi Watanabe, Shigetsugu Hatakeyama, Masaki Matsumoto, Keiichi I Nakayama, Yutaro Otsuka, Hisataka Sabe, Hiroyuki Tsutsui, Toshihisa Anzai

    Circulation   138 ( 18 )   2064 - 2066   2018.10

     More details

  • Identification of the physiological substrates of PDIp, a pancreas-specific protein disulfide isomerase family member. Reviewed International journal

    Fujimoto T, Nakamura O, Saito M, Tsuru A, Matsumoto M, Kohno K, Inaba K, Kadokura H

    The Journal of biological chemistry   293 ( 48 )   18421 - 18433   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    About 20 members of the protein-disulfide isomerase (PDI) family are present in the endoplasmic reticulum of mammalian cells. They are thought to catalyze thiol-disulfide exchange reactions within secretory or membrane proteins to assist in their folding or to regulate their functions. PDIp is a PDI family member highly expressed in the pancreas and known to bind estrogen in vivo and in vitro However, the physiological functions of PDIp remained unclear. In this study, we set out to identify its physiological substrates. By combining acid quenching and thiol alkylation, we stabilized and purified the complexes formed between endogenous PDIp and its target proteins from the mouse pancreas. MS analysis of these complexes helped identify the disulfide-linked PDIp targets in vivo, revealing that PDIp interacts directly with a number of pancreatic digestive enzymes. Interestingly, when pancreatic elastase, one of the identified proteins, was expressed alone in cultured cells, its proenzyme formed disulfide-linked aggregates within cells. However, when pancreatic elastase was co-expressed with PDIp, the latter prevented the formation of these aggregates and enhanced the production and secretion of proelastase in a form that could be converted to an active enzyme upon trypsin treatment. These findings indicate that the main targets of PDIp are digestive enzymes and that PDIp plays an important role in the biosynthesis of a digestive enzyme by assisting with the proper folding of the proenzyme within cells.

    DOI: 10.1074/jbc.RA118.003694

    PubMed

    researchmap

  • Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding. Reviewed International journal

    Hosokawa H, Ungerbäck J, Wang X, Matsumoto M, Nakayama KI, Cohen SM, Tanaka T, Rothenberg EV

    Immunity   49 ( 4 )   782 - 782   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.immuni.2018.09.019

    PubMed

    researchmap

  • Trans-omic Analysis Reveals Selective Responses to Induced and Basal Insulin across Signaling, Transcriptional, and Metabolic Networks. Reviewed International journal

    Kentaro Kawata, Atsushi Hatano, Katsuyuki Yugi, Hiroyuki Kubota, Takanori Sano, Masashi Fujii, Yoko Tomizawa, Toshiya Kokaji, Kaori Y Tanaka, Shinsuke Uda, Yutaka Suzuki, Masaki Matsumoto, Keiichi I Nakayama, Kaori Saitoh, Keiko Kato, Ayano Ueno, Maki Ohishi, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda

    iScience   7   212 - 229   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The concentrations of insulin selectively regulate multiple cellular functions. To understand how insulin concentrations are interpreted by cells, we constructed a trans-omic network of insulin action in FAO hepatoma cells using transcriptomic data, western blotting analysis of signaling proteins, and metabolomic data. By integrating sensitivity into the trans-omic network, we identified the selective trans-omic networks stimulated by high and low doses of insulin, denoted as induced and basal insulin signals, respectively. The induced insulin signal was selectively transmitted through the pathway involving Erk to an increase in the expression of immediate-early and upregulated genes, whereas the basal insulin signal was selectively transmitted through a pathway involving Akt and an increase of Foxo phosphorylation and a reduction of downregulated gene expression. We validated the selective trans-omic network in vivo by analysis of the insulin-clamped rat liver. This integrated analysis enabled molecular insight into how liver cells interpret physiological insulin signals to regulate cellular functions.

    DOI: 10.1016/j.isci.2018.07.022

    PubMed

    researchmap

  • Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation. Reviewed International journal

    Tognon CE, Rafn B, Cetinbas NM, Kamura T, Trigo G, Rotblat B, Okumura F, Matsumoto M, Chow C, Davare M, Pollak M, Mayor T, Sorensen PH

    The Journal of biological chemistry   293 ( 32 )   12502 - 12515   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Many oncogenes, including chimeric oncoproteins, require insulin-like growth factor 1 receptor (IGF1R) for promoting cell transformation. The ETS variant 6 (ETV6)-neurotrophic receptor tyrosine kinase 3 (NTRK3) (EN) chimeric tyrosine kinase is expressed in mesenchymal, epithelial, and hematopoietic cancers and requires the IGF1R axis for transformation. However, current models of IGF1R-mediated EN activation are lacking mechanistic detail. We demonstrate here that IGF-mediated IGF1R stimulation enhances EN tyrosine phosphorylation and that blocking IGF1R activity or decreasing protein levels of the adaptor protein insulin receptor substrate 1/2 (IRS1/2) results in rapid EN degradation. This was observed both in vitro and in vivo in fibroblast and breast epithelial cell line models and in MO91, an EN-expressing human leukemia cell line. Stable isotope labeling with amino acids in cell culture (SILAC)-based MS analysis identified the E3 ligase RING-finger protein 123 (Rnf123, more commonly known as KPC1) as an EN interactor upon IGF1R/insulin receptor (INSR) inhibitor treatment. KPC1/Rnf123 ubiquitylated EN in vitro, and its overexpression decreased EN protein levels. In contrast, KPC1/Rnf123 knockdown rendered EN resistant to IGF1R inhibitor-mediated degradation. These results support a critical function for IGF1R in protecting EN from KPC1/Rnf123-mediated proteasomal degradation. Attempts to therapeutically target oncogenic chimeric tyrosine kinases have traditionally focused on blocking kinase activity to restrict downstream activation of essential signaling pathways. In this study, we demonstrate that IGF1R inhibition results in rapid ubiquitylation and degradation of the EN oncoprotein through a proteasome-dependent mechanism that is reversible, highlighting a potential strategy for targeting chimeric tyrosine kinases in cancer.

    DOI: 10.1074/jbc.RA117.000321

    PubMed

    researchmap

  • GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. Reviewed

    Watanabe S, Fujiyama H, Takafuji T, Kayama K, Matsumoto M, Nakayama KI, Yoshida K, Sugimoto N, Fujita M

    Journal of cell science   131 ( 15 )   2018.8

  • Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding Reviewed

    Hiroyuki Hosokawa, Jonas Ungerbäck, Xun Wang, Masaki Matsumoto, Keiichi I. Nakayama, Sarah M. Cohen, Tomoaki Tanaka, Ellen V. Rothenberg

    Immunity   48 ( 6 )   1119 - 1134.e7   2018.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    DOI: 10.1016/j.immuni.2018.04.024

    PubMed

    researchmap

  • Correction: "UV damage-induced phosphorylation of HBO1 triggers CRL4DDB2-mediated degradation to regulate cell proliferation" [Molecular and Cellular Biology 36, 3, (2016) (394-406)] doi 10.1128/MCB.00809-15

    Ryoichi Matsunuma, Hiroyuki Niida, Tatsuya Ohhata, Kyoko Kitagawa, Satoshi Sakai, Chiharu Uchida, Bunsyo Shiotani, Masaki Matsumoto, Keiichi I. Nakayama, Hiroyuki Ogura, Norihiko Shiiya, Masatoshi Kitagawa

    Molecular and Cellular Biology   36 ( 3 )   394 - 406   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    Histone acetyltransferase binding to ORC-1 (HBO1) is a critically important histone acetyltransferase for forming the prereplicative complex (pre-RC) at the replication origin. Pre-RC formation is completed by loading of the MCM2-7 heterohexameric complex, which functions as a helicase in DNA replication. HBO1 recruited to the replication origin by CDT1 acetylates histone H4 to relax the chromatin conformation and facilitates loading of theMCMcomplex onto replication origins. However, the acetylation status and mechanism of regulation of histone H3 at replication origins remain elusive. HBO1 positively regulates cell proliferation under normal cell growth conditions. Whether HBO1 regulates proliferation in response to DNA damage is poorly understood. In this study, we demonstrated that HBO1 was degraded after DNA damage to suppress cell proliferation. Ser50 and Ser53 of HBO1 were phosphorylated in an ATM/ATR DNA damage sensor-dependent manner after UV treatment. ATM/ATR dependently phosphorylated HBO1 preferentially interacted with DDB2 and was ubiquitylated by CRL4DDB2. Replacement of endogenous HBO1 in Ser50/53Ala mutants maintained acetylation of histone H3K14 and impaired cell cycle regulation in response to UV irradiation. Our findings demonstrate that HBO1 is one of the targets in the DNA damage checkpoint. These results show that ubiquitin-dependent control of the HBO1 protein contributes to cell survival during UV irradiation.

    DOI: 10.1128/MCB.00809-15

    Scopus

    PubMed

    researchmap

  • Correction for Matsunuma et al., "UV Damage-Induced Phosphorylation of HBO1 Triggers CRL4DDB2-Mediated Degradation To Regulate Cell Proliferation". International journal

    Ryoichi Matsunuma, Hiroyuki Niida, Tatsuya Ohhata, Kyoko Kitagawa, Satoshi Sakai, Chiharu Uchida, Bunsyo Shiotani, Masaki Matsumoto, Keiichi I Nakayama, Hiroyuki Ogura, Norihiko Shiiya, Masatoshi Kitagawa

    Molecular and cellular biology   38 ( 7 )   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1128/MCB.00572-17

    PubMed

    researchmap

  • PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth. Reviewed International journal

    Mami Morita, Taku Sato, Miyuki Nomura, Yoshimi Sakamoto, Yui Inoue, Ryota Tanaka, Shigemi Ito, Koreyuki Kurosawa, Kazunori Yamaguchi, Yuki Sugiura, Hiroshi Takizaki, Yoji Yamashita, Ryuichi Katakura, Ikuro Sato, Masaaki Kawai, Yoshinori Okada, Hitomi Watanabe, Gen Kondoh, Shoko Matsumoto, Ayako Kishimoto, Miki Obata, Masaki Matsumoto, Tatsuro Fukuhara, Hozumi Motohashi, Makoto Suematsu, Masaaki Komatsu, Keiichi I Nakayama, Toshio Watanabe, Tomoyoshi Soga, Hiroshi Shima, Makoto Maemondo, Nobuhiro Tanuma

    Cancer cell   33 ( 3 )   355 - 367   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Expression of PKM2, which diverts glucose-derived carbon from catabolic to biosynthetic pathways, is a hallmark of cancer. However, PKM2 function in tumorigenesis remains controversial. Here, we show that, when expressed rather than PKM2, the PKM isoform PKM1 exhibits a tumor-promoting function in KRASG12D-induced or carcinogen-initiated mouse models or in some human cancers. Analysis of Pkm mutant mouse lines expressing specific PKM isoforms established that PKM1 boosts tumor growth cell intrinsically. PKM1 activated glucose catabolism and stimulated autophagy/mitophagy, favoring malignancy. Importantly, we observed that pulmonary neuroendocrine tumors (NETs), including small-cell lung cancer (SCLC), express PKM1, and that PKM1 expression is required for SCLC cell proliferation. Our findings provide a rationale for targeting PKM1 therapeutically in certain cancer subtypes, including pulmonary NETs.

    DOI: 10.1016/j.ccell.2018.02.004

    PubMed

    researchmap

  • Sez6l2 regulates phosphorylation of ADD and neuritogenesis Reviewed

    Hiroaki Yaguchi, Ichiro Yabe, Hidehisa Takahashi, Masashi Watanabe, Taichi Nomura, Takahiro Kano, Masaki Matsumoto, Keiichi I. Nakayama, Masahiko Watanabe, Shigetsugu Hatakeyama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   494 ( 1-2 )   234 - 241   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Increasing evidence shows that immune-mediated mechanisms may contribute to the pathogenesis of central nervous system disorders including cerebellar ataxias, as indicated by the aberrant production of neuronal surface antibodies. We previously reported a patient with cerebellar ataxia associated with production of a new anti-neuronal antibody, anti-seizure-related 6 homolog like 2 (Sez6l2). Sez6l2 is a type 1 membrane protein that is highly expressed in the hippocampus and cerebellar cortex and mice lacking Sez6l2 protein family members develop ataxia. Here we used a proteomics-based approach to show that serum derived from this patient recognizes the extracellular domain of Sez6l2 and that Sez6l2 protein binds to both adducin (ADD) and glutamate receptor 1 (GluR1). Our results indicate that Sez6l2 is one of the auxiliary subunits of the AMPA receptor and acts as a scaffolding protein to link GluR1 to ADD. Furthermore, Sez6l2 overexpression upregulates ADD phosphorylation, whereas siRNA-mediated downregulation of Sez6l2 prevents ADD phosphorylation, suggesting that Sez6l2 modulates AMPAADD signal transduction. (C) 2017 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2017.10.047

    Web of Science

    PubMed

    researchmap

  • Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages Reviewed

    Hirokazu Nakatsumi, Masaki Matsumoto, Keiichi I. Nakayama

    CELL REPORTS   21 ( 9 )   2471 - 2486   2017.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    C-C chemokine ligand 2 (CCL2) plays pivotal roles in tumor formation, progression, and metastasis. Although CCL2 expression has been found to be dependent on the nuclear factor (NF)-kappa B signaling pathway, the regulation of CCL2 production in tumor cells has remained unclear. We have identified a non-canonical pathway for regulation of CCL2 production that is mediated by mammalian target of rapamycin complex 1 (mTORC1) but independent of NF-kappa B. Multiple phosphoproteomics approaches identified the transcription factor forkhead box K1 (FOXK1) as a downstream target of mTORC1. Activation of mTORC1 induces dephosphorylation of FOXK1, resulting in transactivation of the CCL2 gene. Inhibition of the mTORC1-FOXK1 axis attenuated insulin-induced CCL2 production as well as the accumulation of tumor-associated monocytes-macrophages and tumor progression in mice. Our results suggest that FOXK1 directly links mTORC1 signaling and CCL2 expression in a manner independent of NF-kB and that CCL2 produced by this pathway contributes to tumor progression.

    DOI: 10.1016/j.celrep.2017.11.014

    Web of Science

    PubMed

    researchmap

  • Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells Reviewed

    Kazuaki Kita, Masayuki Shiota, Masako Tanaka, Asuka Otsuka, Masaki Matsumoto, Minoru Kato, Satoshi Tamada, Hiroshi Iwao, Katsuyuki Miura, Tatsuya Nakatani, Shuhei Tomita

    Cancer Science   108 ( 9 )   1820 - 1827   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Blackwell Publishing Ltd  

    Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer
    however, the prostate cancer gradually becomes resistant to androgen deprivation therapy, which is termed castration-resistant prostate cancer (CRPC). Androgen receptor splice variant 7 (AR-V7), one of the causes of CRPC, is correlated with resistance to a new-generation AR antagonist (enzalutamide) and poor prognosis. Heat shock protein 70 (Hsp70) inhibitor is known to decrease the levels of full-length AR (AR-FL), but little is known about its effects against CRPC cells expressing AR-V7. In this study, we investigated the effect of the Hsp70 inhibitors quercetin and VER155008 in the prostate cancer cell line LNCaP95 that expresses AR-V7, and explored the mechanism by which Hsp70 regulates AR-FL and AR-V7 expression. Quercetin and VER155008 decreased cell proliferation, increased the proportion of apoptotic cells, and decreased the protein levels of AR-FL and AR-V7. Furthermore, VER155008 decreased AR-FL and AR-V7 mRNA levels. Immunoprecipitation with Hsp70 antibody and mass spectrometry identified Y-box binding protein 1 (YB-1) as one of the molecules regulating AR-FL and AR-V7 at the transcription level through interaction with Hsp70. VER155008 decreased the phosphorylation of YB-1 and its localization in the nucleus, indicating that the involvement of Hsp70 in AR regulation might be mediated through the activation and nuclear translocation of YB-1. Collectively, these results suggest that Hsp70 inhibitors have potential anti-tumor activity against CRPC by decreasing AR-FL and AR-V7 expression through YB-1 suppression.

    DOI: 10.1111/cas.13318

    Scopus

    PubMed

    researchmap

  • Heat shock protein 70 inhibitors suppress androgen receptor expression in LNCaP95 prostate cancer cells Reviewed

    Kazuaki Kita, Masayuki Shiota, Masako Tanaka, Asuka Otsuka, Masaki Matsumoto, Minoru Kato, Satoshi Tamada, Hiroshi Iwao, Katsuyuki Miura, Tatsuya Nakatani, Shuhei Tomita

    CANCER SCIENCE   108 ( 9 )   1820 - 1827   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Androgen deprivation therapy is initially effective for treating patients with advanced prostate cancer; however, the prostate cancer gradually becomes resistant to androgen deprivation therapy, which is termed castration-resistant prostate cancer (CRPC). Androgen receptor splice variant 7 (AR-V7), one of the causes of CRPC, is correlated with resistance to a new-generation AR antagonist (enzalutamide) and poor prognosis. Heat shock protein 70 (Hsp70) inhibitor is known to decrease the levels of full-length AR (AR-FL), but little is known about its effects against CRPC cells expressing AR-V7. In this study, we investigated the effect of the Hsp70 inhibitors quercetin and VER155008 in the prostate cancer cell line LNCaP95 that expresses AR-V7, and explored the mechanism by which Hsp70 regulates AR-FL and AR-V7 expression. Quercetin and VER155008 decreased cell proliferation, increased the proportion of apoptotic cells, and decreased the protein levels of AR-FL and AR-V7. Furthermore, VER155008 decreased AR-FL and AR-V7 mRNA levels. Immunoprecipitation with Hsp70 antibody and mass spectrometry identified Y-box binding protein 1 (YB-1) as one of the molecules regulating AR-FL and AR-V7 at the transcription level through interaction with Hsp70. VER155008 decreased the phosphorylation of YB-1 and its localization in the nucleus, indicating that the involvement of Hsp70 in AR regulation might be mediated through the activation and nuclear translocation of YB-1. Collectively, these results suggest that Hsp70 inhibitors have potential anti-tumor activity against CRPC by decreasing AR-FL and AR-V7 expression through YB-1 suppression.

    DOI: 10.1111/cas.13318

    Web of Science

    researchmap

  • Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice Reviewed

    Lin Cui, Kenji Nakano, Sumalee Obchoei, Kiyoko Setoguchi, Masaki Matsumoto, Tsuyoshi Yamamoto, Satoshi Obika, Kazuaki Shimada, Nobuyoshi Hiraoka

    GASTROENTEROLOGY   153 ( 1 )   292 - +   2017.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:W B SAUNDERS CO-ELSEVIER INC  

    BACKGROUND & AIMS: Small nucleolar noncoding RNAs (snoRNAs) regulate function of ribosomes, and specific snoRNAs are dysregulated in some cancer cells. We investigated dysregulation of snoRNAs in pancreatic ductal adenocarcinoma (PDAC) cells. METHODS: We investigated snoRNA expression in PDAC cell lines by complementary DNA microarray and quantitative reverse transcription polymerase chain reaction. In PDAC (n = 133), intraductal papillary mucinous neoplasm (n = 16), mucinous cystic neoplasm-associated PDAC (n = 1), and non-tumor pancreas (n = 8) and liver (n = 3) tissues from subjects who underwent surgical resection, levels of snoRNA were measured by quantitative reverse transcription polymerase chain reaction and compared with clinicopathologic parameters and survival times determined by Kaplan-Meier analysis. To examine snoRNA function, PDAC cells were transfected with snoRNA-antisense oligonucleotides flanked with amido-bridged nucleic acids, or snoRNA-expression plasmids, and analyzed in proliferation, colony formation, spheroid formation, and invasion assays. To identify snoRNA-related factors, cells were analyzed by gene expression and proteomic profiling and immunoblot assays. Mice were given intrasplenic injections of MIA PaCa2- or Suit2-HLMC cells; tumor-bearing nude mice were then given 3 weekly injections of an antisense oligonucleotides against SNORA23, a H/ACA-box type snoRNA, and tumor growth and metastasis to liver, blood, and pancreas were analyzed. RESULTS: Levels of SNORA23 increased and accumulated at the nucleolus in highly metastatic MIA PaCa2- or Suit2-HLMC cells compared with their parental cells. We detected SNORA23 in human PDAC specimens but not in non-tumor pancreatic tissue. PDAC level of SNORA23 correlated with invasion grade and correlated inversely with disease-free survival time of patients. Expression of SNORA23 in PDAC cells increased their invasive activity and colony formation, and spheroid formation was inhibited by SNORA23 knockdown. In gene expression and proteomic profile analyses, we found SNORA23 to increase expression of spectrin repeat-containing nuclear envelope 2 (SYNE2) messenger RNA and protein. Knockdown of SYNE2 in PDAC cells reduced their invasive activities and anchor-independent survival. Administration of SNORA23 antisense oligonucleotides to mice slowed growth of xenograft tumors, tumor expression of SYNE2, tumor cell dissemination, and metastasis to liver. CONCLUSIONS: We found expression of the snoRNA SNORA23, which mediates sequence-specific pseudouridylation of ribosomal RNAs, to be increased in human PDAC tissues compared with non-tumor tissues, and levels to correlate with tumor invasion grade and patient survival time. SNORA23 increases expression of SYNE2, possibly through modulation of ribosome biogenesis, to promote PDAC cell survival and invasion, and growth and metastasis of xenograft tumors in mice.

    DOI: 10.1053/j.gastro.2017.03.050

    Web of Science

    PubMed

    researchmap

  • Robotic crowd biology with Maholo LabDroids Reviewed

    Nozomu Yachie, Tohru Natsume, Koichi Takahashi, Toshiaki Katayama, Takeshi Sakurada, Genki N. Kanda, Eiji Takagi, Takako Hirose, Tatsuo Katsura, Tetsuo Moriya, Hiroaki Kitano, Junichi Tsujii, Tohru Natsume, Tomoyuki Shiraki, Hirokazu Kariyazaki, Motohisa Kamei, Noriko Abe, Takuya Fukuda, Yukiko Sawada, Yukio Hashiguchi, Kenji Matsukuma, Shinji Murai, Naoyuki Sasaki, Tatsuro Ipposhi, Hideo Urabe, Taku Kudo, Makoto Umeno, Seiki Ono, Kohei Miyauchi, Miki Nakamura, Takahiro Kizaki, Takashi Suyama, Tomohisa Hatta, Tohru Natsume, Tazro Ohta, Koichi Takahashi, Yosuke Ozawa, Nozomu Yachie, Takeshi Sakurada, Kenji Matsukuma, Shinji Murai, Shoji Ihara, Satoshi Tamaki, Erick Antezana, Alexander Garcia-Castro, Jean-Luc Perret, Soh Ishiguro, Hideto Mori, Daniel Evans-Yamamoto, Nanami Masuyama, Masaru Tomita, Junichi Tsujii, Toshiaki Katayama, Hiroaki Kitano, Tomohisa Hatta, Masaki Matsumoto, Hiroshi Nakayama, Ayaka Shirasawa, Kazutaka Shimbo, Naoyuki Yamada, Keiichi I. Nakayama, Tohru Natsume, Takatsune Shimizu, Hideyuki Saya, Satoshi Yamashita, Takahide Matsushima, Hiroshi Asahara, Hidetoshi Eguchi, Manabu Mikamori, Masaki Mori

    NATURE BIOTECHNOLOGY   35 ( 4 )   310 - 312   2017.4

     More details

    Language:English   Publisher:NATURE PUBLISHING GROUP  

    DOI: 10.1038/nbt.3758

    Web of Science

    researchmap

  • A large-scale targeted proteomics assay resource based on an in vitro human proteome Reviewed

    Masaki Matsumoto, Fumiko Matsuzaki, Kiyotaka Oshikawa, Naoki Goshima, Masatoshi Mori, Yoshifumi Kawamura, Koji Ogawa, Eriko Fukuda, Hirokazu Nakatsumi, Tohru Natsume, Kazuhiko Fukui, Katsuhisa Horimoto, Takeshi Nagashima, Ryo Funayama, Keiko Nakayama, Keiichi I. Nakayama

    NATURE METHODS   14 ( 3 )   251 - +   2017.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Targeted proteomics approaches are of value for deep and accurate quantification of protein abundance. Extending such methods to quantify large numbers of proteins requires the construction of predefined targeted assays. We developed a targeted proteomics platform-in vitro proteome-assisted multiple reaction monitoring (MRM) for protein absolute quantification (iMPAQT)-by using &gt; 18,000 human recombinant proteins, thus enabling protein absolute quantification on a genome-wide scale. Our platform comprises experimentally confirmed MRM assays of mass tag (mTRAQ)-labeled peptides to allow for rapid and straightforward measurement of the absolute abundance of predefined sets of proteins by mass spectrometry. We applied iMPAQT to delineate the quantitative metabolic landscape of normal and transformed human fibroblasts. Oncogenic transformation gave rise to relatively small but global changes in metabolic pathways resulting in aerobic glycolysis (Warburg effect) and increased rates of macromolecule synthesis. iMPAQT should facilitate quantitative biology studies based on protein abundance measurements.

    DOI: 10.1038/NMETH.4116

    Web of Science

    PubMed

    researchmap

  • Identification of KIAA1210 as a novel X-chromosome-linked protein that localizes to the acrosome and associates with the ectoplasmic specialization in testes Reviewed

    Tokuko Iwamori, Naoki Iwamori, Masaki Matsumoto, Etsuro Ono, Martin M. Matzuk

    BIOLOGY OF REPRODUCTION   96 ( 2 )   469 - 477   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SOC STUDY REPRODUCTION  

    Cell junctions are necessary for spermatogenesis, and there are numerous types of junctions in testis, such as blood-testis barrier, intercellular bridge, and ectoplasmic specialization (ES). The details of their functions and construction are still unknown. To identify a novel protein essential to the function of a cell junction, we enriched testis membrane protein and analyzed it using a proteomics approach. Here, we report a novel ES protein, which is encoded on the X chromosome and an ortholog of hypothetical human protein KIAA1210. KIAA1210 is expressed in testis predominantly, localized to the sex body in spermatocyte, acrosome, and near ES. Moreover, KIAA1210 possesses a topoisomerase 2 (TOP2)-associated protein PAT1 domain, a herpes simplex virus 1 (HSV-1) large tegument protein UL36 hypothetical domain, and a provisional DNA translocase FtsK domain. Using IP-proteomics with specific antibody to KIAA1210, we identified proteins including TOP2 isoforms as components of a complex with KIAA1210, in cell junctions in testis. The interaction between KIAA1210 and TOP2 was confirmed by two different proteomic analyses. Furthermore, immunofluorescence showed that KIAA1210 and TOP2B co-localize around the sex body in spermatocyte, apical ES, and residual bodies in elongated spermatids. Our findings suggest that KIAA1210 may be essential cell junction protein that interacts with TOP2B to regulate the dynamic change of chromatin structures during spermiogenesis.
    Summary Sentence
    KIAA1210, which is a novel X-chromosome-linked protein, is localized to the acrosome and associates with ectoplasmic specialization, and has a direct or indirect interaction with DNA topoisomerase 2.

    DOI: 10.1095/biolreprod.116.145458

    Web of Science

    PubMed

    researchmap

  • mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide Reviewed

    Akinobu Matsumoto, Alessandra Pasut, Masaki Matsumoto, Riu Yamashita, Jacqueline Fung, Emanuele Monteleone, Alan Saghatelian, Keiichi I. Nakayama, John G. Clohessy, Pier Paolo Pandolfi

    NATURE   541 ( 7636 )   228 - +   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Although long non-coding RNAs (lncRNAs) are non-protein-coding transcripts by definition, recent studies have shown that a fraction of putative small open reading frames within lncRNAs are translated(1-3). However, the biological significance of these hidden polypeptides is still unclear. Here we identify and functionally characterize a novel polypeptide encoded by the lncRNA LINC00961. This polypeptide is conserved between human and mouse, is localized to the late endosome/lysosome and interacts with the lysosomal v-ATPase to negatively regulate mTORC1 activation. This regulation of mTORC1 is specific to activation of mTORC1 by amino acid stimulation, rather than by growth factors. Hence, we termed this polypeptide 'small regulatory polypeptide of amino acid response' (SPAR). We show that the SPAR-encoding lncRNA is highly expressed in a subset of tissues and use CRISPR/Cas9 engineering to develop a SPAR-polypeptide-specific knockout mouse while maintaining expression of the host lncRNA. We find that the SPAR-encoding lncRNA is downregulated in skeletal muscle upon acute injury, and using this in vivo model we establish that SPAR downregulation enables efficient activation of mTORC1 and promotes muscle regeneration. Our data provide a mechanism by which mTORC1 activation may be finely regulated in a tissue-specific manner in response to injury, and a paradigm by which lncRNAs encoding small polypeptides can modulate general biological pathways and processes to facilitate tissue-specific requirements, consistent with their restricted and highly regulated expression profile.

    DOI: 10.1038/nature21034

    Web of Science

    PubMed

    researchmap

  • GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis Reviewed

    Kota Kayama, Shinya Watanabe, Takuya Takafuji, Takahiro Tsuji, Kensuke Hironaka, Masaki Matsumoto, Keiichi I. Nakayama, Masato Enari, Takashi Kohno, Kouya Shiraishi, Tohru Kiyono, Kazumasa Yoshida, Nozomi Sugimoto, Masatoshi Fujita

    EMBO REPORTS   18 ( 1 )   123 - 137   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    The ribosomal protein L11 (RPL11) binds and inhibits the MDM2 ubiquitin ligase, thereby promoting p53 stability. Thus, RPL11 acts as a tumor suppressor. Here, we show that GRWD1 (glutamate-rich WD40 repeat containing 1) physically and functionally interacts with RPL11. GRWD1 is localized to nucleoli and is released into the nucleoplasm upon nucleolar stress. Silencing of GRWD1 increases p53 induction by nucleolar stress, whereas overexpression of GRWD1 reduces p53 induction. Furthermore, GRWD1 overexpression competitively inhibits the RPL11-MDM2 interaction and alle-viates RPL11-mediated suppression of MDM2 ubiquitin ligase activity toward p53. These effects are mediated by the N-terminal region of GRWD1, including the acidic domain. Finally, we show that GRWD1 overexpression in combination with HPV16 E7 and activated KRAS confers anchorage-independent growth and tumorigenic capacity on normal human fibroblasts. Consistent with this, GRWD1 overexpression is associated with poor prognosis in cancer patients. Taken together, our results suggest that GRWD1 is a novel negative regulator of p53 and a potential oncogene.

    DOI: 10.15252/embr.201642444

    Web of Science

    PubMed

    researchmap

  • jPOSTrepo: an international standard data repository for proteomes Reviewed

    Shujiro Okuda, Yu Watanabe, Yuki Moriya, Shin Kawano, Tadashi Yamamoto, Masaki Matsumoto, Tomoyo Takami, Daiki Kobayashi, Norie Araki, Akiyasu C. Yoshizawa, Tsuyoshi Tabata, Naoyuki Sugiyama, Susumu Goto, Yasushi Ishihama

    NUCLEIC ACIDS RESEARCH   45 ( D1 )   D1107 - D1111   2017.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Major advancements have recently been made in mass spectrometry-based proteomics, yielding an increasing number of datasets from various proteomics projects worldwide. In order to facilitate the sharing and reuse of promising datasets, it is important to construct appropriate, high-quality public data repositories. jPOSTrepo (https://repository.jpostdb.org/) has successfully implemented several unique features, including high-speed file uploading, flexible file management and easy-to-use interfaces. This repository has been launched as a public repository containing various proteomic datasets and is available for researchers worldwide. In addition, our repository has joined the ProteomeXchange consortium, which includes the most popular public repositories such as PRIDE in Europe for MS/MS datasets and PASSEL for SRM datasets in the USA. Later MassIVE was introduced in the USA and accepted into the ProteomeXchange, as was our repository in July 2016, providing important datasets from Asia/Oceania. Accordingly, this repository thus contributes to a global alliance to share and store all datasets from a wide variety of proteomics experiments. Thus, the repository is expected to become a major repository, particularly for data collected in the Asia/Oceania region.

    DOI: 10.1093/nar/gkw1080

    Web of Science

    PubMed

    researchmap

  • The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes Reviewed

    Wataru Mizushima, Hidehisa Takahashi, Masashi Watanabe, Shintaro Kinugawa, Shouji Matsushima, Shingo Takada, Takashi Yokota, Takaaki Furihata, Junichi Matsumoto, Masaya Tsuda, Ikuru Chiba, Shun Nagashima, Shigeru Yanagi, Masaki Matsumoto, Keiichi I. Nakayama, Hiroyuki Tsutsui, Shigetsugu Hatakeyama

    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY   100   43 - 53   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    A failing heart shows severe energy insufficiency, and it is presumed that this energy shortage plays a critical role in the development of cardiac dysfunction. However, little is known about the mechanisms that cause energy metabolic alterations in the failing heart. Here, we show that the novel RING-finger protein 207 (RNF207), which is specifically expressed in the heart, plays a role in cardiac energy metabolism. Depletion of RNF207 in neonatal rat cardiomyocytes (NRCs) leads to a reduced cellular concentration of adenosine triphosphate (ATP) and mitochondrial dysfunction. Consistent with this result, we observed here that the expression of RNF207 was significantly reduced in mice with common cardiac diseases including heart failure. Intriguingly, proteomic approaches revealed that RNF207 interacts with the voltage-dependent anion channel (VDAC), which is considered to be a key regulator of mitochondria function, as an RNF207-interacting protein. Our findings indicate that RNF207 is involved in ATP production by cardiomyocytes, suggesting that RNF207 plays an important role in the development of heart failure. (C) 2016 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.yjmcc.2016.09.013

    Web of Science

    PubMed

    researchmap

  • Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-2 glycoprotein I antibodies

    K. Otomo, O. Amengual, Y. Fujieda, H. Nakagawa, M. Kato, K. Oku, T. Horita, S. Yasuda, M. Matsumoto, K. I. Nakayama, S. Hatakeyama, T. Koike, T. Atsumi

    LUPUS   25 ( 12 )   1288 - 1298   2016.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SAGE PUBLICATIONS LTD  

    Objective The objective of this paper is to elucidate the not yet known plasma molecule candidates involved in the induction of tissue factor (TF) expression mediated by 2GPI-dependent anticardiolipin antibody (aCL/2GPI) on monocytes.
    Methods Human serum incubated with FLAG-2GPI was applied for affinity chromatography with anti- FLAG antibody. Immunopurified proteins were analyzed by a liquid chromatography coupled with mass spectrometry (LC-MS). TF mRNA induced by the identified molecules on monocytes was also analyzed.
    Results Apolipoprotein B100 (APOB) was the only identified serum molecule in the MS search. Oxidized LDL, containing APOB as well as ox-Lig1 (a known ligand of 2GPI), was revealed as a 2GPI-binding molecule in the immunoprecipitation assay. TF mRNA was markedly induced by oxidized LDL/2GPI complexes with either WBCAL-1 (monoclonal aCL/2GPI) or purified IgG from APS patients. The activities of lipoprotein-associated phospholipase A2, one of the component molecules of oxidized LDL, were significantly higher in serum from APS patients than in those from controls.
    Conclusion APOB (or oxidized LDL) was detected as a major 2GPI binding serum molecule by LC-MS search. Oxidized LDL/aCL/2GPI complexes significantly induced TF expressions on monocytes. These data suggest that complexes of oxidized LDL and aCL/2GPI may have a crucial role in the pathophysiology of APS.

    DOI: 10.1177/0961203316638165

    Web of Science

    Scopus

    PubMed

    researchmap

  • Phosphoproteomics analyses show subnetwork systems in T-cell receptor signaling Reviewed

    Atsushi Hatano, Masaki Matsumoto, Keiichi I. Nakayama

    GENES TO CELLS   21 ( 10 )   1095 - 1112   2016.10

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    A key issue in the study of signal transduction is how multiple signaling pathways are systematically integrated into the cell. We have now performed multiple phosphoproteomics analyses focused on the dynamics of the T-cell receptor (TCR) signaling network and its subsystem mediated by the Ca2+ signaling pathway. Integration of these phosphoproteomics data sets and extraction of components of the TCR signaling network dependent on Ca2+ signaling showed unexpected phosphorylation kinetics for candidate substrates of the Ca2+-dependent phosphatase calcineurin (CN) during TCR stimulation. Detailed characterization of the TCR-induced phosphorylation of a novel CN substrate, Itpkb, showed that phosphorylation of this protein is regulated by both CN and the mitogen-activated protein kinase Erk in a competitive manner. Phosphorylation of additional CN substrates was also found to be regulated by Erk and CN in a similar manner. The combination of multiple phosphoproteomics approaches thus showed two major subsystems mediated by Erk and CN in the TCR signaling network, with these subsystems regulating the phosphorylation of a group of proteins in a competitive manner.

    DOI: 10.1111/gtc.12406

    Web of Science

    PubMed

    researchmap

  • Inhibition of the Arabidopsis bHLH transcription factor by monomerization through abscisic acid-induced phosphorylation Reviewed

    Yohei Takahashi, Toshinori Kinoshita, Masaki Matsumoto, Ken-ichiro Shimazaki

    PLANT JOURNAL   87 ( 6 )   559 - 567   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    We have demonstrated that the Arabidopsis basic helix-loop-helix (bHLH) transcription factor, ABA-responsive kinase substrate 1 (AKS1; also known as FLOWERING BHLH 3, FBH3), enhances K+ channel expression in guard cells leading to stomatal opening. The expression is suppressed by ABA-induced phosphorylation of AKS1. Here we show that the phosphorylation results in the monomerization of AKS1 multimers and inhibits AKS1 binding to DNA. AKS1 forms homo-multimers which dissociate following phosphorylation. Replacement of a critical amino acid in the bHLH domain inhibited multimer formation and decreased the binding of AKS1 to DNA. The monomerization was elicited via phosphorylation at three serine residues, which is mediated by SNF1-related protein kinase 2.6 (SnRK2.6), in the vicinity of bHLH domain. Furthermore, ABA induced the phosphorylation-dependent release of AKS1 from DNA, thereby suppressing transcriptional activity invivo. Our results document a mechanism that inhibits gene expression by phosphorylation of a bHLH transcription factor.
    Significance Statement The basic helix-loop-helix transcriptional activator, ABA-responsive kinase substrate 1 (AKS1), enhances K+ channel expression in guard cells leading to stomatal opening. Abscisic acid (ABA) induces monomerization of the AKS1 by phosphorylation through protein kinase of SnRK2.6, and results in release of AKS1 from DNA providing a mechanism of ABA-dependent repression of gene expression through phosphorylation.

    DOI: 10.1111/tpj.13217

    Web of Science

    PubMed

    researchmap

  • Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells Reviewed

    Katsuyuki Takahashi, Masako Tanaka, Masakazu Yashiro, Masaki Matsumoto, Asuka Ohtsuka, Keiichi I. Nakayama, Yasukatsu Izumi, Katsuya Nagayama, Katsuyuki Miura, Hiroshi Iwao, Masayuki Shiota

    CANCER LETTERS   378 ( 1 )   8 - 15   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER IRELAND LTD  

    Heat shock protein 72 (Hsp72) is a molecular chaperone that assists in the folding of nascent polypeptides and in the refolding of denatured proteins. In many cancers, Hsp72 is constitutively expressed at elevated levels, which can result in enhanced stress tolerance. Similarly, following treatment with anticancer drugs, Hsp72 binds to denatured proteins that may be essential for survival. We therefore hypothesized that Hsp72 client proteins may play a crucial role in drug resistance. Here, we aimed to identify proteins that are critical for oxaliplatin (OXA) resistance by analyzing human gastric cancer cell lines, as well as OXA-resistant cells via a mass spectrometry-based proteomic approach combined with affinity purification using anti-Hsp72 antibodies. Stromal cell-derived factor 2 (SDF-2) was identified as an Hsp72 client protein unique to OCUM-2M/OXA cells. SDF-2 was overexpressed in OXA-resistant cells and SDF-2 silencing promoted the apoptotic effects of OXA. Furthermore, Hsp72 prevented SDF-2 degradation in a chaperone activity-dependent manner. Together, our data demonstrate that Hsp72 protected SDF-2 to avoid OXA-induced cell death. We propose that inhibition of SDF-2 may comprise a novel therapeutic strategy to counteract OXA-resistant cancers. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.canlet.2016.05.002

    Web of Science

    PubMed

    researchmap

  • Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes Reviewed

    Yuichiro Fujieda, Olga Amengual, Masaki Matsumoto, Kimiko Kuroki, Hidehisa Takahashi, Michihito Kono, Takashi Kurita, Kotaro Otomo, Masaru Kato, Kenji Oku, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda, Katsumi Maenaka, Shigetsugu Hatakeyama, Keiichi I. Nakayama, Tatsuya Atsumi

    RHEUMATOLOGY   55 ( 6 )   1117 - 1126   2016.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Objective. Phosphatidylserine-dependent, also called aPS-PT, recognizes the phosphati dylserine-prothrombin complex, which is associated with APS. We have previously reported that aPS-PT induces tissue factor (TF) expression on monocytes through the p38 mitogen-activated protein kinase pathway. However, the cell surface interaction between prothrombin and aPS-PT, which is involved in the activation of cell-signalling pathways, has remained unknown. The objective of this study was to identify membrane proteins involved in the binding of prothrombin and aPS-PT to monocyte surfaces as well as the induction of TF expression.
    Methods. RAW264.7 cells with FLAG-tagged prothrombin were incubated and separated using affinity chromatography with anti-FLAG antibody-conjugated Sepharose beads. Immunopurified proteins were then analysed by an online nano-liquid chromatography-tandem mass spectrometry. The binding between prothrombin and the identified protein, ribophorin II (RPN2), was analysed by ELISA and surface plasmon resonance. To elucidate the role of RPN2 in TF expression, the TF mRNA level in RAW264.7 cells treated with RPN2 small interfering RNA was determined by quantitative real-time PCR (qPCR).
    Results. RPN2 was identified as a candidate molecule involved in the binding of prothrombin to the cell surface. The binding between prothrombin and RPN2 was confirmed by ELISA and surface plasmon resonance. RAW264.7 cells treated with RPN2 small interfering RNA showed significant reduction of the TF expression mediated by prothrombin and a mouse monoclonal aPS-PT.
    Conclusion. We identified that RPN2 is one of the prothrombin-binding proteins on monocyte surfaces, suggesting that RPN2 is involved in the pathophysiology of thrombosis in patients with APS.

    DOI: 10.1093/rheumatology/kew005

    Web of Science

    PubMed

    researchmap

  • Identification of low-abundance proteins in serum via the isolation of HSP72 complexes Reviewed

    Masako Tanaka, Masayuki Shiota, Takafumi Nakao, Ryo Uemura, Satoshi Nishi, Yasuyuki Ohkawa, Masaki Matsumoto, Maki Yamaguchi, Mayuko Osada-Oka, Azusa Inagaki, Katsuyuki Takahashi, Keiichi I. Nakayama, Min Gi, Yasukatsu Izumi, Katsuyuki Miura, Hiroshi Iwao

    JOURNAL OF PROTEOMICS   136   214 - 221   2016.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Heat shock protein 72 (HSP72) is an intracellular molecular chaperone that is overexpressed in tumor cells, and has also been detected in extracellular regions such as the blood. HSP72 forms complexes with peptides and proteins that are released from tumors. Accordingly, certain HSP72-binding proteins/peptides present in the blood of cancer patients may be derived from tumor cells. In this study, to effectively identify low-abundance proteins/peptides in the blood as tumor markers, we established a method for isolating HSP72-binding proteins/peptides from serum. Nine HSP72-specific monoclonal antibodies were conjugated to N-hydroxysulfosuccinimide-activated Sepharose beads (NHq) and used to isolate HSP72 complexes from serum samples. Precipitated proteins were then identified by LC-MS/MS analysis. Notably, this approach enabled the isolation of low-abundance proteins from serum without albumin removal. Moreover, by subjecting the serum samples of ten patients with multiple myeloma (MM) to NHq analysis, we identified 299 proteins present in MM HSP72 complexes, including 65 intracellular proteins. Among the intracellular proteins detected, 21 were present in all serum samples tested, while 11 were detected in both the conditioned media from cultured multiple myeloma cells and serum from MM patients. These results suggest that the NHq method can be applied to discover candidate tumor markers. (C) 2016 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jprot.2016.01.008

    Web of Science

    PubMed

    researchmap

  • Akt1-mediated Gata3 phosphorylation controls the repression of IFN gamma in memory-type Th2 cells Reviewed

    Hiroyuki Hosokawa, Tomoaki Tanaka, Yusuke Endo, Miki Kato, Kenta Shinoda, Akane Suzuki, Shinichiro Motohashi, Masaki Matsumoto, Keiichi I. Nakayama, Toshinori Nakayama

    NATURE COMMUNICATIONS   7   11289   2016.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Th2 cells produce Th2 cytokines such as IL-4, IL-5 and IL-13, but repress Th1 cytokine IFN gamma. Recent studies have revealed various distinct memory-type Th2 cell subsets, one of which produces a substantial amount of IFNg in addition to Th2 cytokines, however it remains unclear precisely how these Th2 cells produce IFNg. We herein show that phosphorylation of Gata3 at Ser308, Thr315 and Ser316 induces dissociation of a histone deacetylase Hdac2 from the Gata3/Chd4 repressive complex in Th2 cells. We also identify Akt1 as a Gata3-phosphorylating kinase, and the activation of Akt1 induces derepression of Tbx21 and Ifng expression in Th2 cells. Moreover, T-bet-dependent IFNg expression in IFN gamma-producing memory Th2 cells appears to be controlled by the phosphorylation status of Gata3 in human and murine systems. Thus, this study highlights the molecular basis for posttranslational modifications of Gata3 that control the regulation of IFNg expression in memory Th2 cells.

    DOI: 10.1038/ncomms11289

    Web of Science

    PubMed

    researchmap

  • インスリン作用のトランスオミクス解析

    黒田 真也, 小鍛治 俊也, 伊藤 有紀, 幡野 敦, 山本 香織, 柚木 克之, 中山 敬一, 松本 雅記, 曽我 朋義

    糖尿病   59 ( Suppl.1 )   S - 334   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本糖尿病学会  

    researchmap

  • Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels Reviewed

    Daichi Inoue, Masaki Matsumoto, Reina Nagase, Makoto Saika, Takeshi Fujino, Keiiehi. I. Nakayama, Toshio Kitamura

    EXPERIMENTAL HEMATOLOGY   44 ( 3 )   172 - 176   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    Recent progress in deep sequencing technologies has revealed many novel mutations in a variety of genes in patients with myelodysplastic syndromes (MDS). Most of these mutations are thought to be loss-of-function mutations, with some exceptions, such as the gain-of-function IDH1/2 and SRSF2 mutations. Among the mutations, ASXL1 mutations attract much attention; the ASXL1 mutations are identified in a variety of hematologic malignancies and always predicts poor prognosis. It was found that the C-terminal truncating mutants of the ASXL1 or ASXL1 deletion induced MDS-like diseases in mouse. In addition, it has recently been reported that ASXL1 mutations are frequently found in clonal hematopoiesis in healthy elderly people, who frequently progress to hematologic malignancies. However, the underlying molecular mechanisms by which ASXL1 mutations induce hematologic malignancies are not fully understood. Moreover, whether ASXL1 mutations are loss-of-function mutations or dominant-negative or gain-of-function mutations remains a matter of controversy. We here present solid evidence indicating that the C-terminal truncating ASXL1 protein is indeed expressed in cells harboring homozygous mutations of ASXL1, indicating the ASXL1 mutations are dominant-negative or gain-of-function mutations; for the first time, we detected the truncated ASXL1 proteins in two cell lines lacking the intact ASXL1 gene by mass spectrometry and Western blot analyses. Thus, together with our previous results, the present results indicate that the truncating ASXL1 mutant is indeed expressed in MDS cells and may play a role in MDS pathogenesis not previously considered. Copyright (C) 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.

    DOI: 10.1016/j.exphem.2015.11.011

    Web of Science

    PubMed

    researchmap

  • UV Damage-Induced Phosphorylation of HBO1 Triggers CRL4(DDB2)-Mediated Degradation To Regulate Cell Proliferation Reviewed

    Ryoichi Matsunuma, Hiroyuki Niida, Tatsuya Ohhata, Kyoko Kitagawa, Satoshi Sakai, Chiharu Uchida, Bunsyo Shiotani, Masaki Matsumoto, Keiichi I. Nakayama, Hiroyuki Ogura, Norihiko Shiiya, Masatoshi Kitagawa

    MOLECULAR AND CELLULAR BIOLOGY   36 ( 3 )   394 - 406   2016.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    Histone acetyltransferase binding to ORC-1 (HBO1) is a critically important histone acetyltransferase for forming the prereplicative complex (pre-RC) at the replication origin. Pre-RC formation is completed by loading of the MCM2-7 heterohexameric complex, which functions as a helicase in DNA replication. HBO1 recruited to the replication origin by CDT1 acetylates histone H4 to relax the chromatin conformation and facilitates loading of the MCM complex onto replication origins. However, the acetylation status and mechanism of regulation of histone H3 at replication origins remain elusive. HBO1 positively regulates cell proliferation under normal cell growth conditions. Whether HBO1 regulates proliferation in response to DNA damage is poorly understood. In this study, we demonstrated that HBO1 was degraded after DNA damage to suppress cell proliferation. Ser50 and Ser53 of HBO1 were phosphorylated in an ATM/ATR DNA damage sensor-dependent manner after UV treatment. ATM/ATR-dependently phosphorylated HBO1 preferentially interacted with DDB2 and was ubiquitylated by CRL4(DDB2). Replacement of endogenous HBO1 in Ser50/53Ala mutants maintained acetylation of histone H3K14 and impaired cell cycle regulation in response to UV irradiation. Our findings demonstrate that HBO1 is one of the targets in the DNA damage checkpoint. These results show that ubiquitin-dependent control of the HBO1 protein contributes to cell survival during UV irradiation.

    DOI: 10.1128/MCB.00809-15

    Web of Science

    PubMed

    researchmap

  • Tissue-specific expression of histone H3 variants diversified after species separation Reviewed

    Kazumitsu Maehara, Akihito Harada, Yuko Sato, Masaki Matsumoto, Keiichi I. Nakayama, Hiroshi Kimura, Yasuyuki Ohkawa

    EPIGENETICS & CHROMATIN   8   35   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: The selective incorporation of appropriate histone variants into chromatin is critical for the regulation of genome function. Although many histone variants have been identified, a complete list has not been compiled.
    Results: We screened mouse, rat and human genomes by in silico hybridization using canonical histone sequences. In the mouse genome, we identified 14 uncharacterized H3 genes, among which 13 are similar to H3.3 and do not have human or rat counterparts, and one is similar to human testis-specific H3 variant, H3T/H3.4, and had a rat paralog. Although some of these genes were previously annotated as pseudogenes, their tissue-specific expression was confirmed by sequencing the 3'-UTR regions of the transcripts. Certain new variants were also detected at the protein level by mass spectrometry. When expressed as GFP-tagged versions in mouse C2C12 cells, some variants were stably incorporated into chromatin and the genome-wide distributions of most variants were similar to that of H3.3. Moreover, forced expression of H3 variants in chromatin resulted in alternate gene expression patterns after cell differentiation.
    Conclusions: We comprehensively identified and characterized novel mouse H3 variant genes that encoded highly conserved amino acid sequences compared to known histone H3. We speculated that the diversity of H3 variants acquired after species separation played a role in regulating tissue-specific gene expression in individual species. Their biological relevance and evolutionary aspect involving pseudogene diversification will be addressed by further functional analysis.

    DOI: 10.1186/s13072-015-0027-3

    Web of Science

    PubMed

    researchmap

  • Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer Reviewed

    Shojiro Kikuchi, Nobuaki Kaibe, Koji Morimoto, Hirokazu Fukui, Hirotaka Niwa, Yoshihiro Maeyama, Masashi Takemura, Masaki Matsumoto, Shoji Nakamori, Hiroto Miwa, Seiichi Hirota, Mitsuru Sasako

    GASTRIC CANCER   18 ( 3 )   485 - 494   2015.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Microenvironments control cancer growth and progression. We explored the prognostic impact of stromal reaction and cancer stromal cells on relapse risk and survival after curative gastrectomy in gastric cancer patients.
    Tissue samples were obtained from 107 patients with gastric adenocarcinoma who underwent curative (R0) gastrectomy. Primary stromal cells isolated from gastric cancer tissue (GCSC) and normal gastric tissue (Gastric stromal cell: GSC) in each patient were cultured and subjected to comprehensive proteome (LC-MS/MS) and real-time RT-PCR analysis. Expression of Ephrin A2 receptors (EphA2) in cancers and GCSC was evaluated immunohistochemically. Intermingling of EphA2-positive cancer cells and GCSC (IC/A2+) and overexpression of EphA2 in cancer cells (Ca/A2+) in invasive parts of tumors were assessed, as were relationships of IC/A2+, Ca/A2+, and clinicopathological factors with relapse-free survival and overall survival.
    Proteome analysis showed that EphA2 expression was significantly higher in GCSC than GSC. Real-time RT-PCR analysis showed that levels of EphA1/A2/A3/A5 and EphB2/B4 were a parts per thousand yen2.0-fold higher in GCSC than GSC. Ca/A2 and IC/A2 were positive in 65 (60.7 %) and 26 (24.3 %) patients, respectively. Relapse was significantly more frequent in IC/A2-positive than in IC/A2-negative (HR, 2.12; 95 % CI, 1.16-5.41; p = 0.0207) patients. Among the 54 patients who received S-1 adjuvant chemotherapy, relapse-free survival (RFS) was significantly shorter in those who were IC/A2-positive than in those who were IC/A2-negative and Ca/A2-negative (HR, 2.83; 95 % CI, 1.12-12.12; p = 0.0339). Multivariable analysis indicated that pathological stage (p = 0.010) and IC/A2+ (p = 0.008) were independent risk factors for recurrence.
    IC/A2+ was predictive of relapse after curative (R0) gastrectomy.

    DOI: 10.1007/s10120-014-0390-y

    Web of Science

    PubMed

    researchmap

  • Methylation of Gata3 protein at Arg-261 regulates transactivation of the Il5 gene in T helper 2 cells Reviewed

    Hosokawa, H., Kato, M., Tohyama, H., Tamaki, Y., Endo, Y., Kimura, M.Y., Tumes, D.J., Motohashi, S., Matsumoto, M., Nakayama, K.I., Tanaka, T., Nakayama, T.

    Journal of Biological Chemistry   290 ( 21 )   13095 - 13103   2015

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1074/jbc.M114.621524

    Scopus

    PubMed

    researchmap

  • Reconstruction of Insulin Signal Flow from Phosphoproteome and Metabolome Data Reviewed

    Katsuyuki Yugi, Hiroyuki Kubota, Yu Toyoshima, Rei Noguchi, Kentaro Kawata, Yasunori Komori, Shinsuke Uda, Katsuyuki Kunida, Yoko Tomizawa, Yosuke Funato, Hiroaki Miki, Masaki Matsumoto, Keiichi I. Nakayama, Kasumi Kashikura, Keiko Endo, Kazutaka Ikeda, Tomoyoshi Soga, Shinya Kuroda

    CELL REPORTS   8 ( 4 )   1171 - 1183   2014.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Cellular homeostasis is regulated by signals through multiple molecular networks that include protein phosphorylation and metabolites. However, where and when the signal flows through a network and regulates homeostasis has not been explored. We have developed a reconstruction method for the signal flow based on time-course phosphoproteome and metabolome data, using multiple databases, and have applied it to acute action of insulin, an important hormone for metabolic homeostasis. An insulin signal flows through a network, through signaling pathways that involve 13 protein kinases, 26 phosphorylated metabolic enzymes, and 35 allosteric effectors, resulting in quantitative changes in 44 metabolites. Analysis of the network reveals that insulin induces phosphorylation and activation of liver-type phosphofructokinase 1, thereby controlling a key reaction in glycolysis. We thus provide a versatile method of reconstruction of signal flow through the network using phosphoproteome and metabolome data.

    DOI: 10.1016/j.celrep.2014.07.021

    Web of Science

    PubMed

    researchmap

  • Fbw7 Targets GATA3 through Cyclin-Dependent Kinase 2-Dependent Proteolysis and Contributes to Regulation of T-Cell Development Reviewed

    Kyoko Kitagawa, Kiyoshi Shibata, Akinobu Matsumoto, Masaki Matsumoto, Tatsuya Ohhata, Keiichi I. Nakayama, Hiroyuki Niida, Masatoshi Kitagawa

    MOLECULAR AND CELLULAR BIOLOGY   34 ( 14 )   2732 - 2744   2014.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    Proper development of T cells depends on lineage-specific regulators controlled transcriptionally and posttranslationally to ensure precise levels at appropriate times. Conditional inactivation of F-box protein Fbw7 in mouse T-cell development resulted in reduced thymic CD4 single-positive (SP) and splenic CD4(+) and CD8(+) cell proportions. Fbw7 deficiency skewed CD8 SP lineage differentiation, which exhibited a higher incidence of apoptosis. Similar perturbations during development of CD8-positive cells were reported with transgenic mice, which enforced GATA3 (T-cell differentiation regulator) expression throughout T-cell development. We observed augmented GATA3 in CD4/CD8 double negative (DN) stage 4, CD4 SP, and CD8 SP lineages in Fbw7-deficient thymocytes. Using overexpressed proteins in cultured cells, we demonstrated that Fbw7 bound to, ubiquitylated, and destabilized GATA3. Two Cdc4 phosphodegron (CPD) candidate sequences, consensus Fbw7 recognition domains, were identified in GATA3, and phosphorylation of Thr-156 in CPD was required for Fbw7-mediated ubiquitylation and degradation. Phosphorylation of GATA3 Thr-156 was detected in mouse thymocytes, and cyclin-dependent kinase 2 (CDK2) was identified as a respondent for phosphorylation at Thr-156. These observations suggest that Fbw7-mediated GATA3 regulation with CDK2-mediated phosphorylation of CPD contributes to the precise differentiation of T-cell lineages.

    DOI: 10.1128/MCB.01549-13

    Web of Science

    PubMed

    researchmap

  • Structural elucidation of an asparagine-linked oligosaccharide from the hyperthermophilic archaeon, Pyrococcus furiosus Reviewed

    Daisuke Fujinami, Masaki Matsumoto, Takuya Noguchi, Kenji Sonomoto, Daisuke Kohda

    CARBOHYDRATE RESEARCH   387   30 - 36   2014.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCI LTD  

    An oligosaccharide chain attached to the asparagine residue in a structurally defined peptide was produced by an in vitro oligosaccharide-transfer reaction, using membrane fractions that contained the oligosaccharyltransferase from the hyperthermophilic archaeon, Pyrococcus furiosus. The chemical structure of the N-glycan was elucidated by sugar analysis, NMR spectroscopy, and MS spectrometry, which revealed the structure.
    alpha-D-ManpNAc-(1 -&gt; 4)-alpha-D-GlcAp-(1 -&gt; 3)-alpha-D-Manp-(1 -&gt; 2)-alpha-D-Manp-(1 -&gt; 3)-beta-D-GalpNAc-Asm 3 2 up arrow up arrow 1 1 beta-D-Xylp beta-D-Xylp
    The shorter glycan structures lacking one or two xylose residues were also transferred by the P. furiosus oligosaccharyltransferase. The archaeal N-glycans are known to exhibit a high degree of structural variation. The structure of the P. furiosus N-glycan is novel and unique. The present data will be useful for structural and functional studies of the P. furiosus oligosaccharyltransferase. (C) 2014 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.carres.2014.01.021

    Web of Science

    PubMed

    researchmap

  • Identification of anti-Sez612 antibody in a patient with cerebellar ataxia and retinopathy Reviewed

    Hiroaki Yaguchi, Ichiro Yabe, Hidehisa Takahashi, Fumihiko Okumura, Akiko Takeuchi, Kazuhiro Horiuchi, Takahiro Kano, Atsuhiro Kanda, Wataru Saito, Masaki Matsumoto, Keiichi I. Nakayama, Shigetsugu Hatakeyama, Hidenao Sasaki

    JOURNAL OF NEUROLOGY   261 ( 1 )   224 - 226   2014.1

     More details

    Language:English   Publisher:SPRINGER HEIDELBERG  

    DOI: 10.1007/s00415-013-7134-5

    Web of Science

    PubMed

    researchmap

  • ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway Reviewed

    Shungo Adachi, Masae Homoto, Rikou Tanaka, Yusaku Hioki, Hiroshi Murakami, Hiroaki Suga, Masaki Matsumoto, Keiichi I. Nakayama, Tomohisa Hatta, Shun-ichiro Iemura, Tohru Natsume

    NUCLEIC ACIDS RESEARCH   42 ( 15 )   10037 - 10049   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Low-density lipoprotein receptor (LDLR) mRNA is unstable, but is stabilized upon extracellular signal-regulated kinase (ERK) activation, possibly through the binding of certain proteins to the LDLR mRNA 3'-untranslated region (UTR), although the detailed mechanism underlying this stability control is unclear. Here, using a proteomic approach, we show that proteins ZFP36L1 and ZFP36L2 specifically bind to the 3'-UTR of LDLR mRNA and recruit the CCR4-NOT-deadenylase complex, resulting inmRNA destabilization. We also show that the C-terminal regions of ZFP36L1 and ZFP36L2 are directly phosphorylated by p90 ribosomal S6 kinase, a kinase downstream of ERK, resulting in dissociation of the CCR4-NOT-deadenylase complex and stabilization of LDLR mRNA. We further demonstrate that targeted disruption of the interaction between LDLR mRNA and ZFP36L1 and ZFP36L2 using antisense oligonucleotides results in upregulation of LDLR mRNA and protein. These results indicate that ZFP36L1 and ZFP36L2 regulate LDLR protein levels downstream of ERK. Our results also show the usefulness of our method for identifying critical regulators of specific RNAs and the potency of antisense oligonucleotide-based therapeutics.

    DOI: 10.1093/nar/gku652

    Web of Science

    PubMed

    researchmap

  • Accurate quantitative mapping of human proteome by using comprehensive targeted proteomics

    Matsumoto Masaki, I. Nakayama Keiichi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2014   28 - 28   2014

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2014.0.28.0

    CiNii Article

    researchmap

  • F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation. Reviewed International journal

    Kanae Yumimoto, Masaki Matsumoto, Ichiro Onoyama, Kazunori Imaizumi, Keiichi I Nakayama

    The Journal of biological chemistry   288 ( 40 )   28488 - 502   2013.10

     More details

    Language:English  

    Although identification of substrates for an enzyme is a key step in elucidation of its biological functions, detection of the interaction between enzymes and substrates remains challenging. We recently developed a new approach, termed differential proteomics-based identification of ubiquitylation substrates (DiPIUS), for the discovery of substrates of ubiquitin ligases. We have now applied this approach to Fbxw7, the F-box protein component of an Skp1-Cul1-F-box protein-type ubiquitin ligase and, thereby, identified two similar transcription factors, old astrocyte specifically induced substance (OASIS) and BBF2 human homolog on chromosome 7 (BBF2H7), as candidate substrates. Coimmunoprecipitation analysis confirmed that the α and γ isoforms of Fbxw7 interact with OASIS and BBF2H7 in vivo. Sustained overexpression of Fbxw7 resulted in marked down-regulation of OASIS and BBF2H7, whereas RNAi-mediated Fbxw7 depletion stabilized both proteins. Mutation of a putative Cdc4 phosphodegron in OASIS and BBF2H7 attenuated their association with Fbxw7 and resulted in their stabilization. Depletion of Fbxw7 promoted the differentiation of mouse C2C12 mesenchymal cells into osteoblasts in association with the accumulation of OASIS. Conversely, overexpression of Fbxw7 in C2C12 cells resulted in down-regulation of Col1A1 mRNA, a target of OASIS. Conditional ablation of Fbxw7 in primary mouse mesenchymal cells promoted chondrogenesis in association with up-regulation of BBF2H7, whereas overexpression of Fbxw7 inhibited chondrogenesis in ATDC5 cells. Collectively, our results suggest that OASIS and BBF2H7 are bona fide substrates of Fbxw7 and that Fbxw7 controls osteogenesis and chondrogenesis by targeting OASIS and BBF2H7, respectively, for degradation.

    DOI: 10.1074/jbc.M113.465179

    PubMed

    researchmap

  • Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1 Reviewed

    Asataro Yamamoto, Ryu Takeya, Masaki Matsumoto, Keiichi I. Nakayama, Hideki Sumimoto

    FEBS JOURNAL   280 ( 20 )   5145 - 5159   2013.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Superoxide production by Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1 (Nox activator 1) and is markedly enhanced upon cell stimulation with phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC). The mechanism underlying PMA-induced enhancement of Nox1 activity, however, remains to be elucidated. Here we show that, in response to PMA, Noxo1 undergoes phosphorylation at multiple sites, which is inhibited by the PKC inhibitor GF109203X. Among them, Thr341 in Noxo1 is directly phosphorylated by PKC invitro, and alanine substitution for this residue reduces not only PMA-induced Noxo1 phosphorylation but also PMA-dependent enhancement of Nox1-catalyzed superoxide production. Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1, an interaction that participates in Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1; this serine is the major residue that is phosphorylated by PKA invitro. Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1 activity in different manners.

    DOI: 10.1111/febs.12489

    Web of Science

    PubMed

    researchmap

  • FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes. Reviewed International journal

    Arisa Hirano, Kanae Yumimoto, Ryosuke Tsunematsu, Masaki Matsumoto, Masaaki Oyama, Hiroko Kozuka-Hata, Tomoki Nakagawa, Darin Lanjakornsiripan, Keiichi I Nakayama, Yoshitaka Fukada

    Cell   152 ( 5 )   1106 - 18   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In the mammalian circadian clockwork, CRY1 and CRY2 repressor proteins are regulated by posttranslational modifications for temporally coordinated transcription of clock genes. Previous studies revealed that FBXL3, an F-box-type E3 ligase, ubiquitinates CRYs and mediates their degradation. Here, we found that FBXL21 also ubiquitinates CRYs but counteracts FBXL3. Fbxl21(-/-) mice exhibited normal periodicity of wheel-running rhythms with compromised organization of daily activities, while an extremely long-period phenotype of Fbxl3(-/-) mice was attenuated in Fbxl3/Fbxl21 double-knockout mice. The double knockout destabilized the behavioral rhythms progressively and sometimes elicited arrhythmicity. Surprisingly, FBXL21 stabilized CRYs and antagonized the destabilizing action by FBXL3. Predominantly cytosolic distribution of FBXL21 contrasts with nuclear localization of FBXL3. These results emphasize the physiological importance of antagonizing actions between FBXL21 and FBXL3 on CRYs, and their combined actions at different subcellular locations stabilize oscillation of the circadian clock.

    DOI: 10.1016/j.cell.2013.01.054

    PubMed

    researchmap

  • A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. Reviewed International journal

    Ryohei Narumi, Tatsuo Murakami, Takahisa Kuga, Jun Adachi, Takashi Shiromizu, Satoshi Muraoka, Hideaki Kume, Yoshio Kodera, Masaki Matsumoto, Keiichi Nakayama, Yasuhide Miyamoto, Makoto Ishitobi, Hideo Inaji, Kikuya Kato, Takeshi Tomonaga

    Journal of proteome research   11 ( 11 )   5311 - 22   2012.11

     More details

    Language:English  

    Protein phosphorylation is a key mechanism of cellular signaling pathways and aberrant phosphorylation has been implicated in a number of human diseases. Thus, approaches in phosphoproteomics can contribute to the identification of key biomarkers to assess disease pathogenesis and drug targets. Moreover, careful validation of large-scale phosphoproteome analysis, which is lacking in the current protein-based biomarker discovery, significantly increases the value of identified biomarkers. Here, we performed large-scale differential phosphoproteome analysis using IMAC coupled with the isobaric tag for relative quantification (iTRAQ) technique and subsequent validation by selected/multiple reaction monitoring (SRM/MRM) of human breast cancer tissues in high- and low-risk recurrence groups. We identified 8309 phosphorylation sites on 3401 proteins, of which 3766 phosphopeptides (1927 phosphoproteins) were able to be quantified and 133 phosphopeptides (117 phosphoproteins) were differentially expressed between the two groups. Among them, 19 phosphopeptides were selected for further verification and 15 were successfully quantified by SRM using stable isotope peptides as a reference. The ratio of phosphopeptides between high- and low-risk groups quantified by SRM was well correlated with iTRAQ-based quantification with a few exceptions. These results suggest that large-scale phosphoproteome quantification coupled with SRM-based validation is a powerful tool for biomarker discovery using clinical samples.

    DOI: 10.1021/pr3005474

    PubMed

    researchmap

  • Ribophorin II Is Involved in the Tissue Factor Expression Mediated by Phosphatidylserine-Dependent Antiprothrombin Antibody On Monocytes. Reviewed

    Yuichiro Fujieda, Olga Amengual, Yusaku Kanetsuka, Toshio Odani, Kotaro Otomo, Kenji Oku, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda, Kimiko Kuroki, Katsumi Maenaka, Masaki Matsumoto, Shigetsugu Hatakeyama, Tatsuya Atsumi

    ARTHRITIS AND RHEUMATISM   64 ( 10 )   S741 - S741   2012.10

     More details

    Language:English   Publisher:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Comprehensive Identification of Substrates for F-box Proteins by Differential Proteomics Analysis Reviewed

    Kanae Yumimoto, Masaki Matsumoto, Koji Oyamada, Toshiro Moroishi, Keiichi I. Nakayama

    JOURNAL OF PROTEOME RESEARCH   11 ( 6 )   3175 - 3185   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Although elucidation of enzyme substrate relations is fundamental to the advancement of biology, universal approaches to the identification of substrates for a given enzyme have not been established. It is especially difficult to identify substrates for ubiquitin ligases, given that most such substrates are immediately ubiquitylated and degraded as a result of their association with the enzyme. We here describe the development of a new approach, DiPIUS (differential proteomics-based identification of ubiquitylation substrates), to the discovery of substrates for ubiquitin ligases. We applied DiPIUS to Fbxw7 alpha, Skp2, and Fbxl5, three of the most well-characterized F-box proteins, and identified candidate substrates including previously known targets. DiPIUS is thus a powerful tool for unbiased and comprehensive screening for substrates of ubiquitin ligases.

    DOI: 10.1021/pr201216u

    Web of Science

    PubMed

    researchmap

  • Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling Reviewed

    Ning Liu, Masaki Matsumoto, Kyoko Kitagawa, Yojiro Kotake, Sayuri Suzuki, Senji Shirasawa, Keiichi I. Nakayama, Makoto Nakanishi, Hiroyuki Niida, Masatoshi Kitagawa

    EMBO JOURNAL   31 ( 10 )   2365 - 2377   2012.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The tumour suppressor gene product Mig-6 acts as an inhibitor of epidermal growth factor (EGF) signalling. However, its posttranslational modifications and regulatory mechanisms have not been elucidated. Here, we investigated the phosphorylation of human Mig-6 and found that Chk1 phosphorylated Mig-6 in vivo as well as in vitro. Moreover, EGF stimulation promoted phosphorylation of Mig-6 without DNA damage and the phosphorylation was inhibited by depletion of Chk1. EGF also increased Ser280-phosphorylated Chk1, a cytoplasmic-tethering form, via PI3K pathway. Mass spectrometric analyses suggested that Ser 251 of Mig-6 was a major phosphorylation site by Chk1 in vitro and in vivo. Substitution of Ser 251 to alanine increased inhibitory activity of Mig-6 against EGF receptor (EGFR) activation. Moreover, EGF-dependent activation of EGFR and cell growth were inhibited by Chk1 depletion, and were rescued by co-depletion of Mig-6. Our results suggest that Chk1 phosphorylates Mig-6 on Ser 251, resulting in the inhibition of Mig-6, and that Chk1 acts as a positive regulator of EGF signalling. This is a novel function of Chk1. The EMBO Journal (2012) 31, 2365-2377. doi: 10.1038/emboj.2012.88; Published online 13 April 2012

    DOI: 10.1038/emboj.2012.88

    Web of Science

    PubMed

    researchmap

  • Crystal Structure of the C-Terminal Globular Domain of Oligosaccharyltransferase from Archaeoglobus fulgidus at 1.75 angstrom Resolution Reviewed

    Shunsuke Matsumoto, Mayumi Igura, James Nyirenda, Masaki Matsumoto, Satoru Yuzawa, Nobuo Noda, Fuyuhiko Inagaki, Daisuke Kohda

    BIOCHEMISTRY   51 ( 20 )   4157 - 4166   2012.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Protein N-glycosylation occurs in the three domains of life. Oligosaccharyltransferase (OST) transfers glycan to asparagine in the N-glycosylation sequon. The catalytic subunit of OST is called STT3 in eukaryotes, AglB in archaea, and PglB in eubacteria. The genome of a hyperthermophilic archaeon, Archaeoglobus fulgidus, encodes three AglB paralogs. Two of them are the shortest AglBs across all domains of life. We determined the crystal structure of the C-terminal globular domain of the smallest AglB to identify the minimal structural unit. The Archaeoglobus AglB lacked a beta-barrel-like structure, which had been found in other AglB and PglB structures. In agreement, the deletion in a larger Pyrococcus AglB confirmed its dispensability for the activity. By contrast, the Archaeoglobus AglB contains a kinked helix bearing a conserved motif, called DK/MI motif. The lysine and isoleucine residues in the motif participate in the Ser/Thr recognition in the sequon. The Archaeoglobus AglB structure revealed that the kinked helix contained an unexpected insertion. A revised sequence alignment based on this finding identified a variant type of the DK motif with the insertion. A mutagenesis study of the Archaeoglobus AglB confirmed the contribution of this particular type of the DK motif to the activity. When taken together with our previous results, this study defined the classification of OST: one group consisting of eukaryotes and most archaea possesses the DK-type Ser/Thr pocket, and the other group consisting of eubacteria and the remaining archaea possesses the MI-type Ser/Thr pocket. This classification provides a useful framework for OST studies.

    DOI: 10.1021/bi300076u

    Web of Science

    PubMed

    researchmap

  • Genetic Reevaluation of the Role of F-Box Proteins in Cyclin D1 Degradation Reviewed

    Tomoharu Kanie, Ichiro Onoyama, Akinobu Matsumoto, Masanori Yamada, Hirokazu Nakatsumi, Yuki Tateishi, So Yamamura, Ryosuke Tsunematsu, Masaki Matsumoto, Keiichi I. Nakayama

    MOLECULAR AND CELLULAR BIOLOGY   32 ( 3 )   590 - 605   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    D-type cyclins play a pivotal role in G(1)-S progression of the cell cycle, and their expression is frequently deregulated in cancer. Cyclin D1 has a half-life of only similar to 30 min as a result of its ubiquitylation and proteasomal degradation, with various F-box proteins, including Fbxo4, Fbxw8, Skp2, and Fbxo31, having been found to contribute to its ubiquitylation. We have now generated Fbxo4-deficient mice and found no abnormalities in these animals. Cyclin D1 accumulation was thus not observed in Fbxo4(-/-) mouse tissues. The half-life of cyclin D1 in mouse embryonic fibroblasts (MEFs) prepared from Fbxo4(-/-), Fbxw8(-/-), and Fbxo4(-/-); Fbxw8(-/-) mice also did not differ from that in wild-type MEFs. Additional depletion of Skp2 and Fbxo31 in Fbxo4(-/-); Fbxw8(-/-) MEFs by RNA interference did not affect cyclin D1 stability. Although Fbxo31 depletion in MEFs increased cyclin D1 abundance, this effect appeared attributable to upregulation of cyclin D1 mRNA. Furthermore, abrogation of the function of the Skp1-Cul1-F-box protein (SCF) complex or the anaphase-promoting complex/cyclosome (APC/C) complexes did not alter the half-life of cyclin D1, whereas cyclin D1 degradation was dependent largely on proteasome activity. Our genetic analyses thus do not support a role for any of the four F-box proteins examined in cyclin D1 degradation during normal cell cycle progression. They suggest the existence of other ubiquitin ligases that target cyclin D1 for proteolysis.

    DOI: 10.1128/MCB.06570-11

    Web of Science

    PubMed

    researchmap

  • Proteome-wide Identification of Ubiquitylation Sites by Conjugation of Engineered Lysine-less Ubiquitin Reviewed

    Kiyotaka Oshikawa, Masaki Matsumoto, Koji Oyamada, Keiichi I. Nakayama

    JOURNAL OF PROTEOME RESEARCH   11 ( 2 )   796 - 807   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Ubiquitin conjugation (ubiquitylation) plays important roles not only in protein degradation but also in many other cellular functions. However, the sites of proteins that are targeted for such modification have remained poorly characterized at the proteomic level. We have now developed a method for the efficient identification of ubiquitylation sites in target proteins with the use of an engineered form of ubiquitin (K0-Ub), in which all seven lysine residues are replaced with arginine. K0-Ub is covalently attached to lysine residues of target proteins via an isopeptide bond, but further formation of a polyubiquitin chain does not occur on K0-Ub. We identified a total of 1392 ubiquitylation sites of 794 proteins from HEK293T cells. Profiling of ubiquitylation sites indicated that the sequences surrounding lysine residues targeted for ubiquitin conjugation do not share a common motif or structural feature Furthermore, we identified a critical ubiquitylation site of the cyclin-dependent kinase inhibitor p27(KiP1). Mutation of this site thus inhibited ubiquitration of and stabilized p27(KiP1), suggesting that this lysine residue is the target site of p27(Kip1) for ubiquitin conjugation in vivo. In conclusion, our method based on K0-Ub is a powerful tool for proteome-wide identification of ubiquitylation sites of target proteins.

    DOI: 10.1021/pr200668y

    Web of Science

    PubMed

    researchmap

  • Comprehensive study of protein ubiquitylation sites by conjugation of engineered lysine-less ubiquitin Reviewed

    Kiyotaka Oshikawa, Masaki Matsumoto, Keiichi I. Nakayama

    Seikagaku   84 ( 6 )   479 - 487   2012

     More details

    Language:Japanese  

    Scopus

    PubMed

    researchmap

  • New horizons in biological research developed by nextgeneration proteomics: Say good-bye to western blotting Reviewed

    Hirokazu Nakatsumi, Masaki Matsumoto, Keiichi Nakayama

    Seikagaku   84 ( 1 )   53 - 57   2012

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Scopus

    PubMed

    researchmap

  • Discovery of early-response kinases in DNA-damage signaling using phosphoproteome analysis

    Adachi Jun, Kuga Takahisa, Shiromizu Takashi, Kume Hideaki, Muraoka Satoshi, Hashiguchi Kazunari, Narumi Ryohei, Watanabe Shio, Kuwano Masayoshi, Matsumoto Masaki, Nakayama Kei-ichi, Ikura Masae, Ikura Tsuyoshi, Takata Minoru, Tomonaga Takeshi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2012   188 - 188   2012

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2012.0.188.0

    CiNii Article

    researchmap

  • Comprehensive identification of substrates for calcineurin using quantitative phosphoproteomics

    Hatano Atsushi, Matsumoto Masaki, I. Nakayama Keiichi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2012   187 - 187   2012

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2012.0.187.0

    CiNii Article

    researchmap

  • Absolute quantification of all human proteins by large-sacle targeted proteomics

    Matsumoto Masaki, Oshikawa Kiyotaka, Matsuzaki Fumiko, Nakayama Keiichi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2012   56 - 56   2012

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2012.0.56.0

    CiNii Article

    researchmap

  • Protrudin serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation Reviewed

    Fumiko Matsuzaki, Michiko Shirane, Masaki Matsumoto, Keiichi I. Nakayama

    MOLECULAR BIOLOGY OF THE CELL   22 ( 23 )   4602 - 4620   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC CELL BIOLOGY  

    Neurons are highly polarized cells with long neurites. Vesicular transport is required for neurite extension. We recently identified protrudin as a key regulator of vesicular transport during neurite extension. Expression of protrudin in nonneuronal cells thus induces formation of neurite-like membrane protrusions. We adopted a proteomics approach to identify proteins that associate with protrudin. Among the protrudin-associated proteins, including many with a function related to intracellular trafficking, we focused on KIF5, a motor protein that mediates anterograde vesicular transport in neurons. A coimmunoprecipitation assay confirmed that endogenous protrudin and KIF5 interact in mouse brain. Overexpression of KIF5 induced the formation of membrane protrusions in HeLa cells, reminiscent of the effect of protrudin overexpression. Forced expression of both protrudin and KIF5 promoted protrusion extension in a synergistic manner, whereas depletion of either protein attenuated protrusion formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons. Given that mutation of protrudin or KIF5 is a cause of human hereditary spastic paraplegia, the protrudin-KIF5 axis appears to be integral to neuronal function.

    DOI: 10.1091/mbc.E11-01-0068

    Web of Science

    PubMed

    researchmap

  • Role of Apolipoprotein B100 and Oxidized Low-Density Lipoprotein in Anti-beta2 Glycoprotein I Induced Tissue Factor Expression on Monocytes Reviewed

    Kotaro Otomo, Tatsuya Atsumi, Yuichiro Fujieda, Hisako Nakagawa, Masaru Kato, Olga Amengual, Tetsuya Horita, Shinsuke Yasuda, Masaki Matsumoto, Shigetsugu Hatakeyama, Takao Koike

    ARTHRITIS AND RHEUMATISM   63 ( 10 )   S6 - S6   2011.10

     More details

    Language:English   Publisher:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • TRIM8 regulates Nanog via Hsp90β-mediated nuclear translocation of STAT3 in embryonic stem cells. Reviewed

    Okumura F, Okumura AJ, Matsumoto M, Nakayama KI, Hatakeyama S

    Biochimica et biophysica acta   1813 ( 10 )   1784 - 1792   2011.10

  • Functional Analyses of the Activation Loop of Phototropin2 in Arabidopsis Reviewed

    Shin-ichiro Inoue, Tomonao Matsushita, Yuta Tomokiyo, Masaki Matsumoto, Keiichi I. Nakayama, Toshinori Kinoshita, Ken-ichiro Shimazaki

    PLANT PHYSIOLOGY   156 ( 1 )   117 - 128   2011.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC PLANT BIOLOGISTS  

    Phototropins (phot1 and phot2) are autophosphorylating blue-light receptor kinases that mediate blue-light responses such as phototropism, chloroplast accumulation, and stomatal opening in Arabidopsis (Arabidopsis thaliana). Only phot2 induces the chloroplast avoidance response under strong blue light. The serine (Ser) residues of the kinase activation loop in phot1 are autophosphorylated by blue light, and autophosphorylation is essential for the phot1-mediated responses. However, the role of autophosphorylation in phot2 remains to be determined. In this study, we substituted the conserved residues of Ser-761 and Ser-763 with alanine (S761A S763A) in the phot2 activation loop and analyzed their function by investigating the phot2-mediated responses after the transformation of phot1 phot2 double mutant with this mutant phot2 gene. Transgenic plants expressing the mutant phot2 protein exhibited impaired responses in chloroplast movement, stomatal opening, phototropic bending, leaf flattening, and plant growth; and those expressing phot2 with S761D S763D mutations showed the normal responses. Substitution of both Ser-761 and Ser-763 with alanine in phot2 did not significantly affect the kinase activity in planta. From these results, we conclude that phosphorylation of Ser-761 and Ser-763 in the activation loop may be a common primary step for phot2-mediated responses.

    DOI: 10.1104/pp.111.175943

    Web of Science

    PubMed

    researchmap

  • Proteome of ubiquitin/MVB pathway: possible involvement of iron-induced ubiquitylation of transferrin receptor in lysosomal degradation Reviewed

    Ryo Tachiyama, Daisuke Ishikawa, Masaki Matsumoto, Keiichi I. Nakayama, Tamotsu Yoshimori, Sadaki Yokota, Masaru Himeno, Yoshitaka Tanaka, Hideaki Fujita

    GENES TO CELLS   16 ( 4 )   448 - 466   2011.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Ubiquitylation of membrane proteins triggers their endocytosis at the plasma membrane and subsequent lysosomal degradation through multivesicular bodies (MVBs). A dominant-negative mutant SKD1/Vps4B caused an accumulation of ubiquitylated membrane proteins in MVBs. We have identified 22 membrane proteins whose trafficking is potentially regulated by ubiquitylation. Nine of them, including transferrin receptor (TfR), are indeed ubiquitylated and/or accumulated in MVBs in the cells expressing mutant Vps4. While the recycling route and iron-regulated expression of TfR are well characterized, the mechanism by which the degradation of TfR is regulated is largely unknown. We show that an excess of iron enhances both TfR&apos;s ubiquitylation and degradation in lysosomes. Probably, the up-regulated expression of ferritin, an endogenous iron-chelating molecule, attenuated the iron-induced degradation of TfR. Exogenously introduced lysine-less TfR, compared to the wild-type one, showed resistance to the iron-induced ubiquitylation and degradation, when endogenous TfR, which most certainly heterodimerizes with exogenous ones, was depleted with siRNA. These data suggest that the iron-induced ubiquitylation and degradation of TfR along with MVB pathway physiologically plays an important role in iron homeostasis.

    DOI: 10.1111/j.1365-2443.2011.01499.x

    Web of Science

    PubMed

    researchmap

  • Plasma gelsolin facilitates interaction between beta(2) glycoprotein I and alpha(5)beta(1) integrin Reviewed

    Miyuki Bohgaki, Masaki Matsumoto, Tatsuya Atsumi, Takeshi Kondo, Shinsuke Yasuda, Tetsuya Horita, Keiichi I. Nakayama, Fumihiko Okumura, Shigetsugu Hatakeyama, Takao Koike

    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE   15 ( 1 )   141 - 151   2011.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Antiphospholipid syndrome (APS) is characterized by thrombosis and the presence of antiphospholipid antibodies (aPL) that directly recognizes plasma beta(2)-glycoprotein I (beta(2)GPI). Tissue factor (TF), the major initiator of the extrinsic coagulation system, is induced on monocytes by aPL in vitro, explaining in part the pathophysiology in APS. We previously reported that the mitogen-activated protein kinase (MAPK) pathway plays an important role in aPL-induced TF expression on monocytes. In this study, we identified plasma gelsolin as a protein associated with beta(2)GPI by using immunoaffinity chromatography and mass spectrometric analysis. An in vivo binding assay showed that endogenous beta(2)GPI interacts with plasma gelsolin, which binds to integrin a(5)beta(1) through fibronectin. The tethering of beta(2)GPI to monoclonal anti-beta(2)GPI autoantibody on the cell surface was enhanced in the presence of plasma gelsolin. Immunoblot analysis demonstrated that p38 MAPK protein was phosphorylated by monoclonal anti-beta(2)GPI antibody treatment, and its phosphorylation was attenuated in the presence of anti-integrin a(5)beta(1) antibody. Furthermore, focal adhesion kinase, a downstream molecule of the fibronectin-integrin signalling pathway, was phosphorylated by anti-beta(2)GPI antibody treatment. These results indicate that molecules including gelsolin and integrin are involved in the anti-beta(2)GPI antibody-induced MAPK pathway on monocytes and that integrin is a possible therapeutic target to modify a prothrombotic state in patients with APS.

    DOI: 10.1111/j.1582-4934.2009.00940.x

    Web of Science

    PubMed

    researchmap

  • Phosphoproteomic analysis of human colorectal cancer tissues for exploring a novel factor involved in cancer metastasis

    Shiromizu Takashi, Narumi Ryouhei, Kuga Takahisa, Adachi Jun, Matsubara Hisahiro, Matsumoto Masaki, Nakayama Keiichi, Tomonaga Takeshi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   127 - 127   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.127.0

    CiNii Article

    researchmap

  • Development of large-scale MRM system toward human proteome project

    I. Nakayama Keiichi, Goshima Naoki, Oyamada Koji, Natsume Tohru, Matsumoto Masaki

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   49 - 49   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.49.0

    CiNii Article

    researchmap

  • Proteomic analyses for identification and characterization of mTOR substrates

    Nakatsumi Hirokazu, Matsumoto Masaki, Oyamada Kouji, Nakayama Keiichi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   134 - 134   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.134.0

    CiNii Article

    researchmap

  • Quantitative phosphoproteomic analysis of human colorectal cancer tissues

    Kuga Takahisa, Narumi Ryohei, Murakami Tatsuo, Adachi Jun, Shiromizu Takashi, Kodera Yoshio, Matsumoto Masaki, Nakayama Kei-ichi, Matsubara Hisahiro, Tomonaga Takeshi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   76 - 76   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.76.0

    CiNii Article

    researchmap

  • Global phosphorylation and ubiquitination dynamics in DNA-damage response network

    Adachi Jun, Narumi Ryohei, Sano Shozo, Kuga Takahisa, Shiromizu Takashi, Matsumoto Masaki, Nakayama Kei-ichi, Ikura Masae, Ikura Tsuyoshi, Takata Minoru, ??? Takeshi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   132 - 132   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.132.0

    CiNii Article

    researchmap

  • Quantitative proteomics promotes life science research

    Matsumoto Masaki, Nakayama Keiichi

    Abstracts for Annual Meeting of Japanese Proteomics Society   2011   57 - 57   2011

     More details

    Language:Japanese   Publisher:Japanese Proteomics Society (Japan Human Proteome Organisation)  

    DOI: 10.14889/jhupo.2011.0.57.0

    CiNii Article

    researchmap

  • DiPIUS法を用いたユビキチンリガーゼ基質の網羅的同定

    弓本 佳苗, 松本 雅記, 小山田 浩二, 中山 敬一

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   4P - 0554   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • Human proteins that specifically bind to 8-oxoguanine-containing RNA and their responses to oxidative stress Reviewed

    Hiroshi Hayakawa, Aya Fujikane, Riyoko Ito, Masaki Matsumoto, Keiichi I. Nakayama, Mutsuo Sekiguchi

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   403 ( 2 )   220 - 224   2010.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Exposure of cells to oxygen radicals damage various biologically important molecules. Among the oxidized bases produced in nucleic acids, 8-oxo-7,8-dihydroguanine (8-oxoguanine) is particularly important since it causes base mispairing. To ensure accurate gene expression, organisms must have a mechanism to discriminate 8-oxoguanine-containing RNA from normal transcripts. We searched for proteins that specifically bind to 8-oxoguanine-containing RNA from human HeLa cell extracts, and the candidate proteins were identified using mass spectrometry. Among the identified candidates, splicing isoform 1 of heterogeneous nuclear ribonucleoprotein DO (HNRNPD) and splicing isoform Cl of heterogeneous nuclear ribonucleoprotein C1/C2 (HNRNPC) exhibited strong abilities to bind to oxidized RNA. The amount of HNRNPD protein rapidly decreased when cells were exposed to hydrogen peroxide, an agent that enhances oxidative stress. Moreover, the suppression of HNRNPD expression by siRNA caused cells to exhibit an increased sensitivity to hydrogen peroxide. The application of siRNA against HNRNPC also caused an increase in sensitivity to hydrogen peroxide. Since no additive effect was observed with a combined addition of siRNAs for HNRNPD and HNRNPC, we concluded that the two proteins may function in the same mechanism for the accurate gene expression. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2010.11.011

    Web of Science

    PubMed

    researchmap

  • Comparative Analysis of Human Src-Family Kinase Substrate Specificity in Vitro Reviewed

    Hiroyuki Takeda, Yoshifumi Kawamura, Aya Miura, Masatoshi Mori, Ai Wakamatsu, Jun-ichi Yamamoto, Takao Isogai, Masaki Matsumoto, Keiichi I. Nakayama, Tohru Natsume, Nobuo Nomura, Naoki Goshima

    JOURNAL OF PROTEOME RESEARCH   9 ( 11 )   5982 - 5993   2010.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER CHEMICAL SOC  

    Sic family kinases (SFKs) are the earliest known family of tyrosine kinases and are widely thought to play essential roles in cellular signal transduction. Although numerous functional analyses have been performed, no study has analyzed the specificity of all SFKs on an equal platform. To gain a better understanding of SFK phosphorylation, we designed a high-throughput in vitro kinase assay on the subproteome scale using surface plasmon resonance. We reacted each of the 11 human SFKs with 519 substrate proteins, and significant phosphorylation was detected in 33.6% (1921) of the total 5709 kinase substrate combinations. A large number of novel phosphorylations were included among them. Many substrates were shown to be phosphorylated by multiple SFKs, which might reflect functional complementarity of SFKs. Clustering analysis of phosphorylation results grouped substrates into 10 categories, while the similarity of SFK catalytic specificity exhibited no significant correlation with that of amino acid sequences. In silico predictions of SRC-specific phosphorylation sites were not consistent with experimental results, implying some unknown SRC recognition modes. In an attempt to find biologically meaningful novel substrates, phosphorylation data were integrated with annotation data. The extensive in vitro data obtained in this study would provide valuable clues for further understanding SFK-mediated signal transduction.

    DOI: 10.1021/pr100773t

    Web of Science

    PubMed

    researchmap

  • Nedd4-Interacting Protein 2, a Short Half-life Membrane Protein Degraded in Lysosomes, Negatively Controls Down-Regulation of Connexin43 Reviewed

    Chiho Ohzono, Sachise Etoh, Masaki Matsumoto, Keiichi I. Nakayama, Yuko Hirota, Yoshitaka Tanaka, Hideaki Fujita

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   33 ( 6 )   951 - 957   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

    Nedd4-interacting protein 2 (NDFIP2) has three transmembrane domains and interacts with multiple Nedd4 family ubiquitin ligases through polyprolinetyrosine (PY) motifs located in its N-terminal cytoplasmic domain. It has been postulated that NDFIP2 acts as an adaptor for the ubiquitylation of substrates with Nedd4 ubiquitin ligase. However, whether NDFIP2 promotes or inhibits the ubiquitylation of Nedd4 substrates is still under debate. We show here that although NDFIP2 is detected in the Golgi/trans-Colgi network (TGN) area, it is rapidly delivered to and degraded in lysosomes with its half-life ca. 1.5 h. Intriguingly, knockdown (KD) of NDFIP2 with small interfering RNA (siRNA) impaired both the formation and function of gap junctions. Indeed, KD of NDFIP2 destabilized the gap junction protein connexin43 that contains PY motif. In support of this, overexpression of NDFIP2 stabilized connexin43 and enhanced the formation of gap junctions. Furthermore, the PY motifs of NDFIP2, which are required for its interaction with Nedd4, Atrophin-I interacting protein (AIP) 4 (AIP4)/Itch, and AlP2/WWP2, were necessary for the targeting of NDFIP2 to lysosomes and/or the stability of connexin43 and gap junctions. Collectively these findings suggest that NDFIP2 may inhibit the Nedd4-dependent ubiquitylation of membrane proteins containing PY motifs, such as connexin43, in a competitive manner.

    DOI: 10.1248/bpb.33.951

    Web of Science

    PubMed

    researchmap

  • Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3 Reviewed

    Atsushi Hatano, Masaki Matsumoto, Toru Higashinakagawa, Keiichi I. Nakayama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   397 ( 1 )   93 - 99   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    The chromatin organizer modifier domain (chromodomain) is present in proteins that contribute to chromatin organization and mediates their binding to methylated histone H3. Despite a high level of sequence conservation, individual chromodomains manifest substantial differences in binding preference for methylated forms of histone H3, suggesting that posttranslational modification of the chromodomain might be an important determinant of binding specificity. We now show that mouse Cbx2 (also known as M33), a homolog of Drosophila Polycomb protein, is highly phosphorylated in some cell lines. A low-mobility band of Cbx2 observed on SDS-polyacrylamide gel electrophoresis was thus converted to a higher-mobility band by treatment with alkaline phosphatase. Mass spectrometric analysis revealed serine-42, a conserved amino acid in the chromodomain, as a phosphorylation site of Cbx2. Phosphorylation of the chromodomain of Cbx2 on this residue in vitro resulted in a reduced level of binding to an H3 peptide containing trimethylated lysine-9 as well as an increase in the extent of binding to an H3 peptide containing trimethylated lysine-27, suggesting that such phosphorylation changes the binding specificity of Cbx2 for modified histone H3. Phosphorylation of the chromodomain of Cbx2 may therefore serve as a molecular switch that affects the reading of the histone modification code and thereby controls epigenetic cellular memory. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2010.05.074

    Web of Science

    PubMed

    researchmap

  • Fbxo45, a Novel Ubiquitin Ligase, Regulates Synaptic Activity Reviewed

    Hirobumi Tada, Hirotaka James Okano, Hiroshi Takagi, Shinsuke Shibata, Ikuko Yao, Masaki Matsumoto, Toru Saiga, Keiichi I. Nakayama, Haruo Kashima, Takuya Takahashi, Mitsutoshi Setou, Hideyuki Okano

    JOURNAL OF BIOLOGICAL CHEMISTRY   285 ( 6 )   3840 - 3849   2010.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Neurons communicate with each other through synapses. To establish the precise yet flexible connections that make up neural networks in the brain, continuous synaptic modulation is required. The ubiquitin-proteasome system of protein degradation is one of the critical mechanisms that underlie this process, playing crucial roles in the regulation of synaptic structure and function. We identified a novel ubiquitin ligase, Fbxo45, that functions at synapses. Fbxo45 is evolutionarily conserved and selectively expressed in the nervous system. We demonstrated that the knockdown of Fbxo45 in primary cultured hippocampal neurons resulted in a greater frequency of miniature excitatory postsynaptic currents. We also found that Fbxo45 induces the degradation of a synaptic vesicle-priming factor, Munc13-1. We propose that Fbxo45 plays an important role in the regulation of neurotransmission by modulating Munc13-1 at the synapse.

    DOI: 10.1074/jbc.M109.046284

    Web of Science

    PubMed

    researchmap

  • 定量的リン酸化プロテオミクスによる乳癌の予後不良群と予後良好群の比較

    鳴海 良平, 久家 貴寿, 松本 雅記, 中山 敬一, 石飛 真人, 稲治 英生, 宮本 泰豪, 加藤 菊也, 朝長 毅

    日本プロテオーム学会大会要旨集   2010   102 - 102   2010

     More details

    Language:Japanese   Publisher:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    DOI: 10.14889/jhupo.2010.0.102.2

    CiNii Article

    researchmap

  • 情報基盤ターゲット・プロテオミクスを用いたヒト・プロテオームの絶対定量

    松本 雅記, 五島 直樹, 夏目 徹, 中山 敬一

    日本プロテオーム学会大会要旨集   2010   58 - 58   2010

     More details

    Language:Japanese   Publisher:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    DOI: 10.14889/jhupo.2010.0.58.1

    CiNii Article

    researchmap

  • Fbxo45 Forms a Novel Ubiquitin Ligase Complex and Is Required for Neuronal Development Reviewed

    Toru Saiga, Takaichi Fukuda, Masaki Matsumoto, Hirobumi Tada, Hirotaka James Okano, Hideyuki Okano, Keiichi I. Nakayama

    MOLECULAR AND CELLULAR BIOLOGY   29 ( 13 )   3529 - 3543   2009.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    Fbxo45 is an F-box protein that is restricted to the nervous system. Unlike other F-box proteins, Fbxo45 was found not to form an SCF complex as a result of an amino acid substitution in the consensus sequence for Cul1 binding. Proteomics analysis revealed that Fbxo45 specifically associates with PAM (protein associated with Myc), a RING finger-type ubiquitin ligase. Mice deficient in Fbxo45 were generated and found to die soon after birth as a result of respiratory distress. Fbxo45(-/-) embryos show abnormal innervation of the diaphragm, impaired synapse formation at neuromuscular junctions, and aberrant development of axon fiber tracts in the brain. Similar defects are also observed in mice lacking Phr1 (mouse ortholog of PAM), suggesting that Fbxo45 and Phr1 function in the same pathway. In addition, neuronal migration was impaired in Fbxo45(-/-) mice. These results suggest that Fbxo45 forms a novel Fbxo45-PAM ubiquitin ligase complex that plays an important role in neural development.

    DOI: 10.1128/MCB.00364-09

    Web of Science

    PubMed

    researchmap

  • Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways Reviewed

    Masaki Matsumoto, Koji Oyamada, Hidehisa Takahashi, Takamichi Sato, Shigetsugu Hatakeyama, Keiichi I. Nakayama

    PROTEOMICS   9 ( 13 )   3549 - 3563   2009.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-V C H VERLAG GMBH  

    Activation of the T-cell receptor (TCR) and that of the B-cell receptor (BCR) elicits tyrosine-phosphorylation of proteins that belongs to similar functional categories, but result in distinct cellular responses. Large-scale analyses providing an overview of the signaling pathways downstream of TCR or BCR have not been described, so it has been unclear what components of these pathways are shared and which are specific. We have now performed a systematic analysis and provide a comprehensive list of tyrosine-phosphorylated proteins (PY proteome) with quantitative data on their abundance in T cell, B cell, and nonlymphoid cell lines. Our results led to the identification of novel tyrosine-phosphorylated proteins and signaling pathways not previously implicated in immunoreceptor signal transduction, such as clathrin, zonula occludens 2, eukaryotic translation initiation factor 3, and RhoH, suggesting that TCR or BCR signaling may be linked to downstream processes such as endocytosis, cell adhesion, and translation. Thus comparative and quantitative studies of tyrosine-phosphorylation have the potential to expand knowledge of signaling networks and to promote understanding of signal transduction at the system level.

    DOI: 10.1002/pmic.200900011

    Web of Science

    PubMed

    researchmap

  • Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36 Reviewed

    Akinori Endo, Masaki Matsumoto, Toshifumi Inada, Akitsugu Yamamoto, Keiichi I. Nakayama, Naomi Kitamura, Masayuki Komada

    JOURNAL OF CELL SCIENCE   122 ( 5 )   678 - 686   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:COMPANY OF BIOLOGISTS LTD  

    The nucleolus is a subnuclear compartment and the site of ribosome biogenesis. Previous studies have implicated protein ubiquitylation in nucleolar activity. Here we show that USP36, a deubiquitylating enzyme of unknown function, regulates nucleolar activity in mammalian cells. USP36 localized to nucleoli via the C-terminal region, which contains basic amino acid stretches. Dominant-negative inhibition of USP36 caused the accumulation of ubiquitin-protein conjugates in nucleoli, suggesting that nucleoli are the site of USP36 action. USP36 deubiquitylated the nucleolar proteins nucleophosmin/B23 and fibrillarin, and stabilized them by counteracting ubiquitylation-mediated proteasomal degradation. RNAi-mediated depletion of cellular USP36 resulted in reduced levels of rRNA transcription and processing, a less-developed nucleolar morphology and a slight reduction in the cytoplasmic ribosome level, which eventually led to a reduced rate of cell proliferation. We conclude that by deubiquitylating various nucleolar substrate proteins including nucleophosmin/B23 and fibrillarin, USP36 plays a crucial role in regulating the structure and function of nucleoli.

    DOI: 10.1242/jcs.044461

    Web of Science

    PubMed

    researchmap

  • 細胞周期制御と高次生命現象 プロテオミクスが拓く細胞周期研究の新地平 リン酸化とユビキチン化に関する網羅的解析

    中山 敬一, 弓本 佳苗, 押川 清孝, 松本 雅記

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   81回・31回   3S19 - 7   2008.11

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 定量的プロテオミクスを用いた細胞周期を制御するユビキチンリガーゼ基質の網羅的同定

    弓本 佳苗, 松本 雅記, 中山 敬一

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   81回・31回   3T11 - 2   2008.11

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • Dynamic regulation of ubiquitylation and deubiquitylation at the central spindle during cytokinesis Reviewed

    Akiko Mukai, Emi Mizuno, Kaoru Kobayashi, Masaki Matsumoto, Keiichi I. Nakayama, Naomi Kitamura, Masayuki Komada

    JOURNAL OF CELL SCIENCE   121 ( 8 )   1325 - 1333   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:COMPANY OF BIOLOGISTS LTD  

    During cytokinesis, the central spindle, a bundle of interdigitated anti-parallel microtubules between separating chromosomes, recruits various cytokinetic regulator proteins to the cleavage region. Here, we show that the level of protein ubiquitylation is strikingly and transiently elevated in Aurora B kinase-positive double-band regions of the central spindle during cytokinesis. Two deubiquitylating enzymes UBPY and AMSH, which act on endosomes in interphase, were also recruited to the cleavage region. Whereas UBPY was detected only in the final stage of cytokinesis at the midbody, AMSH localized to a ring structure surrounding the mitotic kinesin MKLP1-positive region of the central spindle and midbody throughout cytokinesis. Depletion of cellular UBPY or AMSH led to defects in cytokinesis. VAMP8, a v-SNARE required for vesicle fusion in cytokinesis, localized to the central spindle region positive for ubiquitylated proteins, and underwent ubiquitylation and deubiquitylation by both UBPY and AMSH. Our results thus implicate the ubiquitylation/deubiquitylation of proteins including VAMP8 in cytokinesis.

    DOI: 10.1242/jcs.027417

    Web of Science

    PubMed

    researchmap

  • Blue light-induced autophosphorylation of phototropin is a primary step for signaling Reviewed

    Shin-ichiro Inoue, Toshinori Kinoshita, Masaki Matsumoto, Keiichi I. Nakayama, Michio Doi, Ken-ichiro Shimazaki

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   105 ( 14 )   5626 - 5631   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    Phototropins are autophosphorylating protein kinases of plant-specific blue light receptors. They regulate various blue light responses, including phototropism, chloroplast movements, hypocotyl growth inhibition, leaf flattening, and stomatal opening. However, the physiological role of autophosphorylation remains unknown. Here, we identified phosphorylation sites of Ser or Thr in the N terminus, Hinge1 region, kinase domain, and C terminus in Arabidopsis phototropin1 (phot1) by liquid chromatography-tandem mass spectrometry in vivo. We substituted these Ser or Thr residues with Ala in phot1 and analyzed their functions by inspecting the phot1-mediated responses of stomatal opening, phototropism, chloroplast accumulation, and leaf flattening after the transformation of the phot1 phot2 double mutant. Among these sites, we found that auto phosphorylation of Ser-851 in the activation loop of the kinase domain was required for the responses mentioned above, whereas the phosphorylation of the other Ser and Thr, except those in the activation loop, was not. Ser-849 in the loop may have an additional role in the responses. Immunological analysis revealed that Ser-851 was phosphorylated rapidly by blue light in a fluence-dependent manner and dephosphorylated gradually upon darkness. We conclude that autophosphorylation of Ser-851 is a primary step that mediates signaling between photochemical reaction and physiological events.

    DOI: 10.1073/pnas.0709189105

    Web of Science

    PubMed

    researchmap

  • [Involvement of ubiquitin-proteasome system in polyglutamine disease]. Reviewed

    Matsumoto M

    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme   51 ( 10 Suppl )   1428 - 1432   2006.8

     More details

  • Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice Reviewed

    S Niki, K Oshikawa, Y Mouri, F Hirota, A Matsushima, M Yano, H Han, Y Bando, K Izumi, M Matsumoto, KI Nakayama, N Kuroda, M Matsumoto

    JOURNAL OF CLINICAL INVESTIGATION   116 ( 5 )   1292 - 1301   2006.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC CLINICAL INVESTIGATION INC  

    Factors that determine the spectrum of target organs involved in autoimmune destruction are poorly understood. Although loss of function of autoimmune regulator (AIRE) in thymic epithelial cells is responsible for autoimmunity, the pathogenic roles of AIRE in regulating target-organ specificity remain elusive. In order to gain insight into this issue, we have established NOD mice, an animal model of type 1 diabetes caused by autoimmune attack against P cell islets, in which Aire has been abrogated. Remarkably, acinar cells rather than P cell islets were the major targets of autoimmune destruction in Aire-deficient NOD mice, and this alteration of intra-pancreatic target-organ specificity was associated with production of autoantibody against pancreas-specific protein disulfide isomerase (PDIp), an antigen expressed predominantly by acinar cells. Consistent with this pathological change, the animals were resistant to the development of diabetes. The results suggest that Aire not only is critical for the control of self-tolerance but is also a strong modifier of target-organ specificity through regulation of T cell repertoire diversification. We also demonstrated that transcriptional expression of PDIp was retained in the Aire-deficient NOD thymus, further supporting the concept that Aire may regulate the survival of autoreactive T cells beyond transcriptional control of self-protein expression in the thymus.

    DOI: 10.1172/JCI26971

    Web of Science

    PubMed

    researchmap

  • Essential role of I kappa B kinase alpha in thymic organogenesis required for the establishment of self-tolerance Reviewed

    Dan Kinoshita, Fumiko Hirota, Tsuneyasu Kaisho, Michiyuki Kasai, Keisuke Izumi, Yoshimi Bando, Yasuhiro Mouri, Akemi Matsushima, Shino Niki, Hongwei Han, Kiyotaka Oshikawa, Noriyuki Kuroda, Masahiko Maegawa, Minoru Irahara, Kiyoshi Takeda, Shizuo Akira, Mitsuru Matsumoto

    JOURNAL OF IMMUNOLOGY   176 ( 7 )   3995 - 4002   2006.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ASSOC IMMUNOLOGISTS  

    I kappa B kinase (IKK) alpha exhibits diverse biological activities through protein kinase-dependent and -independent functions, the former mediated predominantly through a noncanonical NF-kappa B activation pathway. The in vivo function of IKK alpha, however, still remains elusive. Because a natural strain of mice with mutant NF-kappa B-inducing kinase (NIK) manifests autoimmunity as a result of disorganized thymic structure with abnormal expression of Rel proteins in the thymic stroma, we speculated that the NIK-IKK alpha axis might constitute an essential step in the thymic organogenesis that is required for the establishment of self-tolerance. An autoimmune disease phenotype was induced in athymic nude mice by grafting embryonic thymus from IKK alpha-deficient mice. The thymic microenvironment that caused autoimmunity in an IKK alpha-dependent manner was associated with defective processing of NF-kappa B2, resulting in the impaired development of thymic epithelial cells. Thus, our results demonstrate a novel function for IKK alpha in thymic organogenesis for the establishment of central tolerance that depends on its protein kinase activity in cooperation with NIK.

    DOI: 10.4049/jimmunol.176.7.3995

    Web of Science

    researchmap

  • Mammalian E4 is required for cardiac development and maintenance of the nervous system Reviewed

    C Kaneko-Oshikawa, T Nakagawa, M Yamada, H Yoshikawa, M Matsumoto, M Yada, S Hatakeyama, K Nakayama, KI Nakayama

    MOLECULAR AND CELLULAR BIOLOGY   25 ( 24 )   10953 - 10964   2005.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC MICROBIOLOGY  

    Ubiquitin conjugation typically requires three classes of enzyme: E1, E2, and E3. A fourth type of enzyme (E4), however, was recently shown to be required for the degradation of certain types of substrate in yeast. We previously identified UFD2a (also known as E4B) as an E4 in mammals. UFD2a is exclusively expressed in cardiac muscle during mouse embryonic development, but it is abundant in neurons of adult mice and is implicated in the pathogenesis of neurodegenerative disease. The precise physiological function of this enzyme has remained largely unknown, however. Here, we show that mice lacking UFD2a die in utero, manifesting marked apoptosis in the developing heart. Polyubiquitylation activity for an E4 substrate was greatly reduced in Ufd2a(-/-) mouse embryonic fibroblasts. Furthermore, Ufd2a(+/-) mice displayed axonal dystrophy in the nucleus gracilis, as well as degeneration of Purkinje cells accompanied by endoplasmic reticulum stress. These animals also developed a neurological disorder. UFD2a thus appears to be essential for the development of cardiac muscle, as well as for the protection of spinocerebellar neurons from degeneration induced by endoplasmic reticulum stress.

    DOI: 10.1128/MCB.25.24.10953-10964.2005

    Web of Science

    PubMed

    researchmap

  • Large-scale analysis of the human ubiquitin-related proteome Reviewed

    M Matsumoto, S Hatakeyama, K Oyamada, Y Oda, T Nishimura, KI Nakayama

    PROTEOMICS   5 ( 16 )   4145 - 4151   2005.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Protein ubiquitylation contributes to the regulation of many cellular processes including protein degradation, receptor internalization, and repair of DNA damage. We now present a comprehensive characterization of ubiquitin-conjugated and ubiquitin-associated proteins in human cells. The proteins were purified by immunoaffinity chromatography under denaturing or native conditions. They were then digested with trypsin, and the resulting peptides were analyzed by 2-D LC and MS/MS. A total of 670 distinct proteins were identified; 345 proteins (51%) were classified as Urp-D (ubiquitin-related proteome under the denaturing condition) and comprised ubiquitin-conjugated molecules, whereas 325 proteins (49%) were classified as Urp-N (ubiquitin-related proteome only under the native condition) and included molecules that associated with ubiquitylated proteins. The proportions of proteins in various functional categories differed substantially between Urp-D and Urp-N. Many ribosomal subunits were detected in the Urp-D group of proteins and several of these subunits were directly shown to be ubiquitylated by mass spectrometric analysis, suggesting that ubiquitylation might play an important role in the regulation and/or quality control of ribosomal proteins. Our results demonstrate the potential of proteomics analysis of protein ubiquitylation to provide important insight into the regulation of protein stability and other ubiquitin-related cellular functions.

    DOI: 10.1002/pmic.200401280

    Web of Science

    PubMed

    researchmap

  • Recent Advance in Phosphoproteome Analysis

    MATSUMOTO Masaki, NAKAYAMA Keiichi

    J. Mass Spectrom. Soc. Jpn.   53 ( 3 )   117 - 124   2005.6

     More details

    Language:Japanese   Publisher:The Mass Spectrometry Society of Japan  

    Protein phosphorylation is a reversible post-translational modification crucial in signal transduction. To understand signaling processes, it is important to identify phosphorylated proteins and their phosphorylation sites. Because phosphorylation is a dynamic process, elucidation of signaling networks also requires quantitation of these phosphorylation events. This report summarizes recent advances in techniques for phospho-proteomics by using mass spectrometry. In this review, we offer an overview of the several technologies to elucidate phosphoproteome currently available. These technologies involve the enrichment of phosphorylated proteins/peptides and identification and quantification by mass spectrometry.

    DOI: 10.5702/massspec.53.117

    CiNii Article

    CiNii Books

    researchmap

    Other Link: https://jlc.jst.go.jp/DN/JALC/00251591166?from=CiNii

  • Mapping of ubiquitination sites on target proteins Reviewed

    S Hatakeyama, M Matsumoto, KI Nakayama

    UBIQUITIN AND PROTEIN DEGRADATION, PT B   399   277 - 286   2005

     More details

    Language:English   Publishing type:Part of collection (book)   Publisher:ELSEVIER ACADEMIC PRESS INC  

    Although the identification of ubiquitin-conjugated lysine residues on target proteins is extremely significant, to date it is generally quite difficult to identify ubiquitinated sites by usual mutation analysis. More recently, the technology of mass spectrometry is answering these difficult questions. In this chapter, we introduce the method of purification of ubiquitinated target proteins using affinity chromatography with anti-polyubiquitin antibody and the identification of ubiquitinated lysine residues on target proteins using mass spectrometry. Using these techniques, we can obtain comprehensive information about ubiquitinated proteins in various cells and tissues.

    DOI: 10.1016/S0076-6879(05)99019-8

    Web of Science

    PubMed

    researchmap

  • Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B contributes to neuritogenesis Reviewed

    F Okumura, S Hatakeyama, M Matsumoto, T Kamura, KI Nakayama

    JOURNAL OF BIOLOGICAL CHEMISTRY   279 ( 51 )   53533 - 53543   2004.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    E4B ( also known as UFD2a) is a mammalian homolog of Saccharomyces cerevisiae Ufd2, which was originally described as a ubiquitin chain assembly factor (E4). E4B is a U-box-type ubiquitin-protein isopeptide ligase (E3) and likely functions as either an E3 or an E4. With a yeast two-hybrid screen, we have now identified FEZ1 (fasciculation and elongation protein zeta 1) as a protein that interacts with E4B. FEZ1 is implicated in neuritogenesis when phosphorylated by protein kinase Czeta (PKCzeta). Interaction between E4B and FEZ1 in mammalian cells was enhanced by coexpression of constitutively active PKCzeta. E4B mediated the polyubiquitylation of FEZ1 but did not affect its intracellular stability, suggesting that such modification of FEZ1 is not a signal for its proteolysis. Polyubiquitylation of FEZ1 by E4B required Lys(27) of ubiquitin. Expression of a dominant-negative mutant of E4B in rat pheochromocytoma PC12 cells resulted in inhibition of neurite extension induced either by nerve growth factor or by coexpression of FEZ1 and constitutively active PKCzeta. These findings indicate that E4B serves as a ubiquitin ligase for FEZ1 and thereby regulates its function but not its degradation.

    DOI: 10.1074/jbc.M402916200

    Web of Science

    PubMed

    researchmap

  • VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases Reviewed

    T Kamura, K Maenaka, S Kotoshiba, M Matsumoto, D Kohda, RC Conaway, JW Conaway, KI Nakayama

    GENES & DEVELOPMENT   18 ( 24 )   3055 - 3065   2004.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT  

    The ECS (Elongin B/C-Cul2/Cul5-SOCS-box protein) complex is a member of a family of ubiquitin ligases that share a Cullin-Rbx module. SOCS-box proteins recruit substrates to the ECS complex and are linked to Cullin-Rbx via Elongin B/C. VHL has been implicated as a SOCS-box protein, but lacks a C-terminal sequence (downstream of the BC box) of the SOCS box. We now show that VHL specifically interacts with endogenous Cul2-Rbx1 in mammalian cells, whereas SOCS-box proteins associate with Cul5-Rbx2. We also identify LRR-1 and FEM1B as proteins that share a region of homology with VHL (the VHL box, including the BC box and downstream residues) and associate with Cul2-Rbx1. ECS complexes can thus be classified into two distinct protein assemblies, that is, those that contain a subunit with a VHL box (composed of the BC box and a downstream Cul2 box) that interacts with Cul2-Rbx1, and those that contain a subunit with a SOCS box (BC box and downstream Cul5 box) that interacts with Cul5-Rbx2. Domain-swapping analyses showed that the specificity of interaction of VHL-box and SOCS-box proteins with Cullin-Rbx modules is determined by the Cul2 and Cul5 boxes, respectively. Finally, RNAi-mediated knockdown of the Cul2-Rbx1 inhibited the VHL-mediated degradation of HIF-2alpha, whereas knockdown of Cul5-Rbx2 did not affect it. These data suggest that the functions of the Cul2-Rbx1 and Cul5-Rbx2 modules are distinct.

    DOI: 10.1101/gad.1252404

    Web of Science

    PubMed

    researchmap

  • Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase Reviewed

    T Kamura, T Hara, M Matsumoto, N Ishida, F Okumura, S Hatakeyama, M Yoshida, K Nakayama, KI Nakayama

    NATURE CELL BIOLOGY   6 ( 12 )   1229 - 1235   2004.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The cyclin-dependent kinase inhibitor p27(Kip1) is degraded at the G0-G1 transition of the cell cycle by the ubiquitin proteasome pathway(1,2). Although the nuclear ubiquitin ligase (E3) SCFSkp2 is implicated in p27(Kip1) degradation(3-6), proteolysis of p27(Kip1) at the G0 - G1 transition proceeds normally in Skp2(-/-) cells(7,8). Moreover, p27(Kip1) is exported from the nucleus to the cytoplasm at G0 - G1 ( refs 9 - 11). These data suggest the existence of a Skp2- independent pathway for the degradation of p27(Kip1) at G1 phase. We now describe a previously unidentified E3 complex: KPC ( Kip1 ubiquitination- promoting complex), consisting of KPC1 and KPC2. KPC1 contains a RING- finger domain, and KPC2 contains a ubiquitinlike domain and two ubiquitin- associated domains. KPC interacts with and ubiquitinates p27Kip1 and is localized to the cytoplasm. Overexpression of KPC promoted the degradation of p27(Kip1), whereas a dominant- negative mutant of KPC1 delayed p27(Kip1) degradation. The nuclear export of p27(Kip1) by CRM1 seems to be necessary for KPC- mediated proteolysis. Depletion of KPC1 by RNA interference also inhibited p27(Kip1) degradation. KPC thus probably controls degradation of p27(Kip1) in G1 phase after export of the latter from the nucleus.

    DOI: 10.1038/ncb1194

    Web of Science

    PubMed

    researchmap

  • U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy Reviewed

    S Hatakeyama, M Matsumoto, T Kamura, M Murayama, DH Chui, E Planel, R Takahashi, KI Nakayama, A Takashima

    JOURNAL OF NEUROCHEMISTRY   91 ( 2 )   299 - 307   2004.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING LTD  

    Neurofibrillary tangles (NFTs), which are composed of hyperphosphorylated and ubiquitylated tau, are exhibited at regions where neuronal loss occurs in neurodegenerative diseases; however, the mechanisms of NFT formation remain unknown. Molecular studies of frontotemporal dementia with parkinsonism-17 demonstrated that increasing the ratio of tau with exon 10 insertion induced fibrillar tau accumulation. Here, we show that carboxyl terminus of Hsc70-interacting protein (CHIP), a U-box protein, recognizes the microtubule-binding repeat region of tau and preferentially ubiquitylates four-repeat tau compared with three-repeat tau. Overexpression of CHIP induced the prompt degradation of tau, reduced the formation of detergent-insoluble tau and inhibited proteasome inhibitor-induced cell death. NFT bearing neurons in progressive supranuclear palsy, in which four-repeat tau is a component, showed the accumulation of CHIP. Thus, CHIP is a ubiquitin ligase for four-repeat tau and maintains neuronal survival by regulating the quality control of tau in neurons.

    DOI: 10.1111/j.1471-4159.2004.02713.x

    Web of Science

    PubMed

    researchmap

  • Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones Reviewed

    S Hatakeyama, M Matsumoto, M Yada, KI Nakayama

    GENES TO CELLS   9 ( 6 )   533 - 548   2004.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING LTD  

    Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families. Two representative mammalian U-box proteins, UFD2a and CHIP, interact with the molecular chaperones VCP and either Hsp90 or Hsc70, respectively, and are implicated in the degradation of damaged proteins. We have now investigated the roles of mammalian U-box proteins by performing a comprehensive screen for molecules that interact with these proteins in the yeast two-hybrid system. All mammalian U-box proteins tested were found to interact with molecular chaperones or cochaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. These observations suggest that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognize such abnormal proteins.

    DOI: 10.1111/j.1365-2443.2004.00742.x

    Web of Science

    PubMed

    researchmap

  • Molecular clearance of ataxin-3 is regulated by a mammalian E4 Reviewed

    M Matsumoto, M Yada, S Hatakeyama, H Ishimoto, T Tanimura, S Tsuji, A Kakizuka, M Kitagawa, KI Nakayama

    EMBO JOURNAL   23 ( 3 )   659 - 669   2004.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Insoluble aggregates of polyglutamine-containing proteins are usually conjugated with ubiquitin in neurons of individuals with polyglutamine diseases. We now show that ataxin-3, in which the abnormal expansion of a polyglutamine tract is responsible for spinocerebellar ataxia type 3 (SCA3), undergoes ubiquitylation and degradation by the proteasome. Mammalian E4B (UFD2a), a ubiquitin chain assembly factor (E4), copurified with the polyubiquitylation activity for ataxin-3. E4B interacted with, and thereby mediated polyubiquitylation of, ataxin-3. Expression of E4B promoted degradation of a pathological form of ataxin-3. In contrast, a dominant-negative mutant of E4B inhibited degradation of this form of ataxin-3, resulting in the formation of intracellular aggregates. In a Drosophila model of SCA3, expression of E4B suppressed the neurodegeneration induced by an ataxin-3 mutant. These observations suggest that E4 is a rate-limiting factor in the degradation of pathological forms of ataxin-3, and that targeted expression of E4B is a potential gene therapy for SCA3.

    DOI: 10.1038/sj.emboj.7600081

    Web of Science

    PubMed

    researchmap

  • Comprehensive Analysis of Protein Modification : Purification of Protein with Post-translational Modifications by Affinity Chromatography

    MATSUMOTO Masaki, NAKAYAMA Keiichi

    J. Mass Spectrom. Soc. Jpn.   51 ( 5 )   524 - 529   2003.10

     More details

    Language:Japanese   Publisher:The Mass Spectrometry Society of Japan  

    Recent advances in methods for protein identification by a combination of mass spectrometry and protein/DNA sequence database enabled to study of high throughput analysis of proteome. In addition to expression level, numerous characterics of the proteins such as cellular localization, complex formation, stability, and post-transcriptional modifications can be studied by proteomic approach. However, whole proteome analysis has limitation to identify proteins with low expression level. Here we present that our strategy for purification of proteins with post-translational modifications, such as ubiquitylation and phosphorylation by affinity chromatography. Using antibodies against these modification groups, modified proteins were effectively purified. After digestion by trypsin, resulting peptides were subjected to online LC-ESI-MS/MS analysis. In addition to known substrate proteins, novel substrate proteins were identified. Thus, affinity purification of proteins that have post. translational modifications is effective method for focused proteomics.

    DOI: 10.5702/massspec.51.524

    CiNii Article

    CiNii Books

    researchmap

    Other Link: https://jlc.jst.go.jp/DN/JALC/00232573136?from=CiNii

  • Preferential interaction of TIP120A with Cul1 that is not modified by NEDD8 and not associated with Skp1 Reviewed

    K Oshikawa, M Matsumoto, M Yada, T Kamura, S Hatakeyama, KI Nakayama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   303 ( 4 )   1209 - 1216   2003.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    The SCF complex, which consists of the invariable components Skp1, Cul1, and Rbx1 as well as a variable F-box protein, functions as an E3 ubiquitin ligase. The mechanism by which the activity of this complex is regulated, however, has been unclear. The application of tandem affinity purification has now resulted in the identification of a novel Cul1-binding protein: TATA-binding protein-interacting protein 120A (TIP120A, also called CAND1). Immunoprecipitation, immunoblot, and immunofluorescence analyses with mammalian cells revealed that TIP120A physically associates with Cull in the nucleus and that this interaction is mediated by a central region of Cull distinct from its binding sites for Skp1 and Rbx1. Furthermore, TIP120A was shown to interact selectively with Cull that is not modified by NEDD8. The Cul1-TIP120A complex does not include Skp1, raising the possibility that TIP120A competes with Skp1 for binding to Cul1. These observations thus suggest that TIP120A may function as a negative regulator of the SCF complex by binding to nonneddylated Cul1 and thereby preventing assembly of this ubiquitin ligase. (C) 2003 Elsevier Science (USA). All rights reserved.

    DOI: 10.1016/S0006-291X(03)00501-1

    Web of Science

    PubMed

    researchmap

  • Characterization of the mouse gene for the U-box-type ubiquitin lipase UFD2a Reviewed

    C Kaneko, S Hatakeyama, M Matsumoto, M Yada, K Nakayama, KI Nakayama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   300 ( 2 )   297 - 304   2003.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    UFD2a is a mammalian homolog of Saccharomyces cerevisiae Ufd2, originally described as an E4 ubiquitination factor. UFD2a belongs to the U-box family of ubiquitin ligases (E3s) and likely functions as both an E3 and E4. We have isolated and characterized the mouse gene (Ube4b) for UFD2a. A full-length (similar to5700 bp) Ube4b cDNA was isolated and the corresponding gene spans &gt; 100 kb, comprising 27 exons. Luciferase reporter gene analysis of the 5' flanking region of Ube4b revealed that nucleotides -1018 to -943 (relative to the translation initiation site) possess promoter activity. This functional sequence contains two putative Sp1 binding sites but not a TATA box. Immunoblot and immunohistochemical analyses revealed that UFD2a is expressed predominantly in the neuronal tissues. We also show that UFD2a interacts with VCP (a AAA-family ATPase) that is thought to mediate protein folding. These data implicate UFD2a in the degradation of neuronal proteins by the ubiquitin-proteasome pathway. (C) 2002 Elsevier Science (USA). All rights reserved.

    DOI: 10.1016/S0006-291X(02)02834-6

    Web of Science

    PubMed

    researchmap

  • U box proteins as a new family of ubiquitin-protein ligases Reviewed

    S Hatakeyama, M Yada, M Matsumoto, N Ishida, KI Nakayama

    JOURNAL OF BIOLOGICAL CHEMISTRY   276 ( 35 )   33111 - 33120   2001.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The U box is a domain of similar to 70 amino acids that is present in proteins from yeast to humans. The prototype U box protein, yeast Ufd2, was identified as a ubiquitin chain assembly factor that cooperates with a ubiquitin-activating enzyme (EI), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-protein ligase (E3) to catalyze ubiquitin chain formation on artificial substrates. E3 enzymes are thought to determine the substrate specificity of ubiquitination and have been classified into two families, the HECT and RING finger families. Six mammalian U box proteins have now been shown to mediate polyubiquitination in the presence of El and E2 and in the absence of E3. These U box proteins exhibited different specificities for E2 enzymes in this reaction. Deletion of the U box or mutation of conserved amino acids within it abolished ubiquitination activity. Some U box proteins catalyzed polyubiquitination by targeting lysine residues of ubiquitin other than lysine 48, which is utilized by HECT and RING finger E3 enzymes for polyubiquitination that serves as a signal for proteolysis by the 26 S proteasome. These data suggest that U box proteins constitute a third family of E3 enzymes and that E4 activity may reflect a specialized type of E3 activity.

    DOI: 10.1074/jbc.M102755200

    Web of Science

    researchmap

  • Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication

    K Nakayama, H Nagahama, YA Minamishima, M Matsumoto, Nakamichi, I, K Kitagawa, M Shirane, R Tsunematsu, T Tsukiyama, N Ishida, M Kitagawa, K Nakayama, S Hatakeyama

    EMBO JOURNAL   19 ( 9 )   2069 - 2081   2000.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The ubiquitin-proteasome pathway plays an important role in control of the abundance of cell cycle regulators. Mice lacking Skp2, an F-box protein and substrate recognition component of an Skp1-Cullin-F-bos protein (SCF) ubiquitin ligase, were generated. Although Skp2(-/-) animals are viable, cells in the mutant mice contain markedly enlarged nuclei with polyploidy and multiple centrosomes, and show a reduced growth rate and increased apoptosis, Skp2(-/-) cells also exhibit increased accumulation of both cyclin E and p27(Kip1). The elimination of cyclin E during S and G(2) phases is impaired in Skp2(-/-) cells, resulting in loss of cyclin E periodicity. Biochemical studies showed that Skp2 interacts specifically with cyclin E and thereby promotes its ubiquitylation and degradation both in vivo and in vitro. These results suggest that specific degradation of cyclin E and p27(Kip1) is mediated by the SCFSkp2 ubiquitin ligase complex, and that Skp2 may control chromosome replication and centrosome duplication by determining the abundance of cell cycle regulators.

    DOI: 10.1093/emboj/19.9.2069

    Web of Science

    Scopus

    PubMed

    CiNii Article

    researchmap

  • Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome

    A. Yamanaka, S. Hatakeyama, K. I. Kominami, M. Kitagawa, M. Matsumoto, K. I. Nakayama

    Molecular Biology of the Cell   11 ( 8 )   2821 - 2831   2000

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Society for Cell Biology  

    Progression through mitosis requires the precisely timed ubiquitin-dependent degradation of specific substrates. E2-C is a ubiquitin-conjugating enzyme that plays a critical role with anaphase-promoting complex/cyclosome (APC/C) in progression of and exit from M phase. Here we report that mammalian E2-C is expressed in late G2/M phase and is degraded as cells exit from M phase. The mammalian E2-C shows an autoubiquitinating activity leading to covalent conjugation to itself with several ubiquitins. The ubiquitination of E2-C is strongly enhanced by APC/C, resulting in the formation of a polyubiquitin chain. The polyubiquitination of mammalian E2-C occurs only when cells exit from M phase. Furthermore, mammalian E2-C contains two putative destruction boxes that are believed to act as recognition motifs for APC/C. The mutation of this motif reduced the polyubiquitination of mammalian E2-C, resulting in its stabilization. These results suggest that mammalian E2-C is itself a substrate of the APC/C-dependent proteolysis machinery, and that the periodic expression of mammalian E2-C may be a novel autoregulatory system for the control of the APC/C activity and its substrate specificity.

    DOI: 10.1091/mbc.11.8.2821

    Scopus

    PubMed

    researchmap

  • High pressure sensitizes murine erythroleukemia cells to caffeine-induced premature mitosis

    M. Matsumoto, T. Yamaguchi, K. Nakazono, Y. Fukumaki, S. Terada

    Japanese Journal of Physiology   50 ( 3 )   329 - 336   2000

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:The Physiological Society of Japan  

    Murine erythroleukemia (MEL) cells were exposed to a high pressure of 80 MPa or aphidicolin (APH), DNA polymerase inhibitor. The effects of caffeine on cell cycle were examined using these cells. During the culture of 80 MPa-treated MEL cells at atmospheric pressure, the cells arrested in the G2 phase, and cyclin B and hyperphosphorylated p34(cdc2) were accumulated. Namely, maturation promoting factor (MPF) composed of p34(cdc2) and cyclin B was inactive. However, upon exposure to caffeine, these cells entered prematurely into mitosis by activating MPF. Caffeine-induced premature mitosis was suppressed by butyrolactone I and orthovanadate. On the other hand, APH-treated MEL cells, which were not exposed to 80 MPa, were not so sensitive to caffeine-induced premature mitosis despite cyclin B accumulation. In this case, dephosphorylation of p34(cdc2) was not induced by caffeine. Interestingly, caffeine-induced premature mitosis in the 80 MPa-treated cells was also suppressed by APH. These results suggest that the premature mitosis of 80 MPa-treated MEL cells by caffeine is induced by active MPF, and that APH-sensitive molecules such as DNA polymerase may also play an important role in the checkpoint that controls the transition from G2 to M phase.

    DOI: 10.2170/jjphysiol.50.329

    Scopus

    PubMed

    CiNii Article

    researchmap

  • Molecular dissection of the interactions among I kappa B alpha, FWD1, and Skp1 required for ubiquitin-mediated proteolysis of I kappa B alpha

    K Hattori, S Hatakeyama, M Shirane, M Matsumoto, K Nakayama

    JOURNAL OF BIOLOGICAL CHEMISTRY   274 ( 42 )   29641 - 29647   1999.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The SCF complex containing Skp1, Cul1, and the F-box protein FWD1 (the mouse homologue of Drosophila Slimb and Xenopus beta-TrCP) functions as the ubiquitin ligase for I kappa B alpha FWD1 associates with Skp1 through the F-box domain and also recognizes the conserved DS-GXXS motif of I kappa B alpha. The structural requirements for the interactions of FWD1 with I kappa B alpha and with Skp1 have now been investigated further. The D31A mutation (but not the G33A mutation) in the DSGXXS motif of I kappa B alpha abolished the binding of I kappa B alpha to FWD1 and its subsequent ubiquitination without affecting the phosphorylation of I kappa B alpha. The I kappa B alpha mutant D31E still exhibited binding to FWD1 and underwent ubiquitination, These results suggest that, in addition to site-specific phosphorylation at Ser(32) and Ser(36), an acidic amino acid at position 31 is required for FWD1-mediated ubiquitination of I kappa B alpha. Deletion analysis of Skp1 revealed that residues 61-143 of this protein are required for binding to FWD1, On the other hand, the highly conserved residues pro(149), ILe(160), and Leu(164) in the F-box domain of FWD1 were dispensable for binding to Skp1, Together, these data delineate the structural requirements for the interactions among I kappa B alpha, FWD1, and Skp1 that underlie substrate recognition by the SCF ubiquitin ligase complex.

    DOI: 10.1074/jbc.274.42.29641

    Web of Science

    Scopus

    PubMed

    CiNii Article

    researchmap

  • An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin

    M Kitagawa, S Hatakeyama, M Shirane, M Matsumoto, N Ishida, K Hattori, Nakamichi, I, A Kikuchi, K Nakayama, K Nakayama

    EMBO JOURNAL   18 ( 9 )   2401 - 2410   1999.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    beta-catenin plays an essential role in the Wingless/Wnt signaling cascade and is a component of the cadherin cell adhesion complex. Deregulation of beta-catenin accumulation as a result of mutations in adenomatous polyposis coli (APC) tumor suppressor protein is believed to initiate colorectal neoplasia. beta-catenin levels are regulated by the ubiquitin-dependent proteolysis system and beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3 beta (GSK-3 beta)/Axin kinase complex. Here we show that FWD1 (the mouse homologue of Slimb/beta TrCP), an F-box/WD40-repeat protein, specifically formed a multi-molecular complex with beta-catenin, Axin, GSK-3 beta and APC, Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1, FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels. In contrast, a dominant-negative mutant form of FWD1 inhibited the ubiquitination process and stabilized beta-catenin, These results suggest that the Skp1/Cullin/F-box protein FWD1 (SCFFWD1)-ubiquitin ligase complex is involved in beta-catenin ubiquitination and that FWD1 serves as an intracellular receptor for phosphorylated beta-catenin, FWD1 also links the phosphorylation machinery to the ubiquitin-proteasome pathway to ensure prompt and efficient proteolysis of beta-catenin in response to external signals. SCFFWD1 may be critical for tumor development and suppression through regulation of beta-catenin protein stability.

    DOI: 10.1093/emboj/18.9.2401

    Web of Science

    Scopus

    PubMed

    CiNii Article

    researchmap

  • Ubiquitin-dependent degradation of I kappa B alpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1

    S Hatakeyama, M Kitagawa, K Nakayama, M Shirane, M Matsumoto, K Hattori, H Higashi, H Nakano, K Okumura, K Onoe, RA Good, K Nakayama

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   96 ( 7 )   3859 - 3863   1999.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    Activation of the transcription factor nuclear factor kappa B (NF-kappa B) is controlled by proteolysis of its inhibitory subunit (I kappa B) via the ubiquitin-proteasome pathway, Signal-induced phosphorylation of I kappa B alpha by a large multisubunit complex containing I kappa B kinases is a prerequisite for ubiquitination. Here, we show that FWD1 (a mouse homologue of Slimb/beta TrCP), a member of the F-box/WD40-repeat proteins, is associated specifically with I kappa B alpha only when I kappa B alpha is phosphorylated, The introduction of FWD1 into cells significantly promotes ubiquitination and degradation of I kappa B alpha in concert with I kappa B kinases, resulting in nuclear translocation of NF-kappa B. In addition, FWD1 strikingly evoked the ubiquitination of I kappa B alpha in the ira vitro system. In contrast, a dominant-negative form of FWD1 inhibits the ubiquitination, leading to stabilization of I kappa B alpha. These results suggest that the substrate-specific degradation of I kappa B alpha is mediated by a Skp1/Cull 1/F-box protein (SCF) FWD1 ubiquitin-ligase complex and that FWD1 serves as an intracellular receptor for phosphorylated I kappa B alpha. Skp1/Cullin/F-box protein FWD1 might play a critical role in transcriptional regulation of NF-kappa B through control of I kappa B protein stability.

    DOI: 10.1073/pnas.96.7.3859

    Web of Science

    Scopus

    PubMed

    CiNii Article

    researchmap

  • Erratum: Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul1/F-box protein FWD1 (Proceedings of the National Academy of Sciences of the United States America (March 30, 1999) 96:7 (3859- 3863))

    S. Hatakeyama, M. Kitagawa, K. Nakayama, M. Shirane, M. Matsumoto, K. Hattori, H. Higashi, H. Nakano, K. Okumura, K. Onoe, R. A. Good, K. I. Nakayama

    Proceedings of the National Academy of Sciences of the United States of America   96   6571   1999.1

     More details

  • Effects of chemical modification of cysteines 201 and 317 of band 3 on hemolytic properties of human erythrocytes under hydrostatic pressure

    T Yamaguchi, T Nakano, M Matsumoto, S Terada

    JAPANESE JOURNAL OF PHYSIOLOGY   48 ( 3 )   205 - 210   1998.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:CENTER ACADEMIC PUBL JAPAN  

    In the membrane stability of human erythrocytes, the role of two cysteine residues (Cys-201 and Cys-317) in the cytoplasmic domain of band 3 is not clear. So we tried to resolve this problem by examining hemolytic properties under high pressure. From SH contents and spin labeling, it was found that Cys-201 and Cys-317 of band 3 were modified with N-ethylmaleimide (NEM). The hemolysis of intact erythrocytes at 200 MPa was suppressed by the binding of 4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS), anion transport inhibitor, to band 3. Similarly, the suppressive effect of DIDS was observed in the erythrocyte that Cys-201 and Cys-317 were modified with NEM. These results suggest that the cysteine residues in the cytoplasmic domain of band 3 are not essential for the DIDS-induced membrane stabilization.

    DOI: 10.2170/jjphysiol.48.205

    Web of Science

    Scopus

    PubMed

    researchmap

  • Effects of intracellular pH on high pressure-induced hemolysis of anion transport inhibitor-treated erythrocytes

    M Matsumoto, T Yamaguchi, S Terada, E Kimoto

    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES   1280 ( 2 )   243 - 250   1996.4

     More details

    Authorship:Lead author   Language:English   Publisher:ELSEVIER SCIENCE BV  

    Effects of anion transport inhibitors such as 4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS) and 4-acetamido-3'-isothiocyanostilbene-2,2'-disulfonate on hemolysis of human erythrocytes at 200 MPa were examined by changing intracellular pH (7.2-7.9). These inhibitors suppressed the hemolysis at neutral pH but enhanced it at alkaline pH. However, such an enhancement was suppressed by cross-linking of membrane proteins using diamide. From the near-UV CD spectra of band 3 and the relation between hemolysis and anion transport in intact or trypsin-treated erythrocytes, it was found that such hemolytic properties were characterized by the binding of inhibitors to band 3. In addition, spectrin detachment from the erythrocyte membrane by high pressure was considerably suppressed by DIDS treatment at neutral pH, but not by DIDS labeling at alkaline pH. These results suggest that the interaction of the cytoplasmic domain of band 3 with the cytoskeleton, which is induced by the binding of ligands to the exofacial domain of band 3, is dependent on the intracellular pH, i.e., the linking is tightened at neutral pH but relaxed at alkaline pH.

    DOI: 10.1016/0005-2736(95)00302-9

    Web of Science

    Scopus

    PubMed

    CiNii Article

    researchmap

  • Effects of anion transport inhibitors on hemolysis of human erythrocytes under hydrostatic pressure

    Takeo Yamaguchi, Masaki Matsumoto, Eiji Kimoto

    Journal of Biochemistry   118 ( 4 )   760 - 764   1995

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press  

    Effects of anion transport inhibitors on hemolysis of human erythrocytes at 200 mPa were examined. The degree of hemolysis was decreased by treating intact cells with 4,4'-diisothiocyanostilbene-2,2'-disulfonate (DIDS), 4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonate, or bis(sulfosuccinimidyl)suberate, whereas 4,4'-dinitrostilbene-2,2'-disulfonate and pyridoxal 5'-phosphate (PLP) had little effect on the hemolysis. In contrast, the degree of hypotonic hemolysis increased upon treatment with anion transport inhibitors. From the relationship between the hemolysis at 200 mPa and anion transport, it was found that high-pressure-induced hemolysis was suppressed by the covalent binding of anion transport inhibitors to band 3. This idea was supported by the finding that the hemolysis at 200 mPa of trypsin-treated erythrocytes was suppressed by DIDS. Furthermore, the spectrin content in vesicles which are released from erythrocyte ghosts by dimyristoylphosphatidylcholine decreased upon DIDS labeling of hand 3, but did not change upon PLP labeling. These results suggest that the interaction of the cytoplasmic domain of band 3 with spectrin, perhaps via ankyrin, is tightened by the covalent binding of bulky ligands to the exofacial domain of band 3. © 1995 Oxford University Press.

    DOI: 10.1093/oxfordjournals.jbchem.a124977

    Scopus

    PubMed

    researchmap

  • Effects of amphiphilic drugs on high pressure-induced hemolysis of human erythrocytes Reviewed

    M MATSUMOTO, T YAMAGUCHI, E KIMOTO

    PROGRESS IN ANESTHETIC MECHANISM, VOL 3, SPECIAL ISSUE, 1995   410 - 415   1995

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (international conference proceedings)   Publisher:RESEARCH GROUP ANESTHETIC MECHANISM JAPAN  

    Web of Science

    researchmap

  • Hemolytic properties under hydrostatic pressure of neuraminidase or protease-treated human erythrocytes

    Takeo Yamaguchi, Masaki Matsumoto, Eiji Kimoto

    Journal of Biochemistry   114 ( 4 )   576 - 581   1993

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press  

    We investigated the hemolytic properties under high pressure (200 MPa) of human erythrocytes in which sialic acids and glycopeptides had been removed from membrane surface by using neuraminidase and proteolytic enzymes such as trypsin and chymotrypsin, respectively. The degree of hemolysis increased in proportion to the amounts of sialic acids or glycopeptides released from intact erythrocytes. Studies of the time course of hemolysis showed that upon enzymatic digestion erythrocyte membranes became more fragile against high pressure. Such fragility decreased in the presence of chlorpromazine and trifluo-perazine but was unaffected by chlorpromazine methiodide or indomethacin. Furthermore, the effect of cross-linking of membrane proteins by diamide on the fragility was examined. The degree of hemolysis at 200 MPa increased upon removal of sialic acids from red cells in which spectrin is mainly cross-linked, but did not upon enzymatic digestion of red cells in which glycophorins, in addition to cross-linking of themselves, are included in the large-molecular-weight aggregates formed by cross-linking of the membrane skeleton with transmembrane proteins. In the latter case, however, upon reduction of the cross-linking by dithiothreitol the effect of enzymatic digestion appeared again. On the other hand, such an enzymatic digestion effect on osmotic hemolysis was not observed either in intact erythrocytes or in diamide-treated red cells. These results suggest that the interaction of the cytoplasmic domains of glycophorins with cytoskeletal proteins may be weakened by enzymatic digestion of the exofacial domains of glycophorins. © 1993 BY THE JOURNAL OF BIOCHEMISTRY.

    DOI: 10.1093/oxfordjournals.jbchem.a124219

    Scopus

    PubMed

    researchmap

▶ display all

MISC

  • Accelerating data re-analysis in jPOST using metadata from JPDM data papers

    高橋悠志, 吉沢明康, 小林大樹, 守屋勇樹, 幡野敦, 高見知代, 松本雅記, 荒木令江, 田畑剛, 田畑剛, 岩崎未央, 杉山直幸, 小寺義男, 福島敦史, 田中聡, 五斗進, 河野信, 奥田修二郎, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2024 (Web)   2024

  • LPGAT1/LPLAT7による骨格筋中リン脂質のアシル基リモデリング機構の解明とLPGAT1/LPLAT7欠損が骨格筋機能に及ぼす影響

    滝田 紗恵, 梅林 修平, 佐藤 友紀, 妹尾 奈波, 赤堀 拓, 三好 規之, 杉浦 悠毅, 井上 菜穂子, 川名 裕己, 幡野 敦, 松本 雅記, 進藤 英雄, 亀井 康富, 清水 孝雄, 青木 淳賢, 三浦 進司

    脂質生化学研究   65   46 - 49   2023.5

     More details

    Language:Japanese   Publisher:日本脂質生化学会  

    Phosphatidylcholine(PC)は、グリセロール骨格に2つの脂肪酸が結合した構造を有し、結合している脂肪酸の種類およびその組み合わせによって数多くの分子種が存在する。演者らはこれまでに、骨格筋を形成する筋線維タイプ(収縮速度の違う速筋タイプと遅筋タイプ)によって1-palmitoyl型PC(16:0-PC)と1-stearoyl型PC(18:0-PC)の存在比が異なること、この違いにはリン脂質のsn-1位に脂肪酸を導入するLPGAT1が関与していることを認め、さらに骨格筋でのLPGAT1の欠損が運動継続能力の低下を引き起こすことを見出している。本研究では、骨格筋LPGAT1が18:0-PC合成活性を有するか否かを検討したところ、骨格筋には18:0-PC合成活性が存在し、LPGAT1の欠損によりその活性は著しく低下した。次に、骨格筋特異的LPGAT1欠損マウスの骨格筋を用いて定量的プロテオミクス解析を実施した結果、LPGAT1の欠損に伴いvacuolar-type ATPase(v-ATPase)量の減少が見出された。加えて、遅筋ではミトコンドリア呼吸鎖複合体Iに含まれるタンパク質、ミトコンドリア内膜に局在するタンパク質量の減少とともに、ミトコンドリア呼吸鎖機能の低下が認められ、LPGAT1によるリン脂質リモデリングが骨格筋機能に影響することが示唆された。(著者抄録)

    J-GLOBAL

    researchmap

  • Development of a method for absolute quantification of the major metabolomes of cancer cells using LC-MS/MS and its application to metabolic analysis.

    金光祥臣, 小林大樹, 中谷航太, 和泉自泰, 馬場健史, 松本雅記

    日本分子生物学会年会プログラム・要旨集(Web)   46th   2023

  • eIF2D counteracts intrinsic ribosome destabilization (IRD) during translation elongation

    市原知哉, 松本有樹修, 幡野敦, 松本雅記, 茶谷悠平, 田口英樹, 中山敬一

    日本分子生物学会年会プログラム・要旨集(Web)   45th   2022

  • ナノ液体クロマトグラフィー質量分析を基盤としたシングルセル分子フェノタイプ解析法の開発

    和泉自泰, 秦康祐, 中谷航太, 山村昌平, 松本雅記, 馬場健史

    日本生化学会大会(Web)   94th   2021

  • Improvement of proteomics assay for central carbon metabolism in human breast cancer cells

    高橋遼, 西本和生, 岡橋伸幸, 松本雅記, 松田史生

    質量分析総合討論会講演要旨集   69th   2021

  • ナノ液体クロマトグラフィー質量分析を基盤としたシングルセル分子フェノタイプ解析

    和泉 自泰, 中谷 航太, 秦 康祐, 原 健士, 松本 雅記, 馬場 健史

    J. Mass. Spectrom. Soc. Jpn.,   68 ( 2 )   44 - 48   2020.4

     More details

    Language:Japanese   Publisher:J. Mass. Spectrom. Soc. Jpn.  

    DOI: 10.5702/massspec.S20-09

    researchmap

  • シングルセル分子フェノタイプ解析に向けた基盤技術の創生

    和泉自泰, 松本雅記, 山村昌平, 馬場健史

    日本プロテオーム学会大会プログラム・抄録集   2019   2019

  • Cooperative Mechanism of SREBP-dependent Cholesterol Synthesis Pathway and p53 on Malignant Formation in Breast Cancer

    Akitoshi Nakayama, Sawako Suzuki, Mizuho Oda, Masaki Matsumoto, Koutaro Yokote, Tomoaki Tanaka

    CANCER SCIENCE   109   221 - 221   2018.1

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:WILEY  

    Web of Science

    researchmap

  • jPOSTプロジェクトが提供するプロテオミクスデータとその解析ツール

    五斗進, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 松本雅記, 高見知代, 小林大樹, 山ノ内祥訓, 荒木令江, 吉沢明康, 田畑剛, 岩崎未央, 杉山直幸, 田中聡, 石濱泰

    第41回日本分子生物学会   41st   2018

  • jPOST統合環境の開発

    奥田修二郎, 渡辺由, 守屋勇樹, 河野信, 松本雅記, 高見知代, 小林大樹, 山ノ内祥訓, 荒木令江, 吉沢明康, 田畑剛, 岩崎未央, 杉山直幸, 田中聡, 五斗進, 石濱泰

    トーゴ―の日2018シンポジウム   2018

     More details

  • プロテオーム統合データベースの機能深化

    守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 松本雅記, 高見知代, 小林大樹, 山ノ内祥訓, 荒木令江, 吉沢明康, 田畑剛, 岩崎未央, 杉山直幸, 田中聡, 五斗進, 石濱泰

    第41回日本分子生物学会   41st   2018

  • jPOST:同定結果のFDR改善を目指す再解析プロトコルの開発

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 杉山直幸, 田中聡, 五斗進, 石濱泰

    日本生化学会大会(Web)   2017年度   [3P - 0172]   2017.12

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 3次元培養を用いた変異p53とSREBP2依存的コレステロール合成経路の乳癌悪性化機構に対する役割

    中山 哲俊, 鈴木 佐和子, 樋口 誠一郎, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    生命科学系学会合同年次大会   2017年度   [2P - 0877]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    researchmap

  • Heat shock protein 72によるStromal cell-derived factor 2の保護はオキサリプラチン耐性ヒト胃癌細胞においてオキサリプラチン誘導性の細胞死を抑制する

    高橋 克之, 田中 昌子, 八代 正和, 松本 雅記, 大塚 明日香, 中山 敬一, 泉 康雄, 永山 勝也, 三浦 克之, 岩尾 洋, 塩田 正之

    大阪市医学会雑誌   66   40 - 41   2017.12

     More details

    Language:Japanese   Publisher:大阪市医学会  

    researchmap

  • 3次元培養を用いた変異p53とSREBP2依存的コレステロール合成経路の乳癌悪性化機構に対する役割

    中山 哲俊, 鈴木 佐和子, 樋口 誠一郎, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    生命科学系学会合同年次大会   2017年度   [2P - 0877]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    researchmap

  • jPOST:プロテオーム統合データベースプロジェクト

    奥田修二郎, 渡辺由, 守屋勇樹, 河野信, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 田中聡, 五斗進, 石濱泰

    日本生化学会大会(Web)   2017年度   [3P - 0171]   2017.12

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • jPOST:プロテオームデータベースの開発

    守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 田中聡, 五斗進, 石濱泰

    日本生化学会大会(Web)   2017年度   [3P - 0173]   2017.12

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 乳がん悪性化形質に対するSREBP依存的コレステロール合成経路と変異p53の協調的作用機構

    中山 哲俊, 鈴木 佐和子, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    日本癌学会総会記事   76回   P - 1108   2017.9

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • Controlling false discovery rate in accumulated public proteome dataset

    Akiyasu C. Yoshizawa, Tsuyoshi Tabata, Yuki Moriya, Shin Kawano, Shujiro Okuda, Yu Watanabe, Tadashi Yamamoto, Masaki Matsumoto, Tomoyo Takami, Daiki Kobayashi, Norie Araki, Naoyuki Sugiyama, Satoshi Tanaka, Susumu Goto, Yasushi Ishihama

    American Society for Mass Spectrometry Annual Conference   65th   MP321   2017.6

     More details

    Language:English  

    researchmap

  • データベース検索エンジンを用いたタンパク質同定における特異性向上

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 杉山直幸, 田中聡, 五斗進, 石濱泰

    質量分析総合討論会講演要旨集   65th   107   2017.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • jPOST再解析プロトコル:偽陽性と偽陰性の同時減少を目指す

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 杉山直幸, 田中聡, 五斗進, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2017 ( 0 )   115 - 115   2017

     More details

    Language:Japanese   Publisher:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    CiNii Article

    J-GLOBAL

    researchmap

  • jPOST:プロテオーム統合データベースの開発

    守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 田中聡, 五斗進, 石澤泰

    日本プロテオーム学会大会プログラム・抄録集   2017   116   2017

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • プロテオーム統合データベースjPOST:質量分析データ・リポジトリ

    奥田修二郎, 渡辺由, 守屋勇樹, 河野信, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 田中聡, 五斗進, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2017 ( 0 )   114 - 197   2017

     More details

    Language:Japanese   Publisher:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    CiNii Article

    J-GLOBAL

    researchmap

  • jPOST:再解析プロトコルによる同定結果の質的向上

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 杉山直幸, 田中聡, 五斗進, 石濱泰

    トーゴ―の日シンポジウム2017   2017

     More details

  • Reducing false positive identifications for proteome datasets accumulated in jPOST repository

    Yoshizawa A, Tabata T, Moriya Y, Kawano S, Okuda S, Watanabe Y, Yamamoto T, Matsumoto M, Takami T, Kobayashi D, Araki N, Sugiyama N, Tanaka S, Goto S, Ishihama Y

    16th Human Proteome Organization World Congress (HUPO2017)   2017

     More details

  • jPOST: Development of reanalysis protocol toward control of false discovery rate in peptide identification

    Akiyasu C. Yoshizawa, Tsuyoshi Tabata, Mio Iwasaki, Yuki Moriya, Shin Kawano, Shujiro Okuda, Yu Watanabe, Tadashi Yamamoto, Masaki Matsumoto, Tomoyo Takami, Daiki Kobayashi, Norie Araki, Naoyuki Sugiyama, Satoshi Tanaka, Susumu Goto, Yasushi Ishihama

    ConBio2017   2017

     More details

  • 1細胞メタボロミクスに向けた基盤技術開発

    和泉自泰, 原健士, 中谷航太, 秦康祐, 山村昌平, 松本雅記, 馬場健史

    日本生物工学会大会講演要旨集   69th   2017

  • 三次元培養を用いた乳癌悪性化に関する変異p53とコレステロール合成経路の役割

    中山 哲俊, 鈴木 佐和子, 橋本 直子, 樋口 誠一郎, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    日本癌学会総会記事   75回   J - 3028   2016.10

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • 膵臓で特異的に発現するPDIファミリータンパク質(PDIp)の生理的機能の解析

    藤本拓志, 斎藤美知子, 都留秋雄, 松本雅記, 河野憲二, 稲葉謙次, 門倉広

    日本蛋白質科学会年会プログラム・要旨集   16th   66   2016.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 質量スペクトルはデータベース検索“グレーゾーン”を明瞭化するか

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 山本格, 松本雅記, 小林大樹, 荒木令江, 杉山直幸, 五斗進, 石濱泰

    質量分析総合討論会講演要旨集   64th   15   2016.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • プロテオーム統合データベースjPOST:質量分析データ・リポジトリの公開

    奥田修二郎, 渡辺由, 守屋勇樹, 河野信, 山本格, 松本雅記, 高見知世, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 五斗進, 石濱泰

    日本分子生物学会年会プログラム・要旨集(Web)   39th   ROMBUNNO.1PS7‐4(2P‐0039) (WEB ONLY)   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • プロテオーム統合データベースjPOST:再解析プロトコルの開発

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知世, 小林大樹, 荒木令江, 杉山直幸, 五斗進, 石濱泰

    日本分子生物学会年会プログラム・要旨集(Web)   39th   ROMBUNNO.3P‐0880 (WEB ONLY)   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • プロテオーム統合データベースjPOSTの開発

    五斗進, 奥田修二郎, 渡邉由, 守屋勇樹, 河野信, 山本格, 松本雅記, 高見知代, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2016   88   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • jPOST:プロテオームデータベースプロジェクト

    守屋勇樹, 河野信, 奥田修二郎, 渡辺由, 山本格, 松本雅記, 高見知世, 小林大樹, 荒木令江, 吉沢明康, 田畑剛, 杉山直幸, 五斗進, 石濱泰

    日本分子生物学会年会プログラム・要旨集(Web)   39th   ROMBUNNO.1P‐0076 (WEB ONLY)   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • プロテオーム統合データベースjPOST:再解析プロトコルの開発

    吉沢明康, 田畑剛, 守屋勇樹, 河野信, 奥田修二郎, 渡邉由, 山本格, 松本雅記, 高見知世, 小林大樹, 荒木令江, 杉山直幸, 五斗進, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2016   177   2016

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • jPOST:プロテオーム解析ワークフローの標準化

    守屋勇樹, 河野信, 奥田修二郎, 山本格, 松本雅記, 小林大樹, 荒木令江, 吉沢明康, 五斗進, 田畑剛, 杉山直幸, 石濱泰

    日本生化学会大会(Web)   88th   3P0417 (WEB ONLY) - [3P0417]   2015.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 乳癌幹細胞制御におけるp53-Rb-GATA3転写因子群の役割

    中山 哲俊, 鈴木 佐和子, 橋本 直子, 樋口 誠一郎, 永野 秀和, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    日本癌学会総会記事   74回   P - 2069   2015.10

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • miR-874によるp53依存的癌抑制機構の解析

    橋本 直子, 木下 崇, 野畑 二次郎, 中山 哲俊, 鈴木 穣, 菅野 純夫, 松本 雅記, 関 直彦, 田中 知明, 横手 幸太郎

    日本内分泌学会雑誌   91 ( 1 )   305 - 305   2015.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • 癌幹細胞制御を目指した転写因子p53とGATA3-Ruvbl2コンプレックスの機能的役割と乳癌患者における予後・悪性度との関わり

    中山 哲俊, 鈴木 佐和子, 橋本 直子, 永野 秀和, 小田 瑞穂, 松本 雅記, 田中 知明, 横手 幸太郎

    日本内分泌学会雑誌   91 ( 1 )   305 - 305   2015.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • 膵臓特異的に発現しているPDIファミリータンパク質(PDIp)の生理的な機能の解析

    藤本拓志, 斎藤美知子, 都留秋雄, 松本雅記, 河野憲二, 稲葉謙次, 門倉広

    日本生化学会大会(Web)   88th   1P0429 (WEB ONLY)   2015

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • jPOST: Japan Proteome Standard Repository/Database

    守屋勇樹, 河野信, 奥田修二郎, 山本格, 松本雅記, 小林大樹, 荒木令江, 吉沢明康, 五斗進, 田畑剛, 杉山直幸, 石濱泰

    日本プロテオーム学会大会プログラム・抄録集   2015 (Web)   2015

  • 癌幹細胞制御を目指した転写因子p53とGATA3の機能的役割と乳癌における予後・悪性度との関わり(Functional role of GATA3-RuvBL2 complex in cancer stem cell regulation and its concerns in prognosis of breast cancer)

    中山 哲俊, 鈴木 佐和子, 橋本 直子, 永野 秀和, 小田 瑞穂, 松本 雅記, 横手 幸太郎, 田中 知明

    日本癌学会総会記事   73回   J - 1095   2014.9

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • がん代謝

    松崎 芙美子, 松本 雅記, 中山 敬一

    がん分子標的治療   12 ( 2 )   175 - 180   2014.6

     More details

    Language:Japanese   Publisher:(株)メディカルレビュー社  

    がんが特異な代謝状態にあることは、1920年代にWarburg効果として報告されて以来、フルオロデオキシグルコース(FDG)-ポジトロン断層撮像法(PET)のような画像診断に利用されるなど、広く認識されている。たしかに、がん細胞が速い増殖の維持やそれぞれの置かれた栄養環境へ適応のために、Warburg効果のような代謝状態の改変(代謝リプログラミング)という戦略を利用していることは大いに納得がいく。この代謝リプログラミングの誘導メカニズムや解糖系以外の代謝状態については大部分が長年謎に包まれていたが、近年、それらに関与する役者たちの同定が進むとともに、新たながん特異的代謝リプログラミングの発見も相次ぎ、がん代謝を対象とした治療法開発への期待が高まってきている。しかし、代謝系は非常に複雑なネットワークを形成しているために、特定の酵素の阻害により治療効果が上がるかどうかは不明であり、慎重に作戦を練る必要があるだろう。がん細胞の代謝リプログラミングを介した生存戦略と、代謝酵素を分子標的とするうえでの問題点を、われわれの取り組みも併せて紹介したい。(著者抄録)

    researchmap

  • GATA3結合タンパクの網羅的探索および乳がんにおける予後解析

    中山 哲俊, 橋本 直子, 鈴木 佐和子, 永野 秀和, 松本 雅記, 田中 知明, 横手 幸太郎

    日本内分泌学会雑誌   90 ( 1 )   283 - 283   2014.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • 次世代ターゲットプロテオミクスによるヒト全代謝経路の絶対定量マッピング

    松本雅記, 押川清孝, 松崎芙美子, 五島直樹, 夏目徹, 中山敬一

    日本生化学会大会(Web)   87th   3S07P-5 (WEB ONLY)   2014

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 生物時計の発生と維持と破綻 F-box型E3リガーゼFBXL21によるCRYタンパク質の安定化と概日時計の発振制御

    平野 有沙, 弓本 佳苗, 恒松 良佑, 松本 雅記, 尾山 大明, 秦 裕子, 中川 智貴, ダーリン・ランジャコーン・シリパン, 中山 敬一, 深田 吉孝

    日本生化学会大会プログラム・講演要旨集   86回   1S12a - 3   2013.9

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 時計タンパク質のCRYの安定化を担う新規ユビキチンリガーゼの同定

    平野 有沙, 恒松 良佑, 松本 雅記, 尾山 大明, 秦 裕子, ダーリン・ランジャコーンシリパン, 中山 敬一, 深田 吉孝

    日本生化学会大会プログラム・講演要旨集   85回   3T01 - 08   2012.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • 単球系細胞における酸化LDL(APOB)および抗β2GPI抗体によって誘導される組織因子発現の検討

    大友耕太郎, 渥美達也, 藤枝雄一郎, 中川久子, 加藤将, AMENGUAL Olga, 近祐次郎, 堀田哲也, 保田晋助, 松本雅記, 畠山鎮次, 小池隆夫, 小池隆夫

    日本血栓止血学会誌   23 ( 2 )   166 - 166   2012.4

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 質量分析計によるRNA制御因子の同定法の開発とその応用

    足達俊吾, 穂本真佐江, 田中利好, 日置雄策, 村上裕, 菅裕明, 松本雅記, 中山敬一, 堀本勝久, 家村俊一郎, 夏目徹

    日本分子生物学会年会プログラム・要旨集(Web)   35th   3W12III-1 (WEB ONLY)   2012

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Surveys for mTOR Targets by Proteomic Analysis

    31 ( 12 )   1360 - 1367   2012

     More details

  • 大規模リン酸化プロテオーム解析による大腸癌バイオマーカー探索

    久家貴寿, 鳴海良平, 村岡賢, 足立淳, 松本雅記, 中山敬一, 松原久裕, 松下一之, 野村文夫, 長野一也, 角田慎一, 朝長毅

    生化学   83回・33回   ROMBUNNO.4T16-2 - 2   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 次世代プロテオミクスを用いたヒト総プロテオームの絶対定量

    松本雅記, 中山敬一, 五島直樹, 夏目徹

    生化学   ROMBUNNO.3W16-1   2010

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 「DNA 損傷応答ネットワークにおけるリン酸化・ユビキチン化修飾ダイナミクスのプロテオーム解析」 Reviewed

    足立淳, 鳴海良平, 佐野聖三, 久家貴寿, 白水崇, 松本雅記, 中山敬一, 茂木章, 井倉毅, 高田穣, 朝長毅

    第33 回日本分子生物学会年会第83 回「」本生化学会大会合同大会 2010 年12 月   2010

     More details

    Language:Japanese  

    researchmap

  • 大腸癌臨床検体を用いた定量的大規模リン酸化プロテオーム解析

    久家 貴寿, 鳴海 良平, 松本 雅記, 中山 敬一, 松原 久裕, 松下 一之, 野村 文夫, 朝長 毅

    日本プロテオーム学会大会要旨集   2010 ( 0 )   77 - 77   2010

     More details

    Language:Japanese   Publisher:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    DOI: 10.14889/jhupo.2010.0.77.1

    CiNii Article

    researchmap

  • Proteomics for the study on cell cycle regulation

    Cell technology.   28 ( 1 )   59 - 64   2009.1

  • Aire controls the differentiation program of thymic epithelial cells in the medulla for the establishment of self-tolerance

    Masashi Yano, Noriyuki Kuroda, Hongwei Han, Makiko Meguro-Horike, Yumiko Nishikawa, Hiroshi Kiyonari, Kentaro Maemura, Yuchio Yanagawa, Kunihiko Obata, Satoru Takahashi, Tomokatsu Ikawa, Rumi Satoh, Hiroshi Kawamoto, Yasuhiro Mouri, Mitsuru Matsumoto

    JOURNAL OF EXPERIMENTAL MEDICINE   205 ( 12 )   2827 - U59   2008.11

     More details

    Language:English   Publisher:ROCKEFELLER UNIV PRESS  

    The roles of autoimmune regulator (Aire) in the expression of the diverse arrays of tissue-restricted antigen (TRA) genes from thymic epithelial cells in the medulla (medullary thymic epithelial cells [mTECs]) and in organization of the thymic microenvironment are enigmatic. We approached this issue by creating a mouse strain in which the coding sequence of green fluorescent protein (GFP) was inserted into the Aire locus in a manner allowing concomitant disruption of functional Aire protein expression. We found that Aire(+) (i.e., GFP(+)) mTECs were the major cell types responsible for the expression of Aire-dependent TRA genes such as insulin 2 and salivary protein 1, whereas Aire-independent TRA genes such as C-reactive protein and glutamate decarboxylase 67 were expressed from both Aire(+) and Aire(-) mTECs. Remarkably, absence of Aire from mTECs caused morphological changes together with altered distribution of mTECs committed to Aire expression. Furthermore, we found that the numbers of mTECs that express involucrin, a marker for terminal epidermal differentiation, were reduced in Aire-deficient mouse thymus, which was associated with nearly an absence of Hassall&apos;s corpuscle-like structures in the medulla. Our results suggest that Aire controls the differentiation program of mTECs, thereby organizing the global mTEC integrity that enables TRA expression from terminally differentiated mTECs in the thymic microenvironment.

    DOI: 10.1084/jem.20080046

    Web of Science

    researchmap

  • Kspot, a novel ubiquitin ligase, regulates synaptic activity

    Hirobumi Tada, Hirotaka James Okano, Hiroshi Takagi, Ikuko Yao, Toru Saiga, Masaki Matsumoto, Koiichi I. Nakayama, Haruo Kashima, Takuya Takahashi, Mitsutoshi Setou, Hideyuki Okano

    NEUROSCIENCE RESEARCH   61 ( 0 )   S218 - S218   2008

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ELSEVIER IRELAND LTD  

    We identified a novel ubiquitin ligase (E3), Kspot as a target molecule of a high titer autoantibody produced in the serum of a patient with stomach can cer, associated with psychiatric symptoms.Kspot is highly conserved througho ut species and expressed in the mammalian nervous system. In this study we d emonstrated that Kspot formed an SCF complex and mediated ubiquitination of cellular proteins. Furthermore, overexpression of Kspot in primary cultured rat hippocampal neurons resulted in a decrease in the miniature excitatory p ostsynaptic current frequency. We propose that Kspot plays an important role in the regulation of the neurotransmitter release at the presynaptic site. &lt;b&gt;[J Physiol Sci. 2008;58 Suppl:S123]&lt;/b&gt;

    Web of Science

    CiNii Article

    researchmap

  • ユビキチンと病態生理 ポリグルタミン病とユビキチン介在性蛋白質分解--異常蛋白質の除去機構 (ユビキチン-プロテアソーム系とオートファジー--作動機構と病態生理) -- (ユビキチン系の生理と病態)

    松本 雅記

    蛋白質核酸酵素   51 ( 10 )   1428 - 1432   2006.8

     More details

    Language:Japanese   Publisher:共立出版  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2007008964

  • 翻訳後修飾の網羅的解析--チロシンリン酸化プロテオーム解析によるシグナル伝達研究 (特集 プロテオミクスの細胞機能解析への挑戦)

    松本 雅記, 中山 敬一

    細胞工学   25 ( 6 )   602 - 607   2006.6

     More details

    Language:Japanese   Publisher:秀潤社  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2006202919

  • 抗体アフィニティーカラムを用いた翻訳後修飾タンパク質の網羅的解析--チロシンリン酸化とユビキチン化を中心に (特集1 プロテオーム研究を成功させる 試料調製と解析法)

    松本 雅記, 中山 敬一

    バイオテクノロジージャーナル   6 ( 2 )   163 - 167   2006.3

     More details

    Language:Japanese   Publisher:羊土社  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2006111059

  • 実験メソッド&マニュアル プロテオーム研究なるほどQ&A(第7回)質量分析計によるタンパク質翻訳後修飾の解析

    松本 雅記, 中山 敬一

    バイオテクノロジージャーナル   6 ( 1 )   105 - 108   2006.1

     More details

    Language:Japanese   Publisher:羊土社  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2006059088

  • 新しいユビキチンリガーゼであるKspotはシナプス形成を調節する(Kspot, a novel ubiquitin ligase, may control synapse formation)

    多田 敬典, 岡野 ジェイムス洋尚, 松本 雅記, 中山 敬一, 鹿島 晴雄, 岡野 栄之

    神経化学   44 ( 2-3 )   212 - 212   2005.8

     More details

    Language:English   Publisher:日本神経化学会  

    researchmap

  • 神経系特異的新規ユビキチンリガーゼの機能的解析(Functional Analysis of Novel Ubiquitin Ligase,Potential Target Antigen of Paraneoplastic Neurologic Disorder)

    多田 敬典, 岡野 ジェイムス洋尚, 松本 雅記, 中山 敬一, 鹿島 晴雄, 岡野 栄之

    神経化学   43 ( 2-3 )   360 - 360   2004.8

     More details

    Language:English   Publisher:日本神経化学会  

    researchmap

  • プロテオミクスによる翻訳後修飾ネットワークの網羅的解析(第411回北里医学会招待学術講演会要旨)

    松本 雅記

    北里医学   33 ( 5 )   331 - 331   2003.10

     More details

    Language:Japanese   Publisher:北里大学  

    CiNii Article

    CiNii Books

    researchmap

  • ポリグルタミン病とユビキチン・プロテアソーム系によるタンパク質分解--異常タンパク質の除去機構 (特集 ポリグルタミン病の病態機序)

    松本 雅記, 中山 敬一

    神経研究の進歩   46 ( 5 )   681 - 695   2002.10

     More details

    Language:Japanese   Publisher:医学書院  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2003089854

  • IκBαとβ‐cateninの分解に関与するユビキチン化酵素複合体SCF<sup>FWDI</sup>

    畠山鎮次, 北川雅敏, 松本雅記, 白根道子, 服部公彦, 中野裕康, 奥村康, 菊池章, 中山敬一

    日本分子生物学会年会プログラム・講演要旨集   22nd   256   1999.11

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • NFκB活性化シグナルと生命現象 IκBのユビキチンリガーゼSCFFWD1複合体の同定 (生化学)

    中山敬一, 畠山鎮次, 北川雅敏, 白根道子, 松本雅記, 服部公彦, 中山啓子

    生化学   71 ( 8 )   686 - 686   1999.8

     More details

    Language:Japanese   Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

    researchmap

  • Ubiquitin-dependent degradation of I kappa B alpha is mediated by a ubiquitin ligase Skp1/Cul1/F-box protein FWD1 (vol 96, pg 3859, 1999)

    S Hatakeyama, M Kitagawa, K Nakayama, M Shirane, M Matsumoto, K Hattori, H Higashi, H Nakano, K Okumura, K Onoe, RA Good, K Nakayama

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   96 ( 11 )   6571 - 6571   1999.5

     More details

    Language:English   Publisher:NATL ACAD SCIENCES  

    Web of Science

    researchmap

  • Molecular cloning and cell biological analysis of mouse novel F-box protein cDNAs

    HATAKEYAMA Shigetsugu, KITAGAWA Masatoshi, SHIRANE Michiko, MATSUMOTO Masaki, HATTORI Kimihiko, NAKAYAMA Keiko, NAKAYAMA Kei-ichi

    21   460 - 460   1998.12

     More details

  • Molecular cloning and analysis of murine Skp2 cDNA and genomic DNA

    MATSUMOTO Masatoshi, HATAKEYAMA Shigetsugu, KITAGAWA Kyouko, KITAGAWA Masatoshi, NAKAYAMA Keiko, NAKAYAMA Kei-ichi

    21   500 - 500   1998.12

     More details

  • High pressure induces G2 arrest in murine erythroleukemia cells

    M Matsumoto, T Yamaguchi, Y Fukumaki, R Yasunaga, S Terada

    JOURNAL OF BIOCHEMISTRY   123 ( 1 )   87 - 93   1998.1

     More details

    Authorship:Lead author   Language:English   Publisher:JAPANESE BIOCHEMICAL SOC  

    The effect of high pressure on proliferation and cell cycle progression was examined using murine erythroleukemia (MEL) cells, The MEL cells were exposed to high pressures (0.1-130 MPa) and then cultured for 5 days at atmospheric pressure. The proliferation of MEL cells was unaffected up to 60 MPa, but was suppressed at 80-110 MPa, Above 120 MPa, the cells were fragmented, The cell cycle analysis of 80 MPa-treated MEL cells showed that the cells in S phase are most sensitive to high pressure and they arrest in G2 phase, Interestingly, G2-arrested cells reinitiated DNA synthesis, resulting in giant cells with high DNA contents. Furthermore, when such Ga-arrested cells were exposed to caffeine, premature mitosis, characterized by chromosome pulverization, was observed, These results suggest that the suppression of proliferation in high-pressure-treated MEL cells is associated with G2 arrest following S phase delay, Thus, it seems valuable to apply high pressure to the investigation of the cell cycle.

    DOI: 10.1093/oxfordjournals.jbchem.a021920

    Web of Science

    Scopus

    PubMed

    researchmap

▶ display all

Presentations

  • iMPAQT ver.2: New platform for protein absolute quantification of proteins of interest. 29th Hot Spring Harbor Symposium 2020年2月6-7, Fukuoka Invited

    Masaki Matsumoto

    29th Hot Spring Harbor Symposium  2020.2 

     More details

    Event date: 2020.2

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • タンパク質の精密定量による生命システムの定量的描出

    生体コモンスペース研究会  2021.2 

     More details

    Presentation type:Oral presentation (keynote)  

    researchmap

  • ペプチド先導型プロテオミクス〜精密で信頼性の高いタンパク質定量技術〜

    CBI Annual Meeting 2020  2020.10 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 多重ターゲットプロテオミクスを用いたタンパク質動態解析

    第93回日本生化学会大会  2020.9 

     More details

    Presentation type:Oral presentation (invited, special)  

    researchmap

  • 定量プロテオーム解析のための内部標準ペプチド作成の標準化や共有化について

    松本雅記

    日本プロテオーム学会  2019.7 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • New platform for protein absolute quantification: a tool for pathway structure determination Invited

    Masaki Matsumoto

    1st International symposium on Interdisciplinary Approaches to Integrative Understanding of Biological Signaling Networks  2019.2 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • iMPAQT: a scalable and flexible platform for the quantification of proteins of interest Invited

    松本 雅記

    2018.10  日本生化学会

     More details

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • iMPAQT ver.2.0: 拡張性と柔軟性を備えたタンパク質絶対定量プラットフォーム

    松本 雅記

    MSP2018  2018.5 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • Robotics promotes accurate and reproducible data acquisition in proteomics Invited International conference

    松本 雅記

    Robotics and Semantic Systems for Biology2  2018.1 

     More details

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 定量プロテオミクス技術の開発と応用に関する研究

    松本 雅記

    日本プロテオーム学会大会  2017.7 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • iMPAQT: A Platform for Large-Scale Targeted Proteomics Based on an in Vitro Human Proteome Invited

    松本 雅記

    第65質量分析総合討論会  2017.5 

     More details

    Language:Japanese   Presentation type:Oral presentation (keynote)  

    researchmap

  • iMPAQT: A platform for large scale targeted proteomics based on in vitro human proteome. Invited International conference

    MATSUMOTO Masaki

    1st-Internatinal Symposium of the Kyoto Biomolecular Mass Spectrometry Society.  2017.2 

     More details

    Language:English   Presentation type:Oral presentation (invited, special)  

    researchmap

  • iMPAQT: 組換えタンパク質を利用したタンパク質絶対定量プラットフォーム~がん代謝研究への応用 Invited

    松本 雅記

    第4回次世代がんインフォマティクス研究会  2016.12 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 定量プロテオミクスプラットフォームのためのインフォマティクス Invited

    松本 雅記

    質量分析インフォマティクス研究会・第1回ワークショップ  2016.10 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 大規模定量プロテオミクスで挑むがん代謝の実体解明

    松本 雅記

    BMB2015  2015.12 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 次世代定量プロテオミクスによる癌代謝研究 Invited

    松本 雅記

    第3回がんと代謝研究会  2015.7 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 次世代定量プロテオミクスによるヒトプロテオーム解析 Invited

    松本 雅記

    第33回内分泌代謝学サマーセミナー シンポジウム  2015.7 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 次世代ターゲットプロテオミクスによるヒト全代謝経路の絶対定量マッピング Invited

    松本 雅記

    第87回生化学会大会  2014.10 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • リン酸化定量プロテオミクスによるシグナル伝達研究 Invited

    松本 雅記

    第14回蛋白質科学会年会  2014.6 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 次世代プロテオミクスによる癌代謝経路の網羅的解析 Invited

    松本 雅記

    がんと代謝シンポジウム  2013 

     More details

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • 大規模ターゲットプロテオミクス– Invited

    松本 雅記

    パソシグナリングバイオロジー ワークショップ  2012.4 

     More details

    Language:Japanese   Presentation type:Oral presentation (keynote)  

    researchmap

▶ display all

Industrial property rights

Awards

  • 日本プロテオーム学会賞

    2017.7   日本プロテオーム学会  

    松本 雅記

     More details

Research Projects

  • A Study on Elucidating Obesity and Lifestyle Diseases through the Epigenome-RNA Modification Axis

    Grant number:24H00065

    2024.4 - 2029.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (S)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\204230000 ( Direct Cost: \157100000 、 Indirect Cost:\47130000 )

    researchmap

  • Extracellular matrix controlled stem cell differentiation and its application toward the regeneration of periodontal ligament

    Grant number:24K02630

    2024.4 - 2027.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\18590000 ( Direct Cost: \14300000 、 Indirect Cost:\4290000 )

    researchmap

  • 次世代バイオものづくりを駆動する高度オミクス計測・解析基盤の開発

    2023.10 - 2026.3

    Awarding organization:科学技術振興機構

      More details

    Authorship:Coinvestigator(s) 

    本研究開発では、I. 新たな表現型解析に基づく標的選抜・自動培養システムの開発、II. 世界最高精度のハイスループットマルチオミクス計測技術の開発、III. 代謝マップ拡張のための未知代謝物の戦略的同定法の開発、IV. 多階層における相互作用ネットワークの解析手法の開発、の各項目の技術を高度化し、それらの技術を統合することで、「次世代 バイオものづくりを駆動する高度オミクス計測・解析基盤の創成」を目指す。
    大腸菌などの微生物をモデルとして様々な培養条件下で取得したマルチオミクスデータから遺伝子型と環境条件から 得られる微生物表現型を予測するモデルを構築し、実用微生物における有用物質生産系へと展開を図る。

    researchmap

  • in-situビオチン化プロテオミクスによるタンパク質状態の定量化技術の開発

    Grant number:22K19288

    2022.6 - 2024.3

    System name:科学研究費助成事業

    Research category:挑戦的研究(萌芽)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\6500000 ( Direct Cost: \5000000 、 Indirect Cost:\1500000 )

    researchmap

  • Cancer cell fate control by long-chain ncRNAs that regulate the gene specificity of epigenome factors

    Grant number:22H02901

    2022.4 - 2026.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

    researchmap

  • 高密度かつ機能的な定量プロテオミクスによる細胞老化の分子基盤の解明

    Grant number:22H02607

    2022.4 - 2025.3

    System name:科学研究費助成事業

    Research category:基盤研究(B)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\16900000 ( Direct Cost: \13000000 、 Indirect Cost:\3900000 )

    researchmap

  • Proteome analysis of periodontal ligament matrix and development of regenerative material

    Grant number:21H03127

    2021.4 - 2024.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

      More details

    Grant amount:\17420000 ( Direct Cost: \13400000 、 Indirect Cost:\4020000 )

    researchmap

  • 未開拓プロテオームの同定・定量技術の開発

    Grant number:20H05930

    2020.11 - 2025.3

    System name:科学研究費助成事業 学術変革領域研究(A)

    Research category:学術変革領域研究(A)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\145080000 ( Direct Cost: \111600000 、 Indirect Cost:\33480000 )

    近年、未知のオープンリーディングフレームの発見や非典型的な翻訳開始や終結などが多数見出されており、実際のプロテオームはより複雑でこれまでの常識の範囲の中では探出せないタンパク質を多数含んでいる可能性が高まっている。このような未知のプロテオームの探索には、核酸オミクス解析等で得られた情報を用いて質量分析データを解析する、いわゆるプロテオゲノミクスの利用が考えられる。本研究では、さまざまな先端技術を取り入れることで新たなプロテオゲノミクスの枠組みである『仮説駆動型プロテオゲノミクス解析基盤』を創出を目指す。
    R3年度は、超高出力定量プロテオーム解析システムの確立を行い、前年度に開発したデータベースや内部標準タンパク質作製法と統合して仮説駆動型プロテオゲノミクス解析基盤を構築した。具体的には、測定法としてData-independent acquisition (DIA)と呼ばれる手法を取り入れた。さらに、イオンモビリティーによる気相分画法を利用することで、より高深度の解析を可能とした。データ解析法としては既存のソフトウェアであるDIA-NNを用いたLibrary-free search法を利用した。しかし、DIAN-NNは内部標準を用いた定量に十分に対応していないことから、DIA-NNの結果を用いて内部標準ペプチドを含むデータを再解析する手法を開発し、独自に開発している定量解析環境であるiMPAQT-Quantに実装した。さらに、より微量なタンパク質の検出を可能とするため、内在性シグナルが検出できなかったペプチドに対して、内部標準トリガーで超高感度ターゲットプロテオミクを実施する手法であるSequentially Linked Mass spectrometry(SLiM)法を考案し、その解析ワークフローをiMPAQT-Quantに実装した。

    researchmap

  • 情報/仮説駆動型プロテオゲノミクス戦略の構築

    Grant number:20K21386

    2020.7 - 2022.3

    System name:科学研究費助成事業 挑戦的研究(萌芽)

    Research category:挑戦的研究(萌芽)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\6500000 ( Direct Cost: \5000000 、 Indirect Cost:\1500000 )

    近年、質量分析計の高性能化によって細胞が発現するプロテオームの概要が把握できるようになった。その一方で、各遺伝子とそれがコードするタンパク質の関係性は未だ不明瞭である。本研究では、われわれが独自に構築した大規模絶対定量プロテオーム解析技術iMPAQT法を発展させ、既存のプロテオゲノミクス研究戦略と正反対の「情報/仮説駆動型プロテオゲノミクス」を考案し、核酸情報とプロテオーム情報をつなぐことに成功した。具体的には、R2年度に開発したPeptide-centric ProteoGenomics DataBase (PcPG-DB)に、各種スプライシングバリアント、がんにおける変異などの配列を登録した。より網羅的なペプチド同定のために、近年盛んに行われているdata-independent acquisition (DIA) 法と取り入れるとともに、DIA法で検出できなかった超微量なペプチドをより高感度かつ精密に定量できる新たな手法であるSLIM法を確立し、本方法が実施可能な情報処理インフラを整備した。次に、150種類程度のがん細胞パネルを対象に情報/仮説駆動型プロテオゲノミクス解析を実施し、得られたデータをPcPG-DBから得た予想スペクトルライブラリーを用いて、スプライシングバリアント特異的あるいは疾患関連変異特異的ペプチドを探索した。同定されたペプチド情報は実測結果としてPcPG-DBに反映し、本情報から集連結体を設計し、安定同位体標識組換えタンパク質評品として調製した。これらの連結体を添加した試料を対象にSLIM法を用いて、スプライシング特異的およびがん特異的なペプチドの絶対定量に成功した。

    researchmap

  • 1細胞定量分子フェノタイプ解析に向けた微量試料自動前処理装置の開発

    Grant number:20349811

    2020 - 2022

    System name:戦略的な研究開発の推進 未来社会創造事業 探索加速型

    和泉 自泰

      More details

    近年の様々な技術革新に伴い、1細胞レベルでの核酸情報の取得が可能となってきているが、タンパク質や代謝物の1細胞解析は未だ発達初期段階である。申請者らはこれまで独自の要素技術を組みあわせた1細胞プロテオーム・メタボローム解析 (分子フェノタイプ解析) システムの開発を行ってきたが、従来システムにおいては「定量性」および「スループット」の観点で課題があった。そこで、本研究では上記の課題を解決するために、「1. 1細胞ピッキング装置を用いたマイクロチャンバーウェルプレート内での微量試料調製法の開発」 および 「2.超高感度ナノ液体クロマトグラフィータンデム質量分析(Nano-LC/MS/MS)システムへの微量試料自動導入法の開発」に取り組む。さらに、開発した解析システムを用いた応用研究を展開することで、当該システムの有用性・実用性を検証する。

    researchmap

  • 癌転移形質に寄与する核内非翻訳RNAの探索と抗体分子架橋による次世代核酸薬の創出

    Grant number:19H03517

    2019.4 - 2024.3

    System name:科学研究費助成事業 基盤研究(B)

    Research category:基盤研究(B)

    Awarding organization:日本学術振興会

    崔 林, 中野 賢二, 加藤 聖子, 松本 雅記, 小田 義直

      More details

    Grant amount:\17420000 ( Direct Cost: \13400000 、 Indirect Cost:\4020000 )

    本研究の目的の一つとして多種固形癌におけるSNORA23の転移形質における意義を明ら かにすることである。
    そこで、我々はまず、大腸癌(DLD-1, HT29)、胃癌(44AS, AGS)、肺癌(NCI-H460, NCI-H810)、胆道癌(Gbd15, TGBC2)及び卵巣癌(RMG1, ES-2)細胞にluciferase遺伝子を導入し、それぞれの細胞を同所移植したが、肝転移を認められなかった。そこで、各細胞を脾臓に移植し、 卵巣癌(RMG1, ES2)、胆道癌(Gbd15)、胃癌(44AS)、肺癌(NCI-H460)の肝転移を認め、それらを3サイクル肝転移させることで高転移株(HMC)を作製した。親株とHMCにおいてSNORA23の発現解析を行った結果、RMG1以外の四つの細胞においてSNORA23の有意な発現上昇を確認した。また、in vitro実験においてHMCは親株に比べて浸潤能は明らかに増強され、SNORA23をノックダウンすることによって浸潤能も低下することを明らかにした。
    膵癌の研究ではSNORA23の下流因子としてSYNE2を同定したが、今回の実験において、HMCは親株に比べてSYNE2の変化は認められなかった。これは癌種が違うことによってSNORA23の下流因子が変わる可能性を示し、今後マイクロアレイ解析或いはプロテオミクス解析によって各臓器におけるSNORA 23の下流因子を同定する。
    また、我々は大腸癌、胃癌、肺癌、胆道癌及卵巣癌のフォルマリン切片から癌部位と正常部位からRNAを抽出してSNORA23の発現解析を行う実験を現在進行中である。

    researchmap

  • 高出力絶対定量法の開発によるシグナル伝達経路定量マップの構築

    Grant number:19H04969

    2019.4 - 2021.3

    System name:科学研究費助成事業 新学術領域研究(研究領域提案型)

    Research category:新学術領域研究(研究領域提案型)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\10140000 ( Direct Cost: \7800000 、 Indirect Cost:\2340000 )

    本研究では我々が独自に開発したタンパク質精密絶対定量プラットフォームであるiMPAQT法が有するいくつかの技術的限界を完全に克服するための技術開発を行い、様々な細胞システムにおける広範なシグナル伝達経路の全体構造を定量的に記述する手法の確立を試みる。さらに、確立された新しい技術基盤によってシグナル伝達経路の定量的構造を明らかにし、これまでに構築してきたシグナル伝達ダイナミクス計測技術と併用することで、シグナル伝達の特異性や多様性を生み出す動作原理の解明を最終的な目的としている。H31年度は以下の二つの項目に関して技術開発を行った。
    1.高度多重化連結体タンパク質の構築:
    現行iMPAQTを更に利便性や信頼性を向上させる目的で、a) iMPAQTデータベースから超高感度なプローブペプチドだけで構成される連結体をデザインをアシストするデータベースおよびツールの開発を行った。さらに、超多重化のためのペプチドバーコードタグの構築を行い、100種類の連結体の一斉定量が可能になった。また、リジン・アルギニン要求大腸菌株を作製し、利用することで99.7%同位体標識率を達成できた。
    2.Sequentially Linked Mass-spectrometry (SLiM) 法の確立:
    高スループットなHyper Reaction Monitoring(HRM)と超高感度なMultiple Reaction Monitoring (MRM) 法を連動させて計測するSequentially Linked Mass spectrometry (SLiM) 法を可能とするソフトウェアの開発を行った。HRM法をより高感度に行うための手法として、気相分画法を取り入れ、これで得られたデータを容易に解析できるツールも開発した。

    researchmap

  • 1配偶子定量プロテオミクスによる配偶子インテグリティ評価マーカー探索

    Grant number:19H05243

    2019.4 - 2021.3

    System name:科学研究費助成事業 新学術領域研究(研究領域提案型)

    Research category:新学術領域研究(研究領域提案型)

    Awarding organization:日本学術振興会

    松本 雅記

      More details

    Grant amount:\13260000 ( Direct Cost: \10200000 、 Indirect Cost:\3060000 )

    近年、iPS細胞など全能性幹細胞からのin vitroでの配偶子形成が実現され、基礎医学・生物学領域のみならず医療応用の分野にまで極めて大きなインパクトを与えている。その一方で、得られた配偶子が正しく機能できるか否か、すなわち配偶子インテグリティーの評価には実際の発生の成否を調べるしかない。したがって、配偶子インテグリティーを事前に判断できるマーカー開発が切望されている。そのためには、1細胞単位でのタンパク質発現プロファイリングの開発が必要である。本研究では、われわれが独自に開発してきた革新的なタンパク質絶対定量法iMPAQT法をマウス卵子の1細胞プロテオームに適用し、配偶子インテグリティーの実体をタンパク質レベルで解き明かすことを目指す。本目的達成のため、H31年度は以下の3つの開発を実施した。
    1)マウス対応iMPAQTデータベースの構築:マウスヒト卵子およびその初期発生過程から得られた試料を対象にdata-dependent acquisitionによるショットガンプロテオミクスを行い、マウス卵子のプロテオーム情報を取得し、これを格納したデータベースを開発した。現時点では深度(網羅性)がまだ不足しているため、再度解析を行う計画であるが、研究代表者の異動に伴い、装置の使用が一時的にできない状況が続いているため、次年度に持ち越して行う。
    2)多重連結体による安定同位体標識プローブの大規模作製: 個々の連結体を識別できるペプチドバーコードの開発と、それを組み込んだベクターの作製を完了した。また、上記マウス卵子プロテオーム情報が十分に得られた時点で、連結体の大規模なデザインを開始する。
    3)1卵子プロテオーム計測技術の開発:卵子1細胞等の超微量試料を対象としたプロテオミクス試料調製法の確立を行い、超高感度でプロテオーム解析を可能とする分析プラットフォームの構築に成功した。

    researchmap

  • プロテオームデータベースの機能深化と連携基盤強化

    2018.4 - 2023.3

    System name:統合化推進プログラム

    Awarding organization:JST

    石濱泰

      More details

    Grant type:Competitive

    researchmap

  • The build-up study on the functionality of medicinal mushroom Ganoderma lingzhi based on Japanese genomic editing technology

    Grant number:17H03845

    2017.4 - 2020.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    shimizu kuniyoshi

      More details

    Grant amount:\16510000 ( Direct Cost: \12700000 、 Indirect Cost:\3810000 )

    Reishi (Ganoderma lingzhi) is reported to contain hundreds of kinds of triterpenoids, but due to the enormous variety, each component is necessarily very limited amount. Therefore, in order to improve the production of G. lingzhi triterpenoids by genome editing, we attempted a comprehensive analysis method of triterpenoids derived from G. lingzhi and quantification using LC-MS/MS (MRM: multiple reaction monitoring). The G. lingzhi triterpenoids analytical method was successfully established. In addition, by measuring the α-glucosidase inhibitory activity at each growth stage of G. lingzhi, it was found that the activity changed depending on the growth stage and that the fruiting body was not maximally active. This suggests that mature fruiting bodies are not always necessary when considering the functionality of G. lingzhi.

    researchmap

  • 精密定量プロテオミクスを用いたシグナル伝達の包括的解析

    2017.4 - 2019.3

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • トランスオミクス解析による低酸素応答のシステム的理解

    2017.4 - 2019.3

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 次世代定量プロテオミクスによるがん悪性進展機構の解明

    2017.4 - 2019.3

    System name:挑戦的研究(萌芽)

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • シングルセル・プロテオミクスによるがん幹細胞特性解明

    2016.4 - 2019.3

    System name:基盤研究(B)

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Analysis of the mechanism of HSF1 transcription complex by evolutional approach

    Grant number:16K08625

    2016.4 - 2019.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    TAKII Ryosuke, FUJIMOTO Mitsuaki, NAKAI Akira, MATSUMOTO Masaki

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    To identify the mechanism of HSF1 transcription, we used evolutionary approach. From this results, we identified that two amino acids of HSF1 are necessary to induce HSP70 during heat shock. These two amino acids are conserved form lizard to mammalian HSF1. Finally we identified Factor A by using DNA pulldown assay. Factor A is able to promote HSP70 induction and related cell division.

    researchmap

  • Elucidating the metabolic enzymes network in hypoxic cells using next-generation proteomics

    Grant number:16K14612

    2016.4 - 2017.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research

    Research category:Grant-in-Aid for Challenging Exploratory Research

    Awarding organization:Japan Society for the Promotion of Science

    Oshikawa Kiyotaka, NAKAYAMA Keiichi, Matsumoto Masaki

      More details

    Grant amount:\3770000 ( Direct Cost: \2900000 、 Indirect Cost:\870000 )

    The metabolic network is specific changed in hypoxia conditions, but the precise expression pattern is poorly understood. By comparing hypoxic to normoxic metabolic enzyme levels in various cells, we established four cell lines (normal, cancer, senescent, and G0 cells) from normal diploid fibroblast (TIG-3). To quantify the metabolic enzyme levels (~1,000 enzymes) of hypoxic and normoxic conditions in four cell lines, we performed the in vitro proteome assisted MRM for protein absolute quantification (iMRM). We identified specific metabolic enzymes which were significantly changed in hypoxic conditions.

    researchmap

  • 細胞チップMSシステムを用いた1細胞マルチ分子フェノタイピング

    2015.10 - 2020.4

    System name:戦略的創造研究推進事業-CREST

    Awarding organization:JST

    馬場 健史

      More details

    Grant type:Competitive

    researchmap

  • Elucidation of insulin signal transduction mechanism with mathematical analysis of network dynamics

    Grant number:15KT0108

    2015.7 - 2018.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Matsuzaki Fumiko, MATSUMOTO Masaki

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    In this project, we focused on insulin signal transduction to see this phenomenon and its dynamic characteristics as completely as we could. Phosphoproteomics of time series liver samples taken during a four-hour period after insulin treatment was performed and the data were analyzed using statistical, infomatics and mathematical approaches. As a result, the dynamics of an insulin signaling transduction network with around 10,000 nodes representing protein phosphorylation, and its relation to various biological function were revealed. Furthermore, ordinary differential equation models among insulin, insulin signaling molecules and other protein phosphorylation were built on a large scale and the dynamics of the entire insulin signaling transduction network were characterized quantitatively.

    researchmap

  • プロテオーム統合データベースの構築

    2015.4 - 2018.3

    System name:統合化推進プログラム

    Awarding organization:JST

    石濱泰

      More details

    Grant type:Competitive

    researchmap

  • Screening of essential ICB associate factors for spermatogenesis to understand male infertility

    Grant number:15K21217

    2015.4 - 2018.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)

    Research category:Grant-in-Aid for Young Scientists (B)

    Awarding organization:Japan Society for the Promotion of Science

    Iwamori Tokuko, Kato Yuzuru, Iwamori Naoki, Matsumoto Masaki

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Deletion of intercellular bridge (ICB), which connects all germ cells, caused male infertility. But the function of ICB still remains unknown. To understand the significance of ICB in spermatogenesis, its associating factors were identified and the interactions among each identified protein were comprehensively profiled. Specific antibodies to selected target proteins were developed and used to analyze their localization in testis. As a result, a novel Ectoplasmic Specialization (EPS) associating protein, KIAA1210, was identified. The knockout mouse of KIAA1210 was successfully produced and is under analyses. The results from analyses of KIAA1210 deficient mice will bring deep understandings of interactions between ICB and the other cell junction in spermatogenesis.

    researchmap

  • 水酸化プロテオーム解析を基軸とした酸素応答システムの統合的理解

    2015.4 - 2017.3

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 多階層オミクス動態解析に基づく代謝制御システム解明

    2014.4 - 2016.3

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Molecular mechanisms of crosstalk between DNA-damage response and signal transduction

    Grant number:25290044

    2013.4 - 2017.3

    System name:Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    Kitagawa Masatoshi, NIIDA Hiroyuki

      More details

    Grant amount:\17030000 ( Direct Cost: \13100000 、 Indirect Cost:\3930000 )

    We found that Mig-6, an internal inhibitor of EGFR,is phosphorylated accompanied by EGF stimulation but also UV-irradiation. The results suggest that there is a crosstalk between EGF-signaling and DNA-damage response. Next, we found that HBO1,a histone acetyltransferase, phosphorylated Ser50/Ser53 of HBO1 by ATR after UV irradiation. HBO1 is ubiquitylated by CUL4-DDB1/DDB2 and degraded 6h after UV-irradiation. Moreover, we found that HBO1 participated in nucleotide excision repair(NAR). UV-DNA-damege induced phosphorylation of HBO1 promoted acetylation of histone H3 to induce structural change of chromatin in the damaged sites. These results suggested that the HBO1-mediated chromatin conformational change promoted recruitment of NER-related factors to enhanced the NER.

    researchmap

  • 多次元プロテオミクスによる細胞内パスウェイ構造決定法の確立

    2013.4 - 2016.3

    System name:基盤研究(B)

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 次世代定量プロテオミクスによる発癌ネットワーク同定

    2013.4 - 2015.3

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • トランスオミクス解析によるシグナル伝達ー代謝ー転写制御間の接点解明

    2012.3 - 2014.4

    System name:新学術領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Quantitative phosphoproteomics analysis of the TORC1 signaling

    Grant number:23570225

    2011 - 2013

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    USHIMARU Takashi, MATSUMOTO Masaki

      More details

    Grant amount:\5460000 ( Direct Cost: \4200000 、 Indirect Cost:\1260000 )

    Cells control cell growth and proliferation in response to nutrients. The target of rapamycin complex 1 (TORC1) protein kinase is the center of this nutrition-responsible system and regulates various cellular events in response to nutrition. However, the full view of downstream events is largely unknown. We have previously shown that when cells were treated with the specific TORC1 inhibitor rapamycin, a huge number of proteins were degraded, suggesting that TORC1 mediates protein degradation via phosphorylation. It is very important to disclose of which proteins phosphorylation is changed by TORC1 inactivation. Here we performed quantitative phosphoproeomics analysis to dissect this issue. We found that phosphorylation of a lot of proteins were increased or decreased after rapamycin treatment.

    researchmap

  • 情報基盤定量プロテオミクスによるヒトプロテオームの絶対定量

    2010.4 - 2012.3

    System name:若手研究(B)

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Novel functions and regulatory mechanisms of tumor suppressor Mig-6

    Grant number:22300329

    2010 - 2012

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    KITAGAWA Masatoshi, MATSUMOTO Masaki

      More details

    Grant amount:\17160000 ( Direct Cost: \13200000 、 Indirect Cost:\3960000 )

    Mig-6 acts as an inhibitor of EGF signaling via binding with the EGF receptor (EGFR). Downregulated expression of the Mig-6 gene is observed in breast carcinomas, in which it correlates with reduced overall survival. Mig-6-deficient mice show hyperactivation of endogenous EGFR and develop spontaneous tumors in various organs. Therefore, Mig-6 is an important tumor suppressor. However, its post-translational modifications and regulatory mechanisms have not been elucidated. Here, we investigated the phosphorylation of human Mig-6 and found that Chk1 phosphorylated Mig-6 in vivo as well as in vitro. Moreover, EGF stimulation promoted phosphorylation of Mig-6 without DNA damage and the phosphorylation was inhibited by depletion of Chk1. EGF also increased Ser280-phosphorylated Chk1, a cytoplasmic-tethering form, via PI3K pathway. Mass spectrometric analyses suggested that Ser 251 of Mig-6 was a major phosphorylation site by Chk1 in vitro and in vivo. Substitution of Ser 251 to alanine increased inhibitory activity of Mig-6 against EGFR activation. Moreover, EGF-dependent activation of EGFR and cell growth were inhibited by Chk1-depletion, and were rescued by co-depletion of Mig-6. Our results suggest that Chk1 phosphorylates Mig-6 on Ser 251, resulting in the inhibition of Mig-6, and that Chk1 acts a positive regulator of EGF signaling. This is a novel function of Chk1.

    researchmap

  • 高感度定量プロテオミクスを用いたユビキチンリガーゼ基質探索

    2009.4 - 2011.3

    System name:特定領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 大規模リン酸化プロテオーム解析による細胞周期制御機構の解明

    2008.4 - 2010.3

    System name:特定領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Duplin/CHD8によるp53の機能抑制と発がんに関する研究

    Grant number:20012040

    2008 - 2009

    System name:科学研究費助成事業

    Research category:特定領域研究

    Awarding organization:日本学術振興会

    西山 正章, 白根 道子, 松本 雅記, 束田 裕一

      More details

    Grant amount:\12800000 ( Direct Cost: \12800000 )

    高等真核生物の初期発生における細胞周期の高速回転時において、DNA複製チェックポイントの中心分子であるp53の存在は危険である。つまり正常発生時に容易にDNA複製チェックポイントが活性化され、結果としてp53依存性アポトーシスが誘導される危険を伴う。それ故、初期発生においてはp53を不活化し、有害なアポトーシスを抑制する機構が存在するはずである。p53機能の制御については転写レベルや翻訳後修飾などの観点から研究が進んできたが、そのエピジェネティック制御については今までよく分かっていなかった。
    われわれはプロテオミクス解析により、クロマチンリモデリング因子Duplin/CHD8がp53に結合することを見出した。さらにCHD8はピストンH1とも結合し、p53/CHD8/ピストンH1三量体がDNA上に形成されることが明らかとなった。つまりCHD8が存在するとp53にヒストンH1がリクルートされ、クロマチン構造が変化してp53の転写活性化能は失われる。
    CHD8は発生初期に高発現し、成長に伴ってその発現は急速に低下するので、発生初期に重要な役割を果たしていることが示唆された。CHD8のノックアウトマウスは発生早期にアポトーシスの異常な亢進によりマウス胚が死亡する。このときp53も同時に欠損させるとこのアポトーシスは回避され、マウスは延命した。これらの遺伝学的証拠はCHD8が発生初期におけるp53の強力かつ生理的な抑制因子であることを示している。
    これらの結果より、初期発生においてCHD8はクロマチン上に結合しているp53すらも抑制できる強力な「抗p53最終機構」として、p53の暴走を防ぐことにより正常な発生を保証していると考えられた。

    researchmap

  • Network analysis of signal transduction by quantitative phosphoproteomics

    Grant number:20710168

    2008 - 2009

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Young Scientists (B)

    Awarding organization:Japan Society for the Promotion of Science

    MATSUMOTO Masaki

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    It is well known that cells expresses various responses to extracellular stimuli, but these mechanisms in which distinct stimuli induces specific response remained poorly understood. To resolve this essential issue concerning signal transduction, I established the system for large scale identification and quantification of protein phosphorylations. Using this system, I obtained quantitative time-resolved information about more than 25,000 phosphorylation sites from several cell lines which were treated with various stimulants.

    researchmap

  • ユビキチン化関連酵素E4Bによる神経変性防御機構の解明

    2007.4 - 2009.3

    System name:特定領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 神経変性疾患における膜輸送システムの関与の解析

    Grant number:19300129

    2007 - 2008

    System name:科学研究費助成事業

    Research category:基盤研究(B)

    Awarding organization:日本学術振興会

    白根 道子, 中山 敬一, 松本 雅記, 束田 裕一

      More details

    Grant amount:\19240000 ( Direct Cost: \14800000 、 Indirect Cost:\4440000 )

    本研究では、神経細胞分化・機能維持の分子機構と、神経管形成の分子機構との関連を、protrudinによる膜輸送制御の観点から解明すること、また、膜輸送の、遺伝性痙性対麻痺などの神経変性疾患の発症への関与を解明することを目的としている。
    (1)Protrudinノックノワトマワスを用いた、遺伝性痙性対麻痺の発征のメカニスムの解析
    (1)Protrudinノックアウトマウスを作製する。protrudinノックアウトマウスにおける、Rabや膜輸送の異常の有無や神経分化・神経管形成についての観察、遺伝性痙性対麻痺様あ下肢部の異常についての観察を行った。
    (2)神経細胞におけるprotrudin・タンパク質複合体の解析
    (3)神経細胞内のprotrudin複合体を免疫沈降法により集め、精製し、質量分析により複合体の構成タンパク質を同定した。それらの遺伝子をクローニングし、神経細胞内における遺伝子ノックダウンや、リコンビナントタンパク質の作製・複合体の再構成などを行った。
    (3)FKBP38ノックアウトマウスを用いた、神経管形成のメカニズムの解析
    (5)FKBP38のタンパク質分解制御への関与が示唆されている結果をふまえ、2D-DIGE法によりFKBP38ノックアウトマウスにおいて、野生型マウスと比較して発現変化しているタンパク質を解析した。
    (6)FKBP38ノックアウトマウスにおける膜輸送の異常を調べる。FKBP38ノックアウトマウスの神経細胞における、protrudinやRabの細胞内局在、タンパク質修飾、活性などの異常について調べ、FKBP38がprotrudinまたはその複合体にどのような直接的な働きをしているのか検討した。

    researchmap

  • リン酸化ペプチドの網羅的解析のための新技術開発

    2006.4 - 2008.3

    System name:特定領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 異常タンパク質蓄積による神経変性疾患発症の分子機構の解明

    2006.4 - 2008.3

    System name:特定領域研究

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 神経管形成における多機能シャペロンFKBP38の機能解析

    Grant number:18022030

    2006 - 2007

    System name:科学研究費助成事業

    Research category:特定領域研究

    Awarding organization:日本学術振興会

    白根 道子, 中山 敬一, 松本 雅記

      More details

    Grant amount:\8400000 ( Direct Cost: \8400000 )

    (1)FKBP38ノックアウトマウスの形態異常・神経細胞異常の詳細な観察
    FKBP38ノックアウトマウスの脳や脊髄において、神経細胞突起の異常な伸長が認められた。FKBP38ノックアウトマウスの中枢神経系において、異常のある神経細胞の種類、分化段階、領域を特定した。
    (2)FKBP38ノックアウトマウスにおける膜輸送関連分子の解析
    発生期の神経管形成に膜輸送制御分子であるRabの異常が関係することが知られている。そこで、FKBP38ノックアウトマウスにおけるRabの発現パターン、Rabタンパク質量の変化などを解析する。さらに、Rabタンパク質のユビキチン化、プロテアソーム依存的分解について解析した。
    (3)ProtrudinとRabとの関係の解析
    FKBP38とprotrudinによる膜輸送制御の作用機構を検討する。Protrudinドメイン解析などを行い、Rabとの機能的関連、リン脂質との機能的関連、Rabタンパク質のプロテアソーム依存的分解などについて検討した。さらに、膜輸送との関係について検討した。
    (4)Protrudinノックアウトマウス作製とFKBP38及び膜輸送への関与の解析
    Protrudmノックアウトマウスを作製し、神経管形成、FKBP38やRabや膜輸送について解析した。

    researchmap

  • p53シグナルを抑制する新規がん遺伝子Duplinの発見と機能解析

    Grant number:18012038

    2006 - 2007

    System name:科学研究費助成事業

    Research category:特定領域研究

    Awarding organization:日本学術振興会

    西山 正章, 白根 道子, 松本 雅記

      More details

    Grant amount:\10900000 ( Direct Cost: \10900000 )

    p53は細胞周期停止やアポトーシスを誘導する転写因子であると岡時に、最も有名な癌抑制遺伝子産物の一つである。p53機能の制御は転写レベルや翻訳後修飾などの観点から研究が進んできたが、申請者は最近p53機能に対するエピジェネティックな制御機構を発見した(投稿中)。クロマチンリモデリング因子CHD(Chromo-Helicase-DNA binding domain protein)は修飾されたヒストンに結合し、ATP依存的なヌクレオソーム形成や移動を行うと考えられている分子ファミリーである。CHDは種を超えて保存されており、ヒトではCHD 1〜9の9つのメンバーが存在するが、その機能はまだ不明の点が多い。申請者らはその中の一つCHD8/Duplinについてノックアウトマウスを作製したところ、胎生早期にアポトーシスの異常な亢進によりマウス胚が死亡することを発見した[Nishiyama M, et. al., Mol. Cell. Biol.(2004)]。そこでCHD8の欠損がなぜアポトーシスを引き起こすかという分子機序を解明する過程で、申請者は、CHD8がヒストンH1をリクルートすることによってクロマチン構造の変化を起こし、p53の転写活性を抑制することを見出した。
    さらにp53/CHD8ダブルノックアウトマウスでは、胎生早期におけるアポトーシスが回避され、マウスは延命した。これらの遺伝学的証拠はCHD8がp53の強力かつ生理的な抑制因子であることを示している。つまりCHD8はp53の暴走を防ぐ制御因子であり、その閾値を設定しているものと考えられた。

    researchmap

  • ProtrudinによるRabおよび膜輸送の制御機構の解析

    Grant number:18050027

    2006 - 2007

    System name:科学研究費助成事業

    Research category:特定領域研究

    Awarding organization:日本学術振興会

    白根 道子, 中山 敬一, 松本 雅記

      More details

    Grant amount:\6000000 ( Direct Cost: \6000000 )

    (1)FKBP38ノックアウトマウスにおける異常およびRabの関与の解析
    FKBP38とRabとの機能的連関を解析する。FKBP38ノックアウトマウスにおけるRabの発現パターンを解析した。また、FKBP38ノックアウトマウス細胞抽出液を用いて、Rab23活性を測定する。FKBP38ノックアウト細胞を用いて、細胞内膜輸送について検討した。
    (2)ProtrudinとRabおよび膜輸送との機能的連関の解析
    Rabとprohudinとの機能的連関を解析する。Protrudinはマルチドメインタンパク質であるが、変異protrudinを作製し、ドメイン機能解析を行う。また、変異protrudinのRab結合能、Rab制御能、細胞内局在、膜輸送、神経突起形成能などに関して解析した。
    (3)ProtrudinノックアウトマウスにおけるRab活性、膜輸送、神経突起伸長の解析
    マウス個体におけるRab制御と神経突起形成との関係を解析するために、protrudinノックアウトマウスを作製し、Rabllや他のRabについて発現パターンの変化を解析した。また、protrudinノックアウトマウス細胞抽出液を用いて、Rab活性を測定した。また、各種神経突起マーカーを用いて神経突起形成に関して詳細に観察した。Protrudinノックアウト細胞を用いて、細胞内膜輸送に異常がないか検討した。Protrudinノックアウトマウスで神経管形成に異常がないか解析した。

    researchmap

  • ユビキチンリガーゼCdc4/Fbw7変異にともなう組織特異的細胞増殖機構の解明

    Grant number:18013005

    2006 - 2007

    System name:科学研究費助成事業

    Research category:特定領域研究

    Awarding organization:日本学術振興会

    中山 啓子, 松本 雅記

      More details

    Grant amount:\14600000 ( Direct Cost: \14600000 )

    ユビキチンリガーゼCdc4/Fbw7は、Notch、サイクリンE、c-Mycなど細胞増殖を促進する分子をユビキチン化するリガーゼであることが、試験管内の研究で明らかとなっている。また、様々ながんでCdc4/Fbw7の変異が報告されがん抑制遺伝子であると考えられる。すなわちCdc4/Fbw7の機能不全によりその基質分子が異常に蓄積し、そのために異常な細胞増殖、がん化を引き起こしていると考えられる。
    そこでわれわれは、Cdc4/Fbw7のコンディショナルノックアウトマウスを作製し、Cdc4/Fbw7の生物学的な機能、特に発がんに対する関与を調べた。
    まず、胎仔線維芽細胞でCdc4/Fbw7遺伝子を欠失させた。すると予想に反して細胞の増殖が著しく抑制された。これは、細胞周期のG1期での停止とアポトーシスの増加によるものであった。その際に、タンパク質の発現量を調べてみると、Cdc4/Fbw7の基質と報告されているもののうち、Notch-1が異常な蓄積を示すものの、サイクリンEやc-Mycの蓄積は認められなかった。そこで、Notch-1が転写因子として機能する際の共役因子であるRBP-jとのダブルノックアウトを作製しNotch-1の過剰な機能発現をキャンセルすることを試みた。すると、Cdc4/Fbw7シングルノックアウトで観察された増殖抑制は解除された。このことから、Cdc4/Fbw7は胎仔線維芽細胞においては、Nocthのシグナル量を制御することによって適切な増殖能力を維持していること考えられた。

    researchmap

  • タンパク質翻訳後修飾の網羅的解析に関する研究

    2006

      More details

    Grant type:Competitive

    researchmap

  • 発癌に関与するユビキチンリガーゼBRCA1の機能解析

    2001.4 - 2003.3

    System name:特別研究員奨励費

    松本 雅記

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • ユビキチン-プロテアソーム系によるタンパク質分解に関する研究

      More details

    Grant type:Competitive

    researchmap

  • Study on Ubiquitin-proteasome dependent proteolotic system

      More details

    Grant type:Competitive

    researchmap

▶ display all

 

Teaching Experience

  • 分子細胞医科学

    2024
    Institution name:新潟大学

  • 医学序説 I

    2022
    -
    2023
    Institution name:新潟大学

  • 医学論文を読む(ジャーナルクラブ)A

    2021
    -
    2023
    Institution name:新潟大学

  • 医学序説 II

    2021
    Institution name:新潟大学

  • 分子生物学

    2020
    Institution name:新潟大学

  • 生体内物質と代謝

    2020
    Institution name:新潟大学

  • 医学序説 I

    2020
    -
    2023
    Institution name:新潟大学

▶ display all

 

Academic Activities

  • 日本プロテオーム学会会長

    Role(s): Planning, management, etc.

    2024.1

     More details

    Type:Academic society, research group, etc. 

    researchmap

  • 日本プロテオーム学会理事

    Role(s): Planning, management, etc.

    2015.1 - 2020.12

     More details

    Type:Academic society, research group, etc. 

    researchmap